Volume 28, issue 2 by Canadian Medical Association
Western University
Scholarship@Western
Canadian Journal of Surgery
3-1-1985
Volume 28, issue 2
Canadian Medical Association
Follow this and additional works at: https://ir.lib.uwo.ca/cjs
Part of the Surgery Commons
This Book is brought to you for free and open access by Scholarship@Western. It has been accepted for inclusion in Canadian Journal of Surgery by an
authorized administrator of Scholarship@Western. For more information, please contact tadam@uwo.ca, wlswadmin@uwo.ca.
Recommended Citation
Canadian Medical Association, "Volume 28, issue 2" (1985). Canadian Journal of Surgery. 165.
https://ir.lib.uwo.ca/cjs/165
QUILL ON SCALPEL
This section provides a medium through which Canadian 
surgeons can declare themselves, briefly and informally, on 
the day-to-day affairs of surgery.
Undergraduate Education in Surgery: a Challenge
The days are gone when a Blimey Austin, 
a Botterell or a Gallie taught the whole 
undergraduate course in surgery. Increas­
ing specialization has killed the concept 
of the “ general” surgeon, who had an 
overview of all aspects of surgical disease 
and could teach these to the undergradu­
ate medical student. Paralleling this 
specialization has been the development 
of postgraduate residency training pro­
grams. They have changed the focus of 
teaching in university departments of sur­
gery from the undergraduate to the post­
graduate level, with a consequent de­
emphasis of undergraduate teaching. The 
fact that teaching medical students often 
interferes with operating schedules, office 
hours or laboratory commitments, which 
postgraduate teaching seldom does, is a 
strong disincentive for this type of edu­
cation.
The challenge that faces departments 
of surgery across the country is how to 
get “ surgeon-teachers” back into the 
undergraduate education process. If this 
does not occur, surgeons will confirm 
themselves in the eyes of those from other
disciplines as being interested only in the 
technical aspects of surgical care; the 
opportunities to mould young minds and 
later to attract high-quality individuals 
into surgery will thus be lost. We must 
also recognize that the primary function 
of a university medical school is to teach 
undergraduate students and the tendency 
for the postgraduate tail to wag the 
undergraduate dog must be resisted. The 
advent of systems teaching and the 
revamping of undergraduate medical cur­
ricula have all provided opportunities for 
surgeons to delegate undergraduate edu­
cation to others, with the effect that the 
level of visibility of the department of sur­
gery, in the educational sense, is now 
extremely low in many centres.
How can the department of surgery 
respond to this challenge? Initially, it is 
the ultimate responsibility of each depart­
ment chairman to guarantee to the dean 
of his school that the department will 
place equal emphasis on undergraduate 
education, postgraduate education and 
research when determining its goals and 
objectives. If the department chairman
devalues undergraduate education, the 
staff will certainly not see it as a priority. 
Having made the commitment, the chair­
man must then follow through by recog­
nizing the importance and quality of the 
undergraduate education performed by 
individuals in his department. While this 
may take the form of financial reward, 
promotion to a higher academic level, 
nomination for a prize for teaching excel­
lence or increased administrative respon­
sibility and authority, probably the 
greatest contribution a department chair­
man can make is to provide an organiza­
tional structure that facilitates the whole 
process of undergraduate teaching. In a 
recent survey conducted by the Associa­
tion of Surgical Education, less than half 
of the North American departments of 
surgery were found to have an under­
graduate education office or a secretary 
assigned primarily to that end. Just over 
half had a departmental committee 
responsible for undergraduate surgical 
education, but two thirds had access to 
a centralized medical education office for 
consultation regarding undergraduate
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teaching. Only 15% had a professional 
educator on staff. The issue of teaching 
incentives was also the subject of a panel 
discussion at the 1984 meeting of the 
Association of American Medical Col­
leges. It was clear at that discussion that 
departments of surgery in the United 
States were not considered as major par­
ticipants in the undergraduate teaching 
process. Some of our Canadian medical 
schools may be similarly perceived, so it 
is essential that further erosion of the sur­
geon’s role in undergraduate teaching 
must be resisted at all costs and this incor­
rect perception be changed.
The most effective way to do this is by 
improving the organization of the depart­
ment of surgery as it relates to under­
graduate education. A departmental 
officer for undergraduate education 
should be established with a secretary for 
the director of undergraduate education. 
The director should be a senior, full-time 
surgeon, preferrably with additional post­
graduate training in education, who is as 
committed to undergraduate education as 
some of his peers are to research. The 
appointment of a professional educator, 
who should be cross-appointed to the 
appropriate university or faculty educa­
tional body, will also add to the profes­
sionalism that must accompany excellence 
in education. Such an individual will be 
able to help with the evaluation of 
teachers, the outcomes of undergraduate 
education and course assessment. These
moves will undoubtedly raise the level of 
visibility of the department of surgery at 
a crucial time when it is on the decline. 
If we do not get surgeons back into the 
undergraduate educational process, we 
may at worst forfeit our right to be part 
of a university and at best will deny stu­
dents the opportunity to be exposed to the 
excellence in teaching and problem solv­
ing that many surgeons now demonstrate. 
Departments of surgery — go to it!
J.L. P rovan, mb, ms, frcs, frcsc, FACS
Director of Undergraduate Education, 
Department of Surgery,
University of Toronto,
Toronto, Ont.
M4Y 1J3
The Benefits of War — to Surgery
Ares, the Greek god of war, still wields 
his influence over mankind. It may be 
said with cynicism that Ares has benefited 
only the manufacturers of arms and the 
discipline of surgery. In this issue (pages 
183 to 186), Dr. Campbell Derby gives 
due credit to the military surgeon, who 
treats friend and foe and uses the expe­
rience to benefit all.
In war, men die because of wounds or 
disease, or both. In the Iliad, Homer 
described 147 wounded soldiers whose 
death rate was 77%; that is, 3 dead for 
every 1 who survived. This high mortal­
ity remained remarkably constant until 
the beginning of the 20th century; as 
Derby points out, in the latest wars five 
survived for every six wounded. But dis­
ease was an even bigger threat and, until 
World War II, more soldiers died of dis­
ease than of wounds.
Gunpowder was introduced into war­
fare in the 1300s, and wounds result­
ing from its use were considered poi­
soned, requiring cauterization with boil­
ing oil or the red-hot iron. In 1536, 
Ambroise Pare accidentally rediscovered 
the gentle management of wounds when 
he ran out of boiling oil. As significant 
an observation was that of John Hunter, 
in the Belle Isle campaign in the 1700s, 
who noted the advantages of delayed 
closure of war wounds. He found that the 
body can cope with an open wound but 
not with an abscess. Delayed primary 
closure has had to be rediscovered with 
every successive war — including the 
Falklands campaign.
Napoleon’s remarkable surgeon, Lar- 
rey, developed “ flying ambulantes” to
evacuate the wounded from battlefields. 
Until his time, wounded were left to the 
care of fellow wounded and had to make 
their own way to the rear. Larrey also 
practised emergency operation in the 
field, and at the Battle of Borodino per­
formed 200 amputations in 24 hours. He 
earned the gratitude of the soldiers and 
his emperor.
Forty years later, in the Crimean War, 
cold, filth and disease took its dreadful 
toll. This war taught the world the value 
of nursing care, through the influence and 
organizational talents of Florence Night­
ingale. Ironically, she never accepted the 
germ theory of disease. Two men, Dr. 
Sutherland in public health and a Mr. 
Rawlinson who was a civil engineer, 
ensured working drains and clean water 
in the Barracks Hospital of Scutari. This 
reduced the mortality in 1 month from 
40% to 2% — and Miss Nightingale 
received the credit!
In two conflicts at the beginning of this 
century — the Boer War in South Africa 
and the Russo-Japanese War — penetra­
ting abdominal injuries were treated con­
servatively (by order), until Vera 
Gedroitz, a Russian princess turned sur­
geon, used Larrey’s principles of urgent 
operation in an ambulance train.
In World War I, wound infection and 
gangrene in the trenches dominated the 
picture. Alexis Carrel and Henry Dakin 
developed hypochlorite wound irrigation, 
but then a young surgeon-bacteriologist, 
Alexander Fleming, also studied the 
problem and boldly stated that antisep­
tics did more harm than good. In 1929, 
he noted the effect of an accidental
growth of Penicillium on a culture of 
Staphylococcus aureus. At the beginning 
of World War II, Florey and Chain 
searched for an anti-infective agent and 
in literature research came across Flem­
ing’s article, developed penicillin and 
introduced antibiotics — one of the 
greatest boons to mankind.
The first blood bank in war was made 
possible by the energy and organization 
of the Montreal surgeon Norman Bethune, 
during the Spanish Civil War. This 
achievement led to the extensive use of 
blood in World War II and greatly 
increased the scope of postwar surgery.
And so, through the lessons of war, we 
have learned to treat contaminated 
wounds gently with debridement and 
delayed closure. Hygiene, vaccine and 
antibiotics have become effective 
weapons against Apollo’s arrows of pes­
tilence. Blood transfusion, intravenous 
fluid resuscitation and rapid evacuation 
have effected an unbelievable change in 
the outlook of the wounded. Dr. Derby’s 
article is a timely reminder of the debt we 
owe the military surgeon — and his 
patients.
Peter Cruse, mb, frcsc, frcs(edin),
facs
Member,
Editorial Board
Professor and Head, 
Department of Surgery, 
Foothills Hospital, 
Calgary, Alta.
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Surgical Management of Hydatid Disease of the Liver
Hydatid disease of the liver is increasingly 
prevalent in North America, particularly 
in cities with an immigrant population 
from the Mediterranean area. It is there­
fore important that the practising surgeon 
be aware of presenting signs and symp­
toms and the modern treatment of this 
disease. Akinoglu and coauthors in this 
issue (pages 171 to 174) report a large 
experience with hydatid disease in Tur­
key. They describe clearly the methods of 
presentation and, in particular, the fre­
quency with which biliary communication 
with cyst cavities and superimposed infec­
tion are seen. They indicate that 
ultrasonography and Casoni skin testing 
in their experience have provided satisfac­
tory diagnosis. In North America, the 
availability of other serologic tests such 
as the indirect hemagglutination test 
(IHA) is more specific than the Casoni 
test. Our own experience1 also suggests 
that computerized tomography, where 
available, is superior to ultrasonography 
in providing noninvasive imaging of 
hydatid cysts. The treatment of the dis­
ease remains primarily surgical; it in­
volves evacuation of the cyst, elimina­
tion of the parasite and management of 
the remaining cavity. Some authors have 
advocated hepatic resection for most 
cysts,2 but we agree with Akinoglu and 
colleagues that this is an unnecessarily 
aggressive approach, and reports in the 
literature indicate a higher morbidity and
mortality than with more conservative 
methods.
Conservative management involves 
evacuation of the cyst, protection of the 
peritoneal cavity, elimination of the para­
site and management of the residual 
cavity. The cyst must be evacuated care­
fully with particular attention to protect­
ing the peritoneal cavity from spillage of 
cyst contents. We have used a plastic 
drape sutured to the cyst wall for this pur­
pose, but other equally efficacious 
methods have been described. The endo- 
cyst, daughter cysts and all fluid must be 
removed carefully and completely.
Many compounds have been used as 
scolicidal agents, including formalin, 
hypertonic saline, Hibitane and alcohol. 
Akinoglu and associates describe one 
patient who died from the systemic effects 
of formalin. This complication has been 
previously reported and emphasizes that 
formalin should never be used as a scoli­
cidal agent.
The management of the cyst cavity is 
still controversial. Whether capitonnage 
as used by Akinoglu has any advantages 
over simple cyst closure or partial exci­
sion of cyst wall, is uncertain. We have 
achieved similar results without either 
capitonnage or omentoplasty. The ques­
tion of whether to use drainage tubes is, 
however, important. Our experience sug­
gests that in patients who have neither 
communication of the cyst cavity with the
biliary tract nor infection of the cyst 
cavity, partial excision of the cyst wall or 
closure of the cyst cavity without drains 
is the treatment of choice. Where infec­
tion in the cyst or biliary communication 
exists, drainage tubes are indicated.
Although there are some reports of suc­
cess with medical treatment of hydatid 
disease using mebendazole,3 there is 
insufficient evidence to use this drug as 
primary treatment. We reserve its use for 
patients in whom spillage has occurred 
and for those not amenable to surgical 
treatment.
B. Langer , md, frcsc 
J.C. Langer, md
Department of Surgery,
Toronto General Hospital,
University of Toronto,
101 College St.,
Toronto, Ont.
M5G 1L7
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SESAP IV Question
151. A 56-year-old woman has a smooth, tense, 8-cm mass in the left adnexal area. The right adnexal area, uterus, and 
cervix are normal on pelvic examination. All of the following steps are appropriate for evaluating this problem EXCEPT
(A) laparoscopy
(B) uterine endometrial sampling
(C) barium enema
(D) intravenous pyelography
(E) Pap smear from squamocolumnar junction of the cervix
For the incomplete statement above select the one answer that is best of the five given. For the critique of Item 151 see 
page 146.
(Reproduced by permission from SESAP IV  Syllabus; Surgical Education and Self-Assessment Program No. 4. For enrol­
ment in the Surgical Education and Self-Assessment Program No. 4, please apply to the American College of Surgeons, 
55 East Erie St., Chicago, IL 60611.)
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The first effective anti-herpes 
therapy is now available in an I. V. 
infusion for treatment of initial and 
recurrent m ucosal and cutaneous 
herpes sim plex infections in im­
munocompromised adults and chil­
dren. It is also indicated for severe 
initial episodes of herpes simplex 
infections in im m unocom petent 
patients.
Highly efficacious in con­
trolled clinical studies, ZOVIRAX I.V 
selectively blocks the viral replica­
tion process and significantly short­
ens the period of viral shedding.
ZOVIRAX-treated patients 
become contagion-free faster.
W hat’s m ore, if therapy is 
initiated at the earliest possible m o­
ment, patients will heal faster and 
experience significantly less pain.
To date, efficacy has not 
been complicated or compromised 
by side effects.
Note: ZOVIRAX I.V Infusion 
is for intravenous infusion only
Therapy is recom m ended 
for at least 5 days for immunocom­
petent patients and for at least 7 
days for im m u n ocom p rom ised  
patients.
F i n a l l y . . .ZOVIRAX I.V. 
INFUSION.
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SURGEONS’ UPDATE
What's new in surgery is the subject of this column. The short items are designed to let readers know 
who's doing what and why. Surgeons are interested in what other surgeons are doing in 
research, education, practice and administration. Surgery is a vibrant specialty, and, as 
its practitioners, you must be the source as well as the readers of this column.
Dr. Joseph L. Shugar,
CJS Senior Associate Editor, 
Dies
Almost every surgeon who has con­
tributed to this journal within the last few 
years has also corresponded or spoken 
with Dr. Joseph L. Shugar; most readers 
are familiar with his editorials, con­
tributed regularly since 1979 when he 
joined the staff. All who knew him will 
understand the sadness we feel at the 
announcement that Dr. Shugar died on 
Dec. 21, 1984 during a coronary bypass 
operation at the Ottawa Civic Hospital.
He is described by words like quiet, 
kind, straightforward and unassuming. A 
creative man, with hands that engaged in
Joseph L. Shugar, MD, FRCSC
Contributions to this column are welcome. 
Please send your material to: Mrs. Amy 
Chouinard, Canadian Journal o f  Surgery, 
PO Box 8650, Ottawa, Ont. K1G 0G8.
surgery, writing, sculpting, woodwork­
ing, orchid growing and photography, 
Dr. Shugar will be much missed.
Born in 1919 in Montreal, the youngest 
of four children, his undergraduate 
studies at McGill led to a medical degree 
in 1943. He and Anne were married 
shortly afterwards, during his rotating 
internship at the Royal Victoria, Alexan­
dra and Montreal Neurological hospitals. 
He spent the next 3 years in military serv­
ice, with more than a year in Europe. Dis­
charged in April 1946, he took up 
residency training in general surgery in 
Montreal, to focus later on orthopedics 
at the Massachusetts General, the Boston 
Children’s and Peter Bent Brigham hospi­
tals in Boston. He returned to Montreal 
to become a faculty member at his alma 
mater where he continued teaching until 
he left the province. For much of the time 
he was also Chief of Orthopedic Surgery 
at the Jewish General Hospital.
Seven years ago, Dr. and Mrs. Shugar 
moved to Ottawa with plans to find more 
time for hobbies and family. Dr. Shugar 
became Deputy Chief of Surgery at the 
Grace General Hospital and within 2 
years had accepted a position as Assistant 
Professor in the Department of Surgery, 
University of Ottawa. He also agreed to 
work as Senior Associate Editor of the 
Canadian Journal o f  Surgery.
Throughout, he participated actively in 
his professional associations: as an 
examiner for the Royal College of Phy­
sicians and Surgeons of Canada and as 
a consultant in orthopedics for CARE 
(Medico) Tunisia.
A prize-winning photographer in his 
youth, he never stopped working to cap­
ture beauty. He became a master of 
woodworking and studied with Hans 
Schleeh, Toronto, to develop skills as a 
sculptor of stone and metals.
When he moved to Ottawa, he took up 
yet another form of art — orchid grow­
ing; only a week before he died he was 
awarded second prize in a local orchid 
exhibit.
A close friend commented, “ Joe pos­
sessed a fundamental honesty, interwoven 
with personal and professional integrity. 
He was patient; he was kind; he was a 
most devoted family man. He was a mar­
vellous friend, an excellent teacher, a 
healer, an interpreter of the medical arts 
and a leader in his work. His objectivity 
was always tempered by humanity and 
humour. If things were bad he could con­
vincingly explain how they were likely to 
get better. And if they weren’t going to 
get better . . . well, he had a way of 
softening the blow. He could communi­
cate his inner peace to others and that 
peace was with him to the end.”
Dr. Shugar is survived by his wife 
Anne, three children — Richard, Donna 
and Bill — and four grandchildren.
Surgeons Receive Order of Canada
Drs. Lloyd D. MacLean and Wilbert J. 
Keon became officers of the Order of 
Canada on Dec. 17, 1984. Chosen from 
a group of 400 nominees from across the 
country, the two surgeons will attend 
investiture ceremonies in April.
The Order of Canada, established dur­
ing the centennial celebrations in 1967, is 
the centrepiece of honours available to 
Canadians. The motto “ They desire a 
better country” echoes the emphasis on 
the recipients’ efforts to improve their 
community and nation. There are three 
levels in the Order: companions, officers 
and members, and the constitution limits 
the numbers awarded. There can be only 
150 living companions at any one time, 
and each year 46 officers and 92 members 
can be appointed.
The Governor General, who is the 
Chancellor and Principal Companion for 
the Order, approves the appointments 
and presides over investiture. The honour 
is never awarded posthumously, although 
some people have died before the inves­
titure and their families accepted the 
award.
Individuals submit nominations and
— For prescribing information see page 142 105
about a year is usually needed for tes­
timony and follow-up. An advisory coun­
cil reviews the files on nominees and 
recommends appointments to the Gover­
nor General. The council is chaired by the 
Chief Justice of Canada, with other per­
manent members being the Clerk of the 
Privy Council, the Under Secretary of 
State, the Chairman of Canada Council, 
President of the Royal Society of Canada 
and the President of the Association of 
Universities and Colleges of Canada. To 
ensure representation from across Can­
ada, the Governor General can appoint 
two other council members for 1-year 
terms.
Dr. MacLean, Surgeon-in-Chief of the 
Royal Victoria Hospital, Montreal, and 
Coeditor of this journal, was cited in the 
government announcement of the awards 
as having “ international recognition for 
his work in the field of surgery, especially 
in kidney transplants. A scientist as well, 
he has been responsible for the present 
emphasis on basic research within depart­
ments of surgery in Canadian hospitals.”
He was born in Calgary, attended local 
elementary and high schools and received 
his MD from the University of Alberta 
in 1949. After a rotating internship and 
a straight surgical internship, Dr. 
MacLean undertook residency training in 
general surgery at the University of Min­
nesota where he remained for the next 6 
years, holding positions as instructor, 
assistant and associate professor. In 1962, 
he accepted his current position at the 
Royal Victoria and joined McGill’s 
Department of Surgery, which he chaired 
in alternating 5-year terms from 1968 to 
the present. A fellow of the Royal Col­
lege of Physicians and Surgeons of 
Canada and the Royal Society of Canada,
Llovd D. MacLean, MD, FACS, FRCSC
he has amassed awards and visiting 
professorships throughout the world.
Besides his role on this journal, he is 
a consultant to the World Journal o f  Sur­
gery and the Annals o f  Surgery. He edited 
volumes 15 and 16 of “ Advances in Sur­
gery” and in 1974 participated in the film 
production “ Surgery for Obesity” . He is 
an author of almost 300 scientific articles 
and book chapters.
The other surgeon honoured, Wilbert 
Keon, gained recognition for “ his skills 
as a cardiac surgeon, teacher and medi­
cal administrator” and his role in estab­
lishing the Heart Institute within the 
University of Ottawa and the Ottawa 
Civic Hospital. He is also noted for his 
research into cardiovascular diseases, 
including emergency interventions during 
myocardial infarction and investigations 
into atrial muscle mechanics, defining 
optimal preservation of the myocardium. 
Dr. Keon performed Ottawa’s first heart 
transplant at the Heart Institute in the 
spring of 1984. The government press 
release on the awards refers to the insti­
tute as “ a world class facility at which he 
is director and head of a renowned team 
of surgeons” .
Keon was born just outside Ottawa 
in Sheenboro, PQ, and, with the excep­
tion of the time in training, has spent his 
life in the area. He received his medical 
degree from the University of Ottawa. He 
completed residencies in general surgery 
at the Montreal General Hospital and 
went on to the Toronto General Hospi­
tal and the Hospital for Sick Children for 
training in cardiovascular surgery. After 
becoming a fellow of the Royal College 
of Physicians and Surgeons in both dis­
ciplines, he took up a research and clini­
cal associateship at Peter Bent Brigham
Wilbert J. Keon, MD, FACC, FRCSC 
(photo by Karsh)
Hospital and Harvard Medical Center for 
a year.
A member of the editorial board of this 
journal and of Ontario Medicine and 
Associate Editor of the new Canadian 
Journal o f  Cardiology, he has authored 
more than 50 articles, about 15 book 
chapters and is currently coordinating the 
production of a surgical handbook for 
fourth year clinical clerks; he has collabo­
rated in six films.
Two others in the field of medicine, F. 
Clarke Fraser, a professor of clinical 
genetics, Memorial University of New­
foundland, and Charles-Eugene Marin, 
psychiatrist (and mayor), Ste-Anne-des- 
Monts, PQ, were also appointed to the 
Order.
New Laboratory at Memorial 
Focuses on Carcinoembryonic 
Antigen
Scientists in the Department of Surgery 
at Newfoundland’s Memorial University 
are attempting to direct chemotherapy 
toward cancerous cells and, thus, to pro­
tect healthy cells from the damage caused 
by the potent drugs used in treatment.
The group, headed by Dr. C.H.J. 
Ford, is working in a newly established 
oncology research laboratory funded by 
several grants, including one for $150 000 
from the Terry Fox Special Cancer 
Research Fund.
To date, the investigation has focused 
on monoclonal antibodies to pilot the 
drugs to the offending cells. The re­
searchers chose carcinoembryonic antigen 
(CEA) as the target (although not all 
cancers express the antigen nor is it 
expressed only by cancerous tissues) 
because this antigen if often present in 
carcinomas of the stomach, lung, breast 
and ovary.
The group has characterized several 
antibodies and selected a few for further 
testing in vivo. Cancer cells with and 
without CEA are being grown as xeno­
grafts on immunoincompetent nude mice 
for tests of the efficacy of antibodies in 
their role as the drug delivery system.
Other thrusts of the research are to 
identify the chromosomes responsible for 
producing CEA — a goal the group hopes 
to achieve by fusing rodent cells with lines 
that express CEA and then to see what 
elements in the hybrids correlate with 
human chromosome content.
The Newfoundland studies are part of 
an international effort to test the antibod­
ies, with scientists at the Surgical Immu­
nology Unit, University of Birmingham, 
UK, assessing potential uses in diagnosis, 
and scientists at the National Cancer 
Institute in the United States evaluating 
the therapeutic effects of different com­
binations of drugs and antibodies.
Amy Chouinard
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Radiotherapy Versus Resection 
for Palliation of Carcinoma of 
the Esophagus
To the editors.—In a recent issue (Can J  
Surg 1984; 27: 491-5), Stoller and Brum- 
well examined palliation after operation 
and after radiotherapy for cancer of the 
esophagus. Using a grading system 
designed to assess the subjective responses 
of each patient, the authors concluded 
that there was no difference in palliation 
between radiotherapy and surgical resec­
tion plus bypass. They recommended 
radiotherapy as the best primary treat­
ment for squamous cell esophageal car­
cinoma.
Unfortunately, the data they presented 
did not support this contention. In the 53 
patients treated by radiotherapy, 89% of 
the evaluations (87/98) scored in the 
excellent or good range. Yet 45% (24/53) 
of the patients required a secondary 
procedure to maintain their palliation. 
Thus, the grading system identified very 
few patients (only 11 evaluations) who ran 
into problems sufficient to require a 
secondary procedure to maintain their 
palliation. In the 29 patients treated by 
surgical resection, 80% (36/45) of the 
evaluations revealed excellent or good 
palliation. In contrast, 28% (8/29) of the 
surgically treated patients required secon­
dary intervention, suggesting that most of 
these patients were identified by the grad­
ing system. Unfortunately, the authors 
did not give the number of patients avail­
able for examination in any given time 
period and appear to have a highly 
selected population for their grading 
project. The grading system did not iden­
tify patients who had difficulty swallow­
ing after radiotherapy and conclusions 
based upon the grading system are there­
fore without merit.
Several years ago we reported the inci­
dence of postradiation esophageal stric­
ture in 152 patients with esophageal 
cancer, treated at the Princess Margaret 
Hospital in Toronto.1 In the follow-up 
period, a clinically apparent malignant 
stricture of the esophagus developed in
49% (75/152), while only 33% (50/152) 
had no evidence of stricture. When 
autopsy data were combined with the clin­
ical data, it was noted that 80% of 
patients with carcinoma of the esophagus 
treated by radiation to a dose of at least 
4000 rad had recurrent disease in the 
esophagus, and in 80% of these, the 
recurrence was symptomatic. Thus, 63% 
of the 152 patients with esophageal car­
cinoma had symptomatic recurrence 
when radiotherapy was the primary treat­
ment. We carefully excluded from the 
study patients with advanced disease who 
were treated with low doses of radiation. 
In contrast, only 8 of 30 (27%) of the sur­
gically treated patients in our study had 
clinical or autopsy evidence of stricture 
or obstruction of the esophagus postoper- 
atively. It is interesting that in the report 
by Stoller and Brumwell the incidence of 
clinically identified poor palliation is simi­
lar: 45% in the radiotherapy group and 
28% in the surgically treated group.
From the data we presented previously, 
it could be concluded that patients with 
carcinoma of the esophagus treated sur­
gically received the best palliation. The 
results of Stoller and Brumwell support 
this. Furthermore, when examining the 
results of Stoller and Brumwell, we can 
conclude that although patients with 
cancer of the esophagus may not do well 
in general, their ability to come in for 
follow-up was an indication that 86% of 
the time (123/143 evaluations) they were 
in good or excellent condition. Patients 
who did not come in for a follow-up were 
probably doing poorly or were deceased, 
and therefore were not evaluated. 
Moreover, at 2 years, only 4 (8%) of 53 
patients treated by radiotherapy were 
even available for evaluation, whereas 6 
(21%) of 29 patients treated surgically 
were still available for follow-up. As both 
the objective palliation and survival 
reported by Stoller and Brumwell appears 
better in the surgical group, it is hard to 
understand how the authors have sug­
gested that radiotherapy is the better 
primary treatment for symptomatic squa­
mous and undifferentiated carcinoma of 
the esophagus.
In his editorial (Can J  Surg 1984; 27: 
417), Goldberg concluded that there is a 
need for a prospective, randomized study 
to compare the differences between sur­
gery and radiotherapy. While we await 
such an effort, patients with esophageal 
carcinoma continue to require therapy 
directed primarily at palliation. The 
objective data reported in the highly 
selected series from the Cancer Control 
Agency of British Columbia (Stoller and 
Brumwell) and from the Princess Mar­
garet Hospital (Beatty and associates) 
suggest that surgical resection and bypass 
should be undertaken for the treatment 
of esophageal cancer. Seventy-five per­
cent of patients will be palliated this way. 
When distant metastatic disease is iden­
tified or the patient’s condition prohibits 
a laparotomy, with or without thoracot­
omy for esophagectomy, an alternative, 
namely radiotherapy, is required. In 
almost 50% of these irradiated patients 
it can be anticipated that other palliative 
maneuvers, such as rigid tube placement, 
will be required to establish or maintain 
palliation. Obviously, we all hope for 
more effective treatment modalities than 
current surgery or radiotherapy, modali­
ties that can withstand careful, critical 
scientific evaluation.
J. David Beatty, md, facs, frcsc
Department of General Oncologic Surgery, 
City of Hope National Medical Center, 
Duarte, Calif.
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To the editors.— Thank you for the 
opportunity to consider Dr. Beatty’s 
letter.
After discounting our data (Can J  Surg 
1984; 27: 491-5) as being without merit, 
Beatty claims our findings as evidence 
that surgical resection is better than radio­
therapy for primary treatment of eso­
phageal cancer! In the paper he quotes as
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primary evidence for this argument,1 the 
word “ palliation” is mentioned several 
times. However, in concert with almost 
all other published work I am aware of, 
no definition of palliation was given, and 
although firm conclusions were drawn, 
no data were presented for evaluation. It 
was precisely such anecdotal reports that 
stimulated us to introduce a scoring 
system.
While almost every patient with eso­
phageal cancer treated by radiation in Bri­
tish Columbia is seen and followed up 
until death at the Cancer Control Agency, 
we have no knowledge of the total pool 
from which the referred surgical patients 
originated. This was enunciated in our 
paper and certainly we agree that the sur­
gical series may not be representative. 
Patterns of practice in North America 
make this kind of clinical control extre­
mely difficult.
Dr. Beatty cannot conclude that the 
scoring system did not identify patients 
having problems or that those who did 
not come in for follow-up study were 
doing poorly or were deceased. We did 
not attempt to study these points. This 
would have required patients being seen 
once or more per month — a frequency 
only acceptable if one can send a visitor 
out on rounds to the patients’ homes. 
Thus, a patient who scored A may have 
been asked to return in 3 months. After 
1 month, he may have been swallowing 
poorly, been referred by his family phy­
sician to a suitable specialist, treated and 
been back at grade A or B by the time he 
came in for his next follow-up visit at the 
clinic. At an anecdotal level we did 
encounter instances in which the score 
assigned identified deterioration. We are 
aware that this is an item we must try to 
include in our future studies. Regardless 
of intermittent fluctuations, we believe we 
have shown that patients can be kept at 
A or B grades by judicious interventions 
even if 45% do get recurrent dysphagia 
at one time or another. This is also true 
for surgically treated patients but is 
negated by the initial mortality and mor­
bidity they suffer from the operation.
In our abstract and final sentence, we 
took particular pains to select the word 
“ suggest” in regard to our advocacy of 
radiotherapy. We did this because we 
recognize that our data are not conclu­
sive. However, we believe, with others,2,3 
that adoption of the idea of evaluating by 
numbers a concept as vague as “ pallia­
tion” is overdue and has put anecdotal 
reports out of contention.
Julius L. Stoller, mb, frcs, frcsc
Laurel Medical Centre,
316 -  888 West 8th Avenue,
Vancouver, BC 
V5Z 3Y1
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Thrombosis of the Ulnar Artery
To the editors.—The report by Lee and 
Evans of a case of vibration-induced 
white finger disease (Can J  Surg 1984; 27: 
513-4) warrants further scrutiny. They 
report the case of a 22-year-old man in 
whom pain and swelling of the middle 
finger associated with signs of digital 
ischemia developed after use of an air 
gun. Allen’s test and arteriography con­
firmed occlusion of the ulnar artery.
Thrombosis of the ulnar artery occurs 
typically in manual labourers. It causes 
pain and swelling, usually in the palm, 
and may cause ischemic symptoms in the 
digits.1-3 I believe the vibration-induced 
white finger disease reported by Lee and 
Evans was actually a case of ulnar artery 
thrombosis. It is important to recognize 
ulnar artery thrombosis as the primary 
underlying condition, since some patients 
may require reconstruction of their super­
ficial palmar arch if the ischemic symp­
toms do not respond to the prevention 
of repetitive trauma, stellate ganglion 
block or the administration of reserpine 
intra-arterially.4 For this reason, I sug­
gest a more appropriate title for this 
interesting case report would have been 
“ Ulnar artery thrombosis caused by a 
vibrating tool” .
Robin R. Richards, m d , frcsc
Lecturer in Orthopedic Surgery,
St. Michael’s Hospital,
University of Toronto,
Toronto, Ont.
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To the editors. —Claims by industrial 
workers for the condition known as 
vibration-induced white finger disease 
have been recognized by the Worker’s 
Compensation Board of Ontario since
1944. As pointed out in our article, the 
exact etiology of this condition has not 
been clearly defined. Dr. Richards has 
rightly pointed out that some of these 
cases result from ulnar artery thrombosis.
We recently re-evaluated our patient’s 
condition. When Allen’s test was per­
formed, he had excellent cross-filling 
between both the ulnar and radial arter­
ies. All his digital arteries were found to 
be patent on Doppler examination, and 
the arterial pressures in the digital arter­
ies of the middle fingers of both hands 
were found to be equal. The evidence 
suggests that our patient did not have 
ulnar artery thrombosis but more likely 
spasm of the palmar vasculature.
E.H. Lee , m d , frcsc
Senior Lecturer,
University Department of
Orthopedic Surgery,
Singapore General Hospital,
Singapore 0316
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REVIEW ARTICLE
Carlos Del Campo, md, frcsc
Pulmonary Embolectomy: a Review
Massive pulmonary embolism continues 
to be a major cause of death in spite of 
improved medical therapy. Only a small 
number of patients with pulmonary 
embolism refractory to medical treatment 
are referred for pulmonary embolectomy. 
A literature review of patients with mas­
sive pulmonary embolism treated by pul­
monary embolectomy showed that the 
operation was highly successful in those 
who were unlikely to survive with other 
modes of therapy. Specific indications 
and management are outlined on the 
basis of these cumulative data.
L'embolie pulmonaire massive demeure 
une cause majeure de deces en depit des 
ameliorations de son traitement medical. 
Seul un petit nombre de patients souf- 
frant d'embolies pulmonaires resistantes 
au traitement medical doivent etre sou- 
mis d une embolectomie pulmonaire. La 
revue de la litterature relative au traite­
ment par embolectomie des patients 
souffrant d'embolie pulmonaire massive 
revele que cette operation est souvent 
couronnee de succes chez ceux dont la 
survie serait douteuse par tout autre 
mode de therapie. A partir des donnees 
cumulatives, on decrit les indications 
specifiques et la marche a suivre dans de 
tels cas.
Pulmonary embolectomy remains a con­
troversial operation. Statements such as 
“ there are no indications for the 
operation” 1 to “ prophylactic open 
embolectomy can be justified”2 exem­
plify the extremes of opinion, and neither 
one is applicable to all clinical cases.
From the Division o f Cardiovascular and 
Thoracic Surgery, Halifax Infirmary and 
Dalhousie University, Halifax, NS
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New therapeutic modalities, based on 
better understanding of the pathophysiol­
ogy of the disease, have led to a substan­
tial improvement in the prevention of 
deep venous thrombosis and pulmonary 
embolism. Furthermore, better therapeu­
tic regimens for the symptomatic patient 
with pulmonary embolism, that is, sys­
temic heparinization, inotropic support 
and, recently, locally administered strep­
tokinase, have reduced even further the 
number of patients who in the past would 
have been considered for pulmonary 
embolectomy. In spite o f these advances, 
approximately 200 000 deaths in the 
United States each year are associated wih 
pulmonary embolism.3 In 150 000 of 
these it is the major cause of death4 and 
it is the only cause of death in 50 000 of 
them.5 Since most patients with massive 
pulmonary embolism, if not treated 
promptly, die shortly after the event, 
patients suitable for treatment would be 
those located in acute-care general hospi­
tals when the embolism occurs. In these 
hospitals 15% of patient deaths are due 
to pulmonary embolism,6'7 and it is the 
only cause of death in 3% o f them.4 
Since these figures include patients who 
died in spite o f optimal medical treat­
ment, the question is whether an 
appreciable number of them should have 
been offered a pulmonary embolectomy.
The purpose of this paper is to answer 
this question by analysing the indications, 
techniques and results o f the operation 
and to draw conclusions on its applica­
bility, based on a review o f the literature.
Collection of Data
The literature was reviewed, including 
series and isolated reports of pulmonary 
embolectomy. Only cases of massive pul­
monary embolism were considered. This 
was defined as the sudden occurrence of 
an embolus producing severe cardiovas­
cular decompensation, manifested by 
severe hypotension, oliguria and hypoxia 
refractory to aggressive medical treat­
ment. To avoid duplication o f data, iso­
lated cases that were found in later 
cumulative series were excluded. Patients 
who underwent pulmonary embolectomy 
were divided into two groups — those in 
whom cardiopulmonary bypass was used, 
and the others. Each group was then sub­
divided into series o f cases and case 
reports, because usually isolated case 
reports included only successful cases that 
cannot be considered in an accurate anal­
ysis o f survival. On the other hand, the 
total numbers of successful cases are 
important in showing whether the reports 
o f an operation are anecdotal or not. 
Overall figures were calculated separately. 
The circumstances under which pulmo­
nary embolectomy was performed, use of 
partial cardiopulmonary bypass before 
pulmonary embolectomy, pulmonary 
angiography and venous interruption 
were recorded whenever available. Cases 
of transvenous pulmonary embolectomy 
were analysed separately and not included 
in the cumulative data. Only patients who 
left the hospital alive were considered as 
having survived the operation.
Findings
Of 651 pulmonary embolectomies per­
formed in patients with massive pulmo­
nary embolism, the operation was per­
formed with extracorporeal circulation in 
537 patients (82%), and in 26% o f these, 
partial cardiopulmonary bypass was 
started before sternotomy (femoral vein 
to femoral artery bypass) to maintain the 
circulation until the embolus could be 
removed. The remaining 114 patients 
were operated upon without cardiopul­
monary bypass. Survival was superior in 
patients who had cardiopulmonary 
bypass (59.3% versus 47.7% , p =  0.05) 
(Tables I8'21 and n 2,i 1.16,19,22-48) In this 
group 170 patients underwent pulmonary 
angiography before operation. This infor­
mation was not available in most series 
when cardiopulmonary bypass was not 
used; angiography appears not to have 
been done in most instances. Usually the 
embolus occupied from 50% to almost
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100% of the lumen of the pulmonary 
artery. Most patients had bilateral 
emboli. There was no important differ­
ence in the size of clot between the two 
groups. Concomitant venous interruption 
procedures (i.e., inferior vena caval pli­
cation or ligation) were carried out much 
more frequently in patients who had 
cardiopulmonary bypass. There were 379 
long-term survivors.
Discussion
Most patients with large pulmonary 
emboli who can tolerate a 50% occlusion 
of their pulmonary artery will survive 
with aggressive medical therapy.49 
Nevertheless, some continue to deteri­
orate rapidly in spite of optimal 
anticoagulation and respiratory and 
inotropic support. If within 1 hour of 
initiating therapy the blood pressure 
remains below 90 mm Hg, the urinary 
output is less than 20 mL and the arterial 
oxygen tension is below 60 mm Hg,50 
alternative treatment should be sought. 
Such patients represent 2% to 6% of all 
those suffering pulmonary embolism.51 
Therefore, between 1000 and 3000 
patients a year should be considered for 
pulmonary embolectomy. With the cur­
rent operative survival rate, between 500 
and 1500 could be expected to survive.
Some authors1 have stated that if the 
patient survives long enough to reach the 
operating room, pulmonary embolectomy 
would have been unnecessary. This may 
be true if the patient has been stabilized 
and is operated on after 24 hours but not 
for the patient requiring operation due to 
continuing rapid deterioration.10 This 
was the case in the series studied since all 
pulmonary embolectomies performed 
under other conditions were excluded.
The present review shows better sur­
vival for patients operated upon with 
cardiopulmonary bypass. These are obvi­
ously the most recent series and thus bet­
ter techniques and better medical support 
may have been a factor. On the other 
hand, femorofemoral cannulation under 
local anesthesia before sternotomy made 
it possible for some patients to undergo 
the procedure who otherwise might not 
have survived long enough to be operated 
upon.
Cardiac arrest occurs on induction of 
anesthesia as a result of peripheral 
vasodilatation in the presence of a fixed 
cardiac output; it is usually fatal.29 
Femorofemoral bypass under local 
anesthesia before induction helps to over­
come this problem because it relieves the 
strain on the right side of the heart, oxy­
genates the blood, maintains the circula­
tion and allows the flow to increase to 
compensate for the vasodilatation.
Although preoperative pulmonary an­
giography was not reported in all cases, 
it was reported much more often in those
who had cardiopulmonary bypass. The 
accuracy of diagnosis was also greater. As 
a result, fewer patients with myocardial 
infarction rather than pulmonary embo­
lism underwent the procedure. When pul­
monary embolectomy is performed with 
this erroneous diagnosis, the mortality is 
100%.“ Thus, pulmonary angiography 
or a conclusive lung scan are mandatory 
before any surgical procedure is carried 
out.
Reports of pulmonary hemorrhagic 
infarction following revascularization of 
ischemic lungs have been only anecdo­
tal,52,53 but this complication should be 
kept in mind after pulmonary embolec­
tomy is performed.
Other reports, not included in this 
review, have shown that pulmonary 
embolectomy performed in a hyperbaric 
chamber with inflow occlusion and 
unilateral pulmonary embolectomy are 
also successful.54,55 This could be an 
alternative in centres where cardiopulmo­
nary bypass is not available.
Prophylactic removal of a pulmonary 
embolus has been advocated to prevent 
pulmonary insufficiency or to provide 
cardiopulmonary reserve should a second 
embolism occur2 or to prevent later 
onset of pulmonary hypertension.29 
These eventualities, however, do not 
occur.1 Provided the pulmonary embo­
lism does not recur, the clinical course of 
most patients is one of gradual resolution 
of the embolus with reestablishment of 
flow in the pulmonary arteries.56 This 
has been shown in the experimental 
animal and in humans.57 Thus, pulmo­
nary embolectomy should not be per­
formed prophylactically. In a small group 
of patients the embolus does not resolve 
and the condition becomes chronic. Satis­
factory results have been obtained with 
embolectomy in these circumstances.56
Most surgeons operating on patients 
with cardiopulmonary bypass elected
some form of venous interruption to pre­
vent recurrence (Table II). This is the cur­
rently accepted practice.
Since the unfavourable initial results of 
the Trendelenburg procedure,58 the mor­
tality of pulmonary embolectomy has 
been markedly reduced, being reported 
retrospectively as low as 10%.28 A ran­
domized trial is not feasible1 due to the 
critical condition of patients who fail to 
respond to medical treatment and the 
small number of cases in each centre.
This collective review shows that pul­
monary embolectomy is a feasible proce­
dure and is associated with an accepta­
ble survival rate. Operative mortality will 
continue to be high due to the precarious 
condition of the patient, but operation 
may be the only chance for survival.
The ideal candidate for pulmonary 
embolectomy is the patient with a diag­
nosis of pulmonary embolism proven 
within 1 hour of the event who fails to 
respond to other modes of treatment, “ a 
difficult group to define and a challenge 
to clinical judgement” .59 Based on the 
data presented here, pulmonary embolec­
tomy should be offered to such patients. 
A coordinated approach between differ­
ent specialities and awareness by the sur­
gical team are essential to improve sur­
vival. Pulmonary embolectomy is feasible 
in the absence of cardiopulmonary bypass 
facilities and gives acceptable results 
(Table I). Pulmonary embolism still 
remains a widespread lethal disease. In 
many cases it occurs in the absence of 
associated terminal illness.
Transvenous Pulmonary Embolectomy
Transvenous catheter embolectomy of 
the pulmonary artery was first described 
by Greenfield and colleagues in 1971.60 
The catheter is inserted through the 
femoral or jugular vein by venotomy and 
guided under fluoroscopy into the pulmo­
nary artery. The embolus is then removed
Table 1—Pulmonary Embolectomy Without Cardiopulmonary Bypass
Published reports
No. of 
patients
Pulmonary
angiography*
Venous
interruption
Survivors, 
no. (%)
Series8"16 109 6 10 52 (47.7)
Case reports17' 21 5 1 3 4
Totals 114 7 13 56 (49 .1 )
*No available information in most series.
Tabje II—Pulmonary Embolectomy With Cardiopulmonary Bypass
No. of Pulmonary CPB before Venous Survivors,
Published reports patients angiography operation interruption no. (%)
Series2'111619'22- 37 526 165 134 219 312 (59.3)
Case reports38"48 11 5 6 8 11
Totals 537 170 140 227 323 (60.1)
CPB = cardiopulmonary bypass.
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by means of a suction cup. Several 
retrievals may be necessary if the embo­
lus fragments. To date, Greenfield’s 
group have reported 25 patients with a 
56% overall survival.61
This method cannot be applied when 
closed chest massage is required or if 
cardiac output cannot be restored, 
because it precludes the use of 
fluoroscopy. Thus, patients who undergo 
this procedure are selected and obviously 
in better condition than those who 
undergo pulmonary embolectomy either 
with closed chest massage or than those 
needing partial cardiopulmonary bypass 
before embolectomy. On this basis, sur­
vival rates with these two techniques can­
not be compared. At present, the trans­
venous technique is not available in most 
hospitals; nevertheless, Greenfield’s 
results are encouraging even if the num­
ber of patients so treated is small. In 
hospitals where cardiopulmonary bypass 
facilities exist and the equipment and 
expertise for transvenous catheter 
embolectomy are available, both tech­
niques could be combined in the future, 
particularly in those patients who require 
partial cardiopulmonary bypass before 
embolectomy due to severe cardiogenic 
shock, but for whom cardiac massage is 
not necessary. Further trials and a larger 
number of patients are needed before 
conclusions can be drawn.
Streptokinase Thrombolysis
Better results have been reported 
recently with direct infusion of strep­
tokinase into the pulmonary artery.62 
Thirty patients with major pulmonary 
emboli were studied; 26 (87%) survived. 
Only 5 (17%) patients were in shock 
before the procedure. This technique, like 
transvenous pulmonary embolectomy, 
cannot be applied when circulatory 
assistance is required (i.e., closed chest 
massage, cardiopulmonary bypass) and 
therefore shares its limitations and indi­
cations.
Pulmonary embolectomy should be a 
continuation of treatment for patients 
with pulmonary embolism who fail to 
respond to medical therapy. It is a com­
bined, well-coordinated medical-surgical 
effort that ultimately will determine 
patient survival.
I thank Mrs. Jean Bone and Miss Patti Snarr 
for their secretarial assistance in the prepara­
tion of this manuscript.
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Ovarian Cancer
The behaviour of epithelial cancer of the 
ovary differs from that of other epithelial 
tumours that the general surgeon nor­
mally contends with for the following 
reasons: first, it often responds well to 
incomplete surgery as it is frequently 
sensitive to chemotherapy and, second, 
its method of spread is unique. Proper 
treatment of this lesion must take these 
characteristics into account. Immediate 
therapy is excision of the tumour mass 
and its principal metastases. This nor­
mally includes removing the uterus and 
its adnexae plus the omentum. Only 
when the remaining tumour masses are 
small will postoperative chemotherapy be 
effective. Moreover, the chemotherapy 
can only be given rationally if the extent 
of dissemination of the disease is care­
fully defined. The spread of this malig­
nant tumour is most often by way of 
free-floating cells in the peritoneal cavity. 
The tumour cells subsequently deposit in 
"watersheds" throughout the peritoneal 
cavity and accumulate on the undersur­
face of the diaphragm and in the omen­
tum. Staging, which describes this 
process and its variations, is therefore of 
great importance and is described in this 
paper in detail.
L'evolution du cancer epithelial de 
I'ovaire differe de cede des autres 
tumeurs epitheliales pour les raisons sui- 
vantes: premierement, il repond souvent 
bien a une chirurgie incomplete car cette 
tumeur est frequemment sensible a la 
chimiotherapie; et deuxiemement, son 
mode de dissemination est unique. Le 
traitement approprie de cette tumeur doit 
tenir compte de ces caracteristiques. Le 
traitement immediat consiste a exciser la
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masse tumorale et ses principales metas­
tases. Ceci comprend habituellement I'a- 
blation de I'uterus et de ses annexes 
ainsi que de I'epiploon. La chimiotherapie 
postoperatoire n'est efficace que quand 
la masse tumorale residuelle est petite. 
Qui plus est, la chimiotherapie ne peut 
etre administree correctement que si 
I'etendue de dissemination de la maladie 
est connue. Cette tumeur se propage le 
plus souvent par voie de cellules flottant 
dans la cavite peritoneale. Ces cellules 
se deposent par la suite dans des 
"points morts" de la cavite peritoneale 
et s'accumulent sous la surface du 
diaphragme et de I'epiploon. Le diagnos­
tic du stade de la maladie qui prend en 
consideration ce processus et ses varia­
tions, est done de premiere importance. 
On le decrit en detail dans cet article.
All general surgeons who operate on 
women must be concerned with the treat­
ment of cancer of the ovary, for these 
patients are often first seen and treated 
by them. The therapy that gynecologic 
oncologists recommend is comprehensi­
ble only when the unique behaviour of 
epithelial cancer of the ovary is under­
stood. Based on this understanding, the 
presentation of the patient, the staging of 
the disease and the surgical therapy fol­
low logically. Although all three aspects 
will be dealt with in this article, I shall 
emphasize the staging procedure, for 
several important reasons. First, if stag­
ing is not done well, there is danger that 
the subsequent treatment may be inap­
propriate. Second, it is this aspect of the 
initial operation that is most often sub­
ject to valid criticism. The ovary is the site 
of many unusual tumours, but I shall dis­
cuss only epithelial tumours. They form 
the majority of all ovarian neoplasms and 
are therefore those most frequently 
encountered by the surgeon. This class of 
ovarian tumour is also highly malignant.
Pathogenesis
Cancer of the ovary afflicts middle-
aged, middle-class women. Those who 
have had no rest from “ incessant ovula­
tion” are at particular risk. Both preg­
nancy and the use of oral contraceptives 
prevent ovulation. For this reason some 
measure of protection from cancer of the 
ovary is gained by pregnancy or the use 
of oral contraceptives.
The course of the disease is straightfor­
ward. The abnormal cells initially leave 
the confines of the ovary by invading the 
ovarian capsule. As the capsule is dis­
rupted, tumour cells are disseminated 
freely into the peritoneal cavity. The 
direction of the flow is towards the 
diaphragm, due to the suction-like action 
of the diaphragm and the rolling motion 
of the intestines. Movement along this 
path is directed by the peritoneal attach­
ments of the ascending and descending 
colon and the mesenteries of the small 
bowel and transverse colon. Because of 
these anatomical barriers, pooling of the 
tumour-laden fluid occurs. This stagna­
tion (with subsequent tumour deposit) 
most commonly occurs in the cul de sac, 
in the right lower and left upper quad­
rants.
The flow is limited by the right 
diaphragm. Here the fluid is engulfed by 
the lymphatic network that lines the sur­
face of the diaphragm. These lymphatics 
also traverse the diaphragm and reach its 
pleural surface. They then enter the 
retrosternal nodes and finally drain into 
the thoracic duct.
The lymphatics on the surface of the 
diaphragm soon become blocked with 
tumour cells. This obstruction upsets the 
drainage pattern of the peritoneal cavity 
and results in ascites.1 Lymphatic drain­
age is now directed to the omentum. As 
a result, the omentum becomes loaded 
with tumour cells. The drainage of the 
peritoneal cavity is thus further ob­
structed and ascites accentuated. There is 
another reason for fluid accumulation: 
the uninvolved surface of the peritoneum, 
as a result of the presence of tumour, 
produces fluid at an excessive rate.
Next, the tumour is most likely to
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invade the intestine and its mesentery. 
The result is both partial and complete 
bowel obstruction. In the former, the 
slow passage of the intestinal contents 
through the intestine is called ‘carcinoma­
tous ileus” . If death follows, in 50% of 
the cases the disease will be found to be 
limited to the abdomen.
Although intraperitoneal spread is the 
most important, there are other means of 
dissemination. It has been recognized 
recently that lymphatic spread may occur 
early in the course of the disease. In 15% 
of patients with stage I disease, the 
lymphatics draining the ovaries are in­
volved.2,3 The lymph vessels draining 
the ovary are located retroperitoneally 
and accompany the ovarian vessels to the 
lower pole of the kidney where they turn 
inwards to the aortic lymph nodes located 
anterior and lateral to the aorta and the 
inferior vena cava. The secondary lym­
phatic drainage of the ovary is to the 
interiliac nodes.
The stage, although the most important 
factor, is not the sole element in determin­
ing prognosis. Prognosis also depends on 
the histologic grade of the tumour and on 
the presence or absence of ascites.4 
However, both factors are closely linked 
to the stage. Low-stage tumours are 
generally of low-grade malignancy. 
Ascites is primarily dependent on 
diaphragmatic metastases. A most impor­
tant prognostic factor is the disease 
remaining after surgical therapy. It 
should be noted that the cell type of 
epithelial tumours is in itself unimportant 
compared with the grade of anaplasia. In 
the future, staging will certainly include 
the factors of histologic grade, ascites and 
residual disease, which will permit a fur­
ther refinement of treatment.
Presentation
It is now generally agreed, contrary to 
what was earlier believed, that cancer of 
the ovary in the early stages is not always 
asymptomatic. These patients commonly 
have complaints of a mild and nonspecific 
digestive upset. Even later, when the dis­
ease is widespread, the symptoms do not 
necessarily suggest an ovarian origin. 
Nausea, loss of appetite and abdominal 
distension are often present at this stage 
and are more suggestive of a gastrointes­
tinal disturbance than a gynecologic one.
The only physical finding of note is a 
pelvic mass. This is most often discovered 
by chance. There is considerable doubt 
that routine physical examination will 
result in increased frequency of early 
diagnosis of this ovarian cancer.5 The 
best hope for early detection would be a 
laboratory test to detect the localized and 
unpalpable tumour. One of the most 
promising of such tests depends on the 
purification of ovarian tumour antigen, 
which is not yet possible. None the less, 
there is reason to be optimistic that such 
tests will be available shortly.6
The presence or absence of ovulation 
is particularly helpful in differentiating 
between benign and malignant ovarian 
tumours. Special attention should be paid 
to a woman who is not ovulating and who 
presents with a pelvic mass. Post­
menopausal women, those who are using 
oral contraceptives and lactating mothers 
with demonstrable ovarian tumours are 
at special risk. In such cases, the work­
ing diagnoses should include ovarian 
cancer until proven otherwise. On the 
other hand, if the patient is ovulating and 
has an ovarian mass measuring less than 
8 cm, the possibility that it is a physio­
logic cyst or a benign neoplasm is much 
more likely; oral contraceptives should be 
given to this patient, and she should be 
re-examined after 6 weeks. In most cases, 
the mass will resolve completely. Fine 
judgement is required to avoid either 
overly aggressive excision of all ovarian 
masses or undue delay in the treatment 
of an early ovarian cancer.
Staging
Rational treatment of ovarian cancer 
depends on accurate staging (Table I).7 
There can be no intelligent planning of 
therapy without a detailed knowledge of 
the presence or absence of metastases. 
The evolution of our present therapy has 
depended on our ability to compare 
results of different modes of treatment 
from different institutions for given stages 
of the disease. The literature on the treat­
ment of ovarian cancer is complicated by 
the frequent lack of careful staging. As 
an example, removal of the omentum has 
been a major part of treatment, giving 
seemingly worthwhile results. In fact, the 
excision and subsequent histologic exami­
nation of the specimen only serve to 
transfer cases from stage I to stage III. 
The presence or absence of omental me­
tastases therefore is more important to 
prognosis than the excision. Prognosis 
cannot be determined accurately without 
meticulous staging. A final justification 
for precise staging is to allow conserva­
tive therapy in certain cases. Admittedly, 
these are unusual cases, but it is only 
when we can be certain that the disease 
is limited to one ovary that the con­
tralateral ovary and uterus may be con­
served. Staging must be carried out 
accurately and completely, for if it is not, 
a second laparotomy may be undertaken 
to the surgeon’s embarrassment and the 
patient’s anxiety and displeasure.
All proper staging begins with an ade­
quate abdominal incision. It is important 
that in a large series of patients with 
cancer of the ovary referred to a tertiary 
hospital, only 17% had had an adequate 
incision.8 It is impossible to persuade the 
oncologist that staging was complete if 
the incision is other than vertical and does 
not extend above the umbilicus. This 
entire process is impossible through a 
Pfannenstiel incision; its use in these cir­
cumstances and many others is to be 
deplored. The incision should be made 
from 4 cm above to 10 cm below the 
umbilicus.
If ascitic fluid is present, it is immedi­
ately collected (before being contami­
nated with blood) and sent for cytologic 
examination. The presence of malignant 
cells in the peritoneal cavity is the first evi­
dence of dissemination of the tumour. In 
the absence of ascites, 36% of one group 
had positive cytologic findings.9 There­
fore, fluid should be collected for cyto-
Table I—Stages of Primary Carcinoma of the Ovary,
International Federation of Gynecology and Obstetrics,
1971 Classification
Stage Description
I Growth limited to the ovaries
IA Growth limited to one ovary; no ascites
1. No tumour on the external surface; capsule intact
2. Tumour present on the external surface or capsule ruptured, or both 
IB Growth limited to both ovaries; no ascites
1. No tumour on the external surface; capsule intact
2. Tumour present on the external surface or capsule(s) ruptured, or both
IC Tumour either stage IA or IB, but with ascites or positive peritoneal washings
II Growth involving one or both ovaries with pelvic extension
IIA Extension or metastases, or both, to the uterus or tubes, or both
IIB Extension to other pelvic tissues
IIC Tumour either stage IIA or IIB, with ascites present or positive peritoneal washings
III Growth involving one or both ovaries with intraperitoneal metastases outside the pelvis or
positive retroperitoneal nodes, or both
Tumour limited to the true pelvis with histologically proven malignant extension to small 
bowel or omentum
IV Growth involving one or both ovaries with distant metastases; if pleural effusion is pre­
sent, cytologic finding must be positive to allot a case to stage IV 
Parenchymal liver metastases equal stage IV 
Special Unexplored cases thought to be ovarian carcinoma 
category
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logic examination from four areas of the 
peritoneal cavity. A lavage of 50 mL of 
normal saline is done at each site. The 
first specimen is collected from the area 
beneath the right diaphragm. After instil­
lation, the saline is aspirated and sent for 
cell-block analysis. This procedure is 
repeated in right and left peritoneal gut­
ters and finally in the pelvis itself.
The abdomen is then explored. At first, 
the nature of the pelvic mass is deter­
mined. There are sharp limitations to the 
diagnosis of ovarian cancer from the 
gross specimen. The surface of the ovar­
ian tumour may not reflect its contents. 
There is an understandable fear of ovar­
ian biopsy because of the possible spillage 
of malignant contents into the peritoneal 
cavity. In doubtful circumstances, the 
ovary should be removed intact. It is then 
opened in the operating room so that its 
contents may be inspected. Frozen section 
is carried out. These examinations are 
best done by the pathologist.
After the character of the mass is 
defined, all peritoneal surfaces are care­
fully inspected. If rough areas or adhe­
sions are discovered, they are excised and 
sent for histologic analysis with careful 
notation of the site from which they were 
obtained. Such areas are often found to 
contain microscopic tumour deposits. 
Specimens should also be taken of the pel­
vic peritoneum and the peritoneum in 
both gutters, even though they may 
appear normal. Both liver surfaces are 
then palpated, as are the stomach and 
pancreas. The large and small intestines 
and their mesenteries are inspected. The 
lower surface of the right hemidiaphragm 
and the omentum merit special care. The 
undersurface of the diaphragm is involved 
in 15% of apparent stage I and 23% of 
apparent stage II disease.2 In order to 
explore this surface properly, it is neces­
sary to extend the incision. The surface 
of the diaphragm is first palpated and 
then inspected. The inspection may be 
done with a laparoscope, a sigmoidoscope 
or a cold-light source. It is unusual to find 
an adequate description of the find­
ings.2,1°'12 Any suspect nodule is biopsied 
with a Kevorkian biopsy forceps or 
curette. Even if the diaphragm appears 
normal, a small specimen is taken.
Each surface of the omentum is care­
fully examined. Even if it is grossly nor­
mal, its removal from the transverse colon 
is recommended. Although the value of 
this excision has not been proven, in addi­
tion to providing adequate biopsy mate­
rial, it may improve the prognosis.
The retroperitoneal area is next in­
spected. In all patients but those with 
obvious stage III or IV disease, a biopsy 
of any palpated or suspicious node should 
be taken. In all other cases, there is much 
merit in taking biopsy specimens of the 
periaortic nodes at the level of the renal
blood vessels. The retroperitoneal space 
in normal circumstances is easy to work 
in. In order to obtain biopsy material, the 
peritoneum is widely opened and fatty tis­
sue and nodes from the front and sides 
of the inferior vena cava and aorta below 
the insertion of the renal blood vessels are 
removed. Any suspicious pelvic nodes are 
also excised. Finally, if the opposite ovary 
is to be spared, a generous biopsy speci­
men must be taken from it.
Treatment
The basis of treatment is the removal 
of the gross mass of the ovarian tumour 
and its principal metastases. This excision 
does not have to be complete in order to 
be successful. Because of the unique pat­
tern of the dissemination of the disease, 
it is possible to achieve the surgical ob­
jectives by abdominal hysterectomy, bila­
teral salpingo-oophorectomy and omen- 
tectomy.
There are two benefits of this excision. 
The first is immediate, the other long 
term. The immediate benefit is the relief 
of gastrointestinal symptoms and the dis­
appearance of ascites. The long-term 
benefit depends on the cancer’s sensitiv­
ity to appropriate chemotherapy. The 
response to therapy is best, however, if 
the residual tumour masses are small.13 
The reason for this relation between size 
and sensitivity is thought to be connected 
both to the patient’s immune status and 
to tumour kinetics. The immunologic 
resistance the body offers the tumour 
appears to be overwhelmed when the 
tumour mass is large. This resistance can 
be restored with excision of the mass. 
Neoplastic growths are resistant to 
chemotherapy when in a resting cycle. It 
has been shown14 that in the case of 
large tumour masses many of the cells are 
in the resting phase. Excision appears to 
force the remaining tumour into the 
proliferative stage, when it becomes sus­
ceptible to chemotherapy. All data sup­
port the value of this excision. Thus, the 
2-year survival of stage III patients may 
be increased from 15% to 70% if no gross 
tumour remains after the initial surgical 
intervention. It is therefore important to 
be aggressively optimistic when presented 
with patients who have cancer of the 
ovary. There are good reasons for this 
optimism. In most cases it is possible, 
with diligent, time-consuming dissection, 
to excise the tumour mass. The tumour 
is rarely inoperable. It is inoperable only 
when it has covered both peritoneal sur­
faces and has left no individual tumour 
masses that permit excision.
If the involvement is extensive, the hys­
terectomy may be subtotal. The oopho­
rectomies are safely accomplished when 
the retroperitoneal spaces are opened. 
The ureters may then be displayed and the 
ovarian vessels safely ligated so that
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Prescribing Information
Marcaine*
(bupivacaine hydrochloride injection U.S.P.).
Indications:
Peripheral nerve block including retrobulbar block, infiltration, sympa­
thetic blockade, caudal, epidural, and pudendal blocks.
Contraindications:
Bupivacaine is contraindicated in persons with known sensitivity to 
local anesthetics of the amide type.
The use of bupivacaine is contraindicated in the presence of sepsis 
near the site of proposed injection, in severe shock and in heart block.
Warnings:
Usage in Pregnancy: There are no adequate and well-controlled studies 
n pregnant women of the effect of bupivacaine on the developing 
fetus. Decreased pup survival in rats and an embryocidal effect in rab 
bits have been observed when bupivacaine hydrochloride was adminis­
tered to these species in doses comparable to nine and five times 
respectively the maximum recommended daily human dose (400 mg). 
Bupivacaine hydrochloride should be used during pregnancy only if the 
potential benefit justifies the potential risk to the fetus. This does not 
exclude the use of Marcaine 0.25% or 0.50% at term for obstetrical 
anesthesia or analgesia.
Obstetrics: The highest (0.75%) concentration is not recommended for 
obstetrical anesthesia. There have been reports of cardiac arrest with 
difficult resuscitation or death following its use for epidural anesthesia 
in obstetrical patients.
Due to the high risk to the fetus, paracervical block is no longer recom­
mended.
The obstetrician is warned that severe persistent hypertension may 
occur after administration of certain oxytocic drugs, if vasopressors 
have already been used during labor (e.g. in the local anesthetic solu­
tion or to correct hypotension).
Until further experience is gained in children younger than 12 years, 
administration of bupivacaine in this age group is not recommended.
Precautions:
Marcaine (bupivacaine) should be used cautiously in persons with 
known drug allergies or sensitivities, particularly to the amide-type local 
anesthetics.
Caution is advised in administration of repeat doses of bupivacaine to 
patients with severe liver disease.
The lowest dosage that gives effective anesthesia should be used, to 
avoid high plasma levels and serious systemic side effects. Injection of 
repeated doses of bupivacaine may cause a significant increase in 
blood levels due to accumulation of the drug or its metabolites or slow 
metabolic degradation.
Tolerance varies with the status of the patient. Debilitated, elderly and 
acutely ill patients may require reduced doses commensurate with age 
and physical condition.
It should be remembered that solutions containing a vasopressor 
agent, e.g. epinephrine, should be used with caution, if at all, in patients 
who are receiving monoamine oxidase inhibitors or anti-depressants 
of the triptyline or imipramine type, because severe, prolonged hyper 
tension may result. Dose-related cardiac arrhythmias may occur if 
preparations containing epinephrine are employed in patients during or 
immediately following the administration of chloroform, halothane, 
cyclopropane, trichloroethylene or other related agents. In deciding 
whether to use these products concurrently in the same patient, 
the combined action of both agents upon the myocardium, the concen­
tration and volume of vasoconstrictor used, and the time since injec­
tion, when applicable, should be taken into account.
The decision to use a local anesthetic containing a vasoconstrictor in 
areas with a limited blood supply or in patients with peripheral vascular 
disease, will depend on the physician’s appraisal of the relative advan­
tages and risks.
Local anesthetics which contain preservatives, i.e. those supplied in mul­
tiple dose vials, should not be used for caudal or epidural anesthesia. 
Epidural Use: It is advised that a test dose, generally 2-3 mL of 0.5% 
bupivacaine (or other amide anesthetic) containing 1:200,000 epine­
phrine (10-15 micrograms) be administered to check that the spinal 
canal or a blood vessel has not been entered while locating the epidural 
needle or catheter.
In the event of spinal injection clinical signs of spinal block would 
become evident in a few minutes.
In the event of intravascular injection a transient increase in pulse rate 
and possibly momentary increase in systolic blood pressure are 
usually detectable with a monitor. The other symptoms and signs of 
"epinephrine response" are less dependable. The effects of other medi­
cation the patient has received may modify this response.
When reinforcing doses are required the test dose should be used 
again to check the catheter location.
Use in Ophthalmic Surgery: When Marcaine 0.75% is used for retrobul­
bar block, complete corneal anesthesia usually precedes onset of clini­
cally acceptable external ocular muscle akinesia. Therefore, presence 
of akinesia rather than anesthesia alone should determine readiness of 
the patient for surgery.
Adverse Reactions:
Reactions to bupivacaine are characteristic of those associated with 
amide-type local anesthetics. A major cause of adverse reactions to 
this group of drugs is excessive plasma levels, which may be due to 
over-dosage, inadvertent intravascular injection, or slow metabolic 
degradation. Other causes of reactions to these local anesthetics may 
be hypersensitivity, idiosyncrasy, or diminished tolerance.
Excessive plasma levels cause systemic reactions involving the central
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nervous system and the cardiovascular system. The central nervous 
system effects are characterized by excitation or depression. The first 
manifestation may be nervousness, dizziness, blurred vision, or tre­
mors, followed by drowsiness, convulsions, unconsciousness, and pos­
sibly respiratory arrest. Since excitement may be transient or absent, 
the first manifestation may be drowsiness, sometimes merging into 
unconsciousness and respiratory arrest.
Other central nervous system effects may be nausea, vomiting, chills, 
constriction of the pupils, or tinnitus. The cardiovascular manifesta­
tions of excessive plasma levels may include depression of the myocar 
dium, blood pressure changes (usually hypotension), and cardiac 
arrest. Recent clinical reports and animal studies suggest this may be 
more likely to occur with the long acting amide local anesthetics such 
as bupivacaine.
Allergic reactions are characterized by cutaneous lesions (e.g. urticaria, 
edema) and other manifestations of allergy.
Reactions following epidural or caudal anesthesia may include: high or 
total spinal block, urinary retention; fecal incontinence, loss of perineal 
sensation and sexual function; persistent analgesia, paresthesia, and 
paralysis of the lower extremities; headache and backache; and slow­
ing of labor and increased incidence of forceps delivery.
It should be noted that reactions due to systemic absorption may be 
slow or rapid in onset. Those of rapid onset include respiratory depres­
sion, cardiovascular collapse and cardiac arrest. This type of reaction 
necessitates a high degree of preparedness since it can occur with little 
warning.
In co-ordinated studies of 3200 procedures carried out by 15 investiga­
tors. there were 2 severe systemic reactions. Both patients experienced 
convulsions as a result of inadvertent vascular injection.
Fetal bradycardia has been observed with the use of bupivacaine. Most 
cases, including a few fatalities, occurred when the paracervical route 
was used (see "Warnings").
In some subjects bupivacaine may produce marked peripheral vaso­
constriction in unanesthetized areas which may last for several hours.
Treatment of Overdose and Severe Reactions:
Toxic effects of local anesthetics require symptomatic treatment; there 
is no specific cure. The physician should be prepared to maintain an 
airway and to support ventilation with oxygen and assisted or con­
trolled respiration as required. Supportive treatment of the cardiovas­
cular system includes intravenous fluids and, when appropriate, vaso 
pressors (preferably those that stimulate the myocardium).
Convulsions may be controlled with oxygen and intravenous adminis­
tration, in small increments, of a barbiturate or muscle relaxant, as 
follows: preferably, an ultra short-acting barbiturate such as thiopental 
or thiamylal; if this is not available, a short-acting barbiturate (e.g. seco­
barbital or pentobarbital) or a short-acting muscle relaxant (succinyl- 
choline). Intravenous muscle relaxants and barbiturates should only be 
administered by those familiar with their use.
Dosage and Administration:
The duration of anesthesia with bupivacaine is such that, for most pro­
cedures, a single dose is sufficient. Maximum dosage limit must be indi­
vidualized in each case after evaluating the size and physical status of 
the patient, as well as the usual rate of systemic absorption from a par­
ticular injection site. Most experience to date is with single doses of 
bupivacaine up to 225 mg with epinephrine 1:200,000, and 175 mg 
without epinephrine; more or less drug may be used depending on indi­
vidualization of each case.
At present there is insufficient clinical evidence with multiple dosage or 
intermittent dose techniques to permit precise recommendations for 
such procedures to be given. However, limited clinical experience in this 
area of use indicates that bupivacaine may be repeated in 3 to 6 hours 
up to a maximum dose of 400 mg in 24 hours. In most cases the dura­
tion of anesthetic effect is prolonged by the addition of epinephrine.
The following doses have generally proved satisfactory for the average 
adult. They may require adjustment in relation to age and the physical 
condition of the patient.
Local infiltration: up to a maximum dosage of 0.25% solution.
Peripheral nerve block: 5 to 30 mL of 0.50% or 5 to 60 mL of 0.25% 
solution.
Sympathetic: 20 to 50 mL of a 0.25% solution.
Epidural: 10 to 20 mL of a 0.25%, 0.50%, or 0.75%t solution. 
caudal: 15 to 30 mL of a 0.25% or 0.50% solution. 
t0.75% not recommended for obstetric use.
Supplied:
Each 20 mL single dose vial contains: bupivacaine 0.25%, 0.50% or
0. 7 5 .  with or without epinephrine 1:200,000. Boxes of 5 vials.
Each 50 mL multiple dose vial contains: bupivacaine 0.25% or 0.50%. 
Boxes of 1 vial.
Note: Bupivacaine solutions without epinephrine may be autoclaved. 
Product Monograph available on request.
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any ovarian mass can then be removed 
easily and safely. When the tumour 
involvement of the omentum is limited, 
its removal from the transverse colon is 
all that is needed. If, however, the tumour 
extends further, the lesser sac should be 
opened and the omentum removed from 
the greater curvature of the stomach. 
Radical and aggressive surgery should not 
extend to the excision o f metastatic 
lesions on the intestines. No data suggest 
that survival is improved when segments 
of the intestine are removed. Since 
obstruction is rarely isolated and intesti­
nal malfunction is an added complicat­
ing factor, the least possible intestinal sur­
gery should be done.
Summary
Epithelial cancer of the ovary often 
masquerades as a bowel disturbance. The 
first surgeon, often operating in the most 
adverse circumstances, has tjie best 
chance to effect a cure and ensure proper 
postoperative care. To achieve these pur­
poses, the natural course o f the disease 
must be taken into account. Once this 
course is understood, staging is likely to 
be complete and special efforts will be 
made to ensure that excision is adequate. 
With postoperative chemotherapy these 
patients can then look to the future with 
optimism.
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Mitral Valve Replacement With Hancock Porcine 
Bioprostheses: Up to 7-Year Follow-up
From February 1976 to May 1981 at the 
University of Ottawa Heart Institute, 137 
mitral valves were replaced with the 
Hancock porcine bioprosthesis. This 
study concerns 111 patients (55 men,
56 women) who had single-valve 
replacement. The average age of the 
patients was 53.0 years. The 
predominant lesion in the 102 patients 
who were receiving their first substitute 
valve was stenosis in 4 6 %  and regurgi­
tation in 42% . Preoperatively, 8 2 %  were 
New York Heart Association (NYHA) 
class III or IV. Additional procedures 
were performed in 44 patients (39.6% ). 
The 26 patients who had multiple valves 
replaced were considered only for dura­
bility studies.
Hospital mortality was 8 .9 %  for iso­
lated replacement and 2 2 %  for replace­
ment associated with aortocoronary 
bypass grafting. At the time of dis­
charge, 50%  of patients were in atrial 
fibrillation, 14% were taking warfarin 
and 82%  antiplatelet agents. Follow-up 
was available for a total of 374 patient- 
years (average of 5.4 years per patient). 
The mean symptomatic improvement 
was 1.6 NYHA classes per patient. Actu­
arial analysis indicated a survival rate of 
70%  at 8 years. Of the 18 late deaths,
4 (22% ) were valve-related. The rates of 
endocarditis and thromboembolism were 
1 .1%  and 5 .8%  patient-year respec­
tively. In the 137 prostheses at risk, 
intrinsic failure occurred at the rate of 
4 .7 %  patient-year for a cumulative rate 
of 35%  at 8 years.
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The authors conclude that the Han­
cock porcine bioprosthesis provides good 
relief of symptoms in the mitral position 
with an acceptable rate of thromboem­
bolism even without anticoagulation. 
Unfortunately, in this position the 
prosthesis has a high late failure rate and 
is therefore not recommended.
A I'institut de cardiologie de I'Universite 
d'Ottawa, de fevrier 1976 a mai 1981, 
137 valvules mitrales ont ete remplacees 
par des protheses de Hancock d'origine 
porcine. Cette etude porte sur 111 
patients (55 hommes, 56 femmes; age 
moyen: 53.0 ans) qui ont subi un rem- 
placement monovalvulaire. Chez 102 
malades qui en etaient a leur premier 
remplacement, les principales lesions 
etaient la stenose (46% ) et la regurgita­
tion (42% ). En preoperatoire, 8 2 %  etaient 
dans les classes III et IV de la New York 
Heart Association (NYHA). Des interven­
tions additionnelles ont du etre prati- 
quees chez 44 patients (3 9 .6 % ). Vingt- 
six malades chez qui on remplaca plus 
d'une valvule n'ont ete consideres que 
pour les etudes de durability.
La mortality hospitaliere fut de 8 .9 %  
pour les remplacements isoles et de 2 2 %  
pour les remplacements associes a des 
pontages aorto-coronariens. Au moment 
de recevoir leur conge, 5 0 %  des patients 
faisaient de la fibrillation auriculaire,
14%  prenaient de la warfarine et 82%  
des anti-agregants plaquettaires. Des 
examens de controle existent pour un 
total de 374 patients-annees (soit une 
moyenne de 5.4 annees par patient). 
L'amelioration symptomatique moyenne 
fut de 1.6 classes NYHA par patient. 
L'analyse actuarieile indique une survie de 
7 0 %  a 8 ans. Des 18 deeds tardifs, 4 
(2 2 % ) etaient relies d un probleme valvu- 
laire. Les taux d'endocardite et de 
thrombo-embolie par patient-annee ont 
yte, respectivement, de 1.1% et 5 .8% . 
Des 137 protheses a risque, une defail- 
lance intrinseque est survenue au rythme
de 4 .7 %  patients-annees pour un taux 
cumulatif de 3 5 %  apres 8 ans.
Les auteurs concluent que dans le rem­
placement de la valvule mitrale la pro- 
these porcine de Hancock offre un bon 
soulagement des symptomes avec un 
taux acceptable de thrombo-embolie 
meme sans anticoagulation. Malheureu- 
sement, dans cette indication elle a aussi 
un haut taux de defaillance et ne peut 
dont etre recommandee.
The Hancock porcine bioprosthesis has 
been the most widely used o f  all tissue 
valves. In the last few years there has been 
a growing concern in the surgical field 
regarding its long-term behaviour.1'6 
Therefore, we reviewed our results with 
this valvular substitute, which we have 
used only in the mitral position.
Patients and Methods
Patients
From February 1976 to May 1981 at the 
University of Ottawa Heart Institute, 137 
glutaraldehyde-stabilized Hancock por­
cine heterografts were implanted in the 
mitral position. There were 111 single­
valve replacements, 21 double-valve 
replacements (20 mitral-aortic) and 5 
triple-valve replacements. All double- and 
triple-valve replacements included the use 
of other types o f substitutes. These 
patients were not considered, except for 
durability studies.
Of the 111 patients who had a single 
mitral valve replaced, 55 were men 
(mean age 53.6 years) and 56 women 
(mean age 52.4 years). Only two men and 
two women were younger than 30 years. 
Twenty-nine (26%) had undergone a 
previous commissurotomy. Nine under­
went reoperation for dysfunction of a 
previous prosthesis. Of the 102 patients 
receiving their first substitute, 47 (46%) 
had predominant stenosis and 43 (42%) 
predominant regurgitation; there was no
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definable predominance in 12 (11.8%). 
Table I shows the symptom status 
preoperatively in 108 of the patients. 
Eighty-nine of these (82.4%) were NYHA 
class III or IV. There were 44 combined 
operative procedures (39.6%), most often 
coronary artery bypass grafting (27/111 
patients, 24.3%).
Follow-up (Table II)
All surviving patients were registered 
with the Valvular Surgery Follow-up 
Clinic. They were examined at yearly 
intervals, if they were living in our geo­
graphic area. They were specifically ques­
tioned about complications related to the 
prosthesis. Telephone interviews with the 
patients and their physicians were con­
ducted if the patient lived too far from 
Ottawa for a personal visit. Two patients 
were lost to follow-up. The other sur­
vivors were followed up for from 32 to 
92 months (374 patient-years, an average 
of 5.4 years per patient). Including 
double- and triple-valve replacements, 
113 valves have been at risk, 63 for more 
than 5 years.
Calculations
Survival and event-free actuarial prob­
ability curves were constructed using the 
method of Cutler and Ederer as presented 
by Grunkemeier and Starr.7 Linearized 
rates of complications were calculated as 
R = E /T , where R is the rate in percent 
patient-year, E is the total number of 
events occurring in each group and T is 
the total follow-up time accounted for by 
all the members of the group as of the 
study date, whether or not they had the 
event.8
Results
Mortality
The hospital mortality (death within 30 
days of operation) was 11.7% (13/111) 
overall, 8.9% for isolated mitral valve 
replacement and 22.2% for mitral valve 
replacement and coronary artery bypass 
grafting. Two early deaths may have been 
related to the prosthesis as they were 
secondary to carotid artery embolism. 
There were 18 late deaths, 11 (61%) from 
cardiac causes, 2 (11 %) from non-cardiac 
causes, 1 from an unknown cause and 4 
(22%) related to the valve (2 from 
endocarditis and 2 secondary to throm­
boembolic complications). The linearized 
death rate was 4.8% patient-year, with an 
actuarial probability of survival of 69.8 
± 4.6% at 6 years (Fig. 1).
Thromboembolic Complications
It has been our policy to place all 
patients with porcine bioprostheses on a 
combination of dipyridamole and acetyl-
salicylic acid (150 mg and 975 mg daily) 
after a 5- to 7-day course of mini­
heparinization. Warfarin anticoagulation 
has been reserved for high-risk patients 
(i.e., those with clots in the left atrium at 
surgery or a combination of atrial fibril­
lation and giant left atrium). At dis­
charge, 14.3% of patients (14/98) were 
taking warfarin, and 82.6% (81/98) 
dipyridamole and acetylsalicylic acid. Of 
the 96 patients with documented predis­
charge electrocardiograms, 48 were in 
atrial fibrillation. Of these, only seven 
(14.6%) were taking anticoagulants.
All episodes of neurologic symptoms, 
transient or permanent, focal or not well 
defined, and all episodes of acute vascu­
lar insufficiency, were considered to be 
secondary to thromboembolism. Twenty- 
two episodes occurred in 18 patients. 
There were seven transient ischemic 
attacks, nine frank cerebrovascular acci­
dents (one fatal) and six peripheral 
embolic episodes (one fatal). Twelve of 
these 18 patients were in atrial fibrillation 
at the time of discharge, 5 in normal sinus 
rhythm, and for 1 the type of rhythm was 
unknown. At the time of the thromboem­
bolic event, 11 patients had been in atrial 
fibrillation since surgery, 3 were in nor­
mal sinus rhythm, for 6 the rhythm was 
unknown, 1 patient had a pacemaker and 
one thromboembolic episode was secon­
dary to bacterial endocarditis. At the time 
of the episode, 11 patients were on 
dipyridamole and acetylsalicylic acid, 3 
on warfarin with or without dipyrida­
mole, 1 on heparin, 5 on no specific ther­
apy and for 2 the anticoagulation status 
was unknown.
The episodes occurred from 5 days to 
64 months after valve replacement 
without any significant time predom­
inance after the first year. The linearized 
incidence was 5.8% patient-year, with an
Table 1-Preoperative Status, New York Heart 
Association Classification (n = 108*1
No, of
NYHA class patients %
1 6 5.5
II 13 12.0
III 47 43.5
IV 42 38.9
’ Status not recorded for 3 patients.
Table II—Follow-up Details
No. of 
patients
Single mitral valve replacement 111
Discharged 98
Long-term deaths 18
Reoperation 9
Lost to follow up 2
Available for follow-up 69
actuarial probability of being free of 
thromboembolism of 73.4 ± 5.1% at 6 
years (Fig. 2). There were also four epi­
sodes of bleeding for which the patients 
required either hospitalization or trans­
fusion.
Endocarditis
There were five episodes of bacterial 
endocarditis, one early at 2 months after 
operation and four late, from 8 to 64 
months. One patient was successfully
YEARS
FIG. 1—Actuarial probability of survival, 
n = number of patients entering each inter­
val, deaths = number of deaths during same 
interval, bars denote mean ± standard error 
of mean, dotted line = less than 25 patients 
completing interval.
FIG. 2—Actuarial probability of throm­
boembolic complications, n = number of 
patients entering each interval, events = num­
ber of complications during same interval, bars 
denote mean ±  standard error of mean, dot­
ted line = less than 25 patients completing 
interval.
YEARS
FIG. 3—Actuarial probability of endocardi­
tis. Format is similar to that in Fig. 2.
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treated medically, two underwent reoper­
ation and survived and two died in septic 
shock. The linearized rate of endocardi­
tis was 1.3% patient-year, with an actu­
arial probability of being free of 
endocarditis of 92.2% ± 3.5% at 6 years 
(Fig. 3).
Reoperation
Of the 113 patients with valves initially 
at risk (including double- and triple-valve 
replacements), 14 required reoperation at 
a mean interval of 51 months. Two 
patients had paravalvular leaks, two 
endocarditis, eight intrinsic tissue failure 
and two had hemodynamic compromise. 
The linearized rate of reoperation was 
3.3% patient-year, with a probability of 
not requiring reoperation of 87% ± 
4.4% at 6 years.
Valve Failure
All patients seen at follow-up were 
assessed for signs of prosthetic failure. 
Failure was defined as the appearance of 
a new murmur, reoperation or death 
secondary to a new hemodynamic lesion. 
Ten patients had their valve removed for 
intrinsic tissue failure. Four patients had 
new diastolic murmurs and five new pan- 
systolic murmurs. In one patient who died 
of thromboembolic complications, the 
valve was found to have thrombosed. 
There were 20 instances of valve failure, 
with 10 occurring after 5 years when the 
rate of failure was 14.6% patient-year.
FIG. 4—Actuarial probability o f valve 
failure. Format is similar to that in Fig. 2.
The actuarial probability of the valve 
being free of failure was 65% ± 7.4% 
at 7 years (Fig. 4).
Clinical Status
Table III shows the clinical status of the 
69 patients with isolated mitral valve 
replacement at the latest follow-up visit. 
There was substantial functional improve­
ment with an average gain of 1.61 NYHA 
classes per patient. Preoperatively, 82% 
of patients were in classes III and IV. At 
the last follow-up, 96% were in classes I 
and II. Only two patients considered 
themselves worse than before they under­
went valve replacement.
Discussion
The Hancock bioprosthesis, in use for 
14 years, has been the most widely 
implanted tissue valve. It was by far the 
most popular bioprosthesis in the 1970s, 
but several reports at the end of that 
decade, concerning the increasing rate of 
late failure, raised doubts in the minds of 
surgeons.2-4,6,9
Our experience seems similar to that of 
other centres. With respect to long-term 
mortality, most deaths seem to be related 
to the basic cardiac condition; only 4 of 
the 18 deaths (22%) were related to val­
vular complications. The overall late mor­
tality of 4.8% patient-year is similar to 
the rates reported by others (ranging from 
5.5% to 6.9%).3,10
We have not used anticoagulation rou­
tinely and have thus had a low overall rate 
of bleeding complications (1.0% patient- 
year). However, the rate of thromboem­
bolic complications is relatively high at 
5.8% patient-year for the whole group 
with 12 of the 48 patients who were in 
atrial fibrillation at the time of discharge 
eventually suffering thromboembolism. 
As shown by many authors,2,3,11 atrial 
fibrillation seems to be an important fac­
tor in the etiology of thromboembolism 
with the Hancock porcine valve. This may 
in part be related to the somewhat res­
tricted flow pattern across the prosthesis, 
leading to some degree of stagnation in 
the immobile fibrillating atrium. In con­
trast, in our experience with the Ionescu-
Shiley valve, which is known for its bet­
ter hemodynamic properties,12 none of 
the patients with mitral valve replacement 
who had thromboembolism were in atrial 
fibrillation either at discharge or at the 
time of throm boem bolism .13 The 
reported incidences of thromboembolism 
may be intrinsic to each type of substi­
tute, as suggested by Ionescu and col­
leagues,14,15 and may not be really 
prevented by anticoagulation. In our 
experience, 3 of the 14 patients taking 
warfarin at the time of discharge suffered 
from thromboembolism, while only 11 of 
the 81 patients on antiplatelet agents had 
such a complication. Of course, in our 
group warfarin was prescribed to patients 
with a higher risk of thromboembolic 
complications and was not given rou­
tinely.
The major problem with the Hancock 
bioprosthesis is the high rate of late 
failure. This phenomenon is now well 
described.2,3,5,6,9,16 It develops rapidly in 
young patients or patients with altered 
calcium metabolism,1,4,17-19 and some 
theories on its etiology have been sug­
gested.5,18,20,21 The quoted probability of 
the valve being failure-free at 5 years 
ranges from 58% to 98%, with linearized 
rates of failure of 1.1 % to 7.1 %, this rate 
tripling after 5 years.3-5,9,11 Recent 
reports have shown a much higher failure 
rate when the valve is used in the mitral 
position compared with the aortic posi­
tion.2,5,6,9 This would be related to a 
higher mechanical stress from the left ven­
tricular systolic pressure. The rate of 
failure in our patients is comparable at 
14.6% patient-year after 5 years with only 
65% of the valves being failure-free at 7 
years.
The Hancock bioprosthesis has a good 
initial performance in the mitral position. 
This is manifested by a good symptomatic 
improvement (1.6 NYHA classes per 
patient) and 96% of the patients being in 
classes I and II at the latest follow-up. 
However, there is a relatively high inci­
dence of thromboembolism with atrial 
fibrillation playing an important role. In 
our experience as in that of others,22 the 
use of warfarin does not seem to reduce 
the incidence of thromboembolism and is 
still associated with a high rate of bleed­
ing complications. Finally, the rate of 
valve failure in the mitral position is dis­
tressing and not acceptable.
For these reasons we have discontinued 
the use of this substitute and do not 
recommend it for mitral valve re­
placement.
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Table Ill-Current Clinical Status, NYHA Class
NYHA class 
preoperatively
NYHA class postoperatively Totals
1 II III IV No. %
1 5 1 0 0 6 9
II 4 3 0 0 7 10
III 17 15 2 0 34 49
IV 14 7 0 1 22 32
Totals
No. 40 26 2 1 69
% 58 38 3 1 100
Average gain: 1.61 NYHA classes per patient.
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TABLE 1
Strong analgesics and structurally related drugs used in the treatment of cancer pain*
Non-proprietary 
(trade) name
IM or SC administration
Dose, mg 
equianalgesic to 
10 mg of IM morphine1
Duration 
compared with 
morphine
Morphine sulfate 10 Same
Papaveretum (Pantopon) 20 Same
Hydromorphone (Dilaudid) hydrochloride 1.3 Slightly shorter
Oxymorphone (Numorphan) hydrochloride 1.1 Slightly shorter
Nalbuphine (Nubain) hydrochloride •12 Same
Heroin, diamorphine hydrochloride (NA in USA) 4-5 Slightly shorter
Levorphanol (levo-Dromoran) tartrate 2.3 Same
Butorphanol (Stadol) tartrate 1.5-2.5 Same
Pentazocine (Talwin) lactate or hydrochloride 60 Same
Meperidine pethidine (Demerol) hydrochloride 80 Shorter
Methadone (Dolophine) hydrochloride 10 Same
‘ From Beaver, WT. Management of cancer pain w ith parenteral medication. JAMA 1980; 244:2653-2657.
f ln terms of the area under the analgesic tim e-effect curve. 
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Preventing Superficial Phlebitis During Infusion of Crystalloid
Solutions in Surgical Patients
Thirty patients who received routine 
intravenous therapy <3.3% dextrose and 
0.3%  normal saline at a rate of 100 
mL/h) were randomized prospectively 
into two groups to receive an antiphle- 
bitic mixture of heparin-hydrocortisone- 
sodium bicarbonate or placebo in a 
double-blinded fashion for 4 to 7 days. 
The code was then broken and the data 
were analysed using x2 analysis with 
respect to the clinical grade and inci­
dence of phlebitis. Phlebitis developed in 
2 of 14 study and 10 of 16 control 
patients. All study patients tolerated 
their intravenous lines longer and needed 
less restarting. The antiphlebitic mixture 
effectively prevented superficial infusion 
phlebitis in patients receiving dextrose- 
saline solutions.
Trente patients soumis a un traitement 
intraveineux de routine (dextrose a 3.3%  
et chlorure de sodium a 0.3%  au rythme 
de 100 mL/h) ont ete repartis au hasard 
de facons prospective a deux groupes 
qui ont recu a double-insu soit un 
melange anticoagulant compose d'hepa- 
rine, d'hydrocortisone et de bicarbonate 
de sodium, soit du placebo, pendant 4 a 
7 jours. Apres quoi, le code d'attribution 
du hasard a ete ouvert et les donnees 
relatives au stade Clinique et & la fre­
quence des phlebites ont ete analysees 
au moyen du test du x2- Des phlebites 
sont survenues chez 2 des 14 patients 
experimentaux et chez 10 des 16 
temoins. Tous les sujets du groupe expe­
rimental ont pu tolerer leur ligne d'admi-
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nistration intraveineuse et ont necessity 
moins de remises en route. Le melange 
anticoagulant a protege de facon efficace 
contre la phlebite superficielle de perfusion 
des patients qui recevaient des solutions 
de dextrose et de chlorure de sodium.
Superficial phlebitis secondary to the 
intravenous administration of fluids 
affects 25% to 70% of all hospitalized 
patients.1 Phlebitis is more prevalent on 
surgical wards where each patient oper­
ated upon receives crystalloid solutions 
for 24 hours or longer. Phlebitis results 
in patient discomfort because of pain and 
swelling. Restarting augments this dis­
comfort, increases nursing time and cost, 
and delays the proper timing of impor­
tant medications because they cannot be 
administered until a new vein is cannu- 
lated. To reduce the incidence of phlebi­
tis and accelerate restarting, many hospi­
tals have resorted to specialty teams. With 
such teams the incidence of phlebitis is 
decreased, indicating that the technique 
used for insertion is one important fac­
tor in its cause.2’3 Unfortunately, these 
teams are costly in economic terms.
The cause of phlebitis is not related to 
the technique of insertion alone. Other 
factors include the pH of the solution 
infused, osmolarity, medications infused 
into the vein, vein diameter and the type 
of catheter used. Each variable has been 
studied before, but to date no study has 
attempted to control all of these impor­
tant variables.4-8 For example, studies 
dealing with the prevention of phlebitis 
are unreliable if the medications infused 
into the line are uncontrolled. This is par­
ticularly important for surgical patients 
since, during anesthesia, many drugs 
known to irritate the intima of veins are 
administered.
Patients and Methods
Thirty patients from one surgical floor 
of the Ottawa General Hospital were 
entered into the study after informed con­
sent was obtained. The protocol was 
approved by the Human Experimental 
Procedures Committee. All patients were 
scheduled to receive 3.33% dextrose in 
0.3% saline (“Vi-'A”), as part of their
regular intravenous therapy, at a rate of 
100 mL/h by constant infusion pump. 
Additional fluids, medications or electro­
lytes were given through separate intra­
venous lines when required.
Using a table of random numbers, the 
pharmacist assigned patients to receive 
either a placebo or the following anti­
phlebitic mixture (APM) in each litre of 
dextrose-saline solution: heparin 1000IU, 
hydrocortisone 5 mg and sodium bicar­
bonate 2.5 mmol.
Teflon catheters, 20 gauge, were used. 
All insertions were carried out by two of 
the authors using identical technique, 
according to a protocol similar to that 
used for subclavian catheters during total 
parenteral nutrition. Under sterile condi­
tions, the skin was cleaned with acetone 
and scrubbed with povidone-iodine solu­
tion. Following catheter insertion, 
povidone-iodine ointment was applied 
and the area covered with a semiperme- 
able membrane.9 Arm boards and gauze 
wraps were used when indicated to pro­
tect intravenous lines located in precari­
ous positions. Signs indicating that the 
patient was part of a study were attached 
to the bed and the intravenous site to pre­
vent administration of other medications 
through the cannula and, when patients 
went to the operating room, we spoke to 
the anesthetist-in-charge to make sure 
that this problem did not occur. Addi­
tional bags of fluid accompanied the 
patient to ensure a constant flow during 
operation and in the recovery room.
The intravenous sites were monitored 
for phlebitis four times daily by the same 
two persons. Educational seminars were 
given to nursing staff before and during 
the 12-month study to ensure prompt 
reporting of infiltrated or phlebitic lines. 
In this way, we were able to distinguish 
between mechanical infiltration and phle­
bitis. Phlebitis was graded as follows: 
grade 1 — pain, no erythema; grade 2— 
pain with erythema or edema, or both; 
grade 3 — grade 2 plus palpable venous 
cord; grade 4 — grade 3 plus induration; 
grade 5 — frank thrombosis, alone or 
with induration.
For practical and ethical reasons we 
discontinued the intravenous therapy 
whenever a phlebitis of grade 2 or greater
124 VOLUME 28, NO. 2, M ARC H  1985 /  THE CANADIAN JOURNAL OF SURGERY
toccurred. The intravenous infusion was 
restarted at another site. If a second epi­
sode of phlebitis occurred, the numerical 
gradings were added to the previous 
grade.
All catheters were removed by the same 
two authors. Those in patients with phle­
bitis (total of 24) were sent immediately 
for semiquantitative cultures of the tip, 
using the technique of Maki.2 The 
presence or absence of a fibrin clot was 
noted.
The project continued until we had 
obtained 30 complete 4- to 7-day studies 
at which time the code was broken and 
the data were analysed in consultation 
with the Department of Statistics.
Results
When the code was broken, the patient 
composition was found to consist of 14 
patients who had received the antiphle- 
bitic mixture and 16 controls who had 
not.
In 2 (14%) of the 14 study patients, 
grade 2 phlebitis developed; in 1 of these 
the phlebitis did not occur until after 120 
hours of infusion. On the other hand, 
phlebitis developed in 10 (62.5%) of the 
16 controls (p < 0.02). Of the 10, 1 had 
grade 1 phlebitis, 2 had grade 2, 6 had 
grade 3 and 1 had grade 4 phlebitis. The 
intravenous infusion had to be stopped 
due to phlebitis in four of the control 
patients, and had to be restarted 32 times 
compared with 18 times for the patients 
who received antiphlebitic mixture. The 
total duration of infusion was shorter 
(due to early onset of phlebitis) in the 
former group (48 hours versus 87 hours).
Of the 50 catheters used, the tips of 24 
were cultured; only 1 contained bacteria 
(less than 15 colonies of diphtheroid 
bacilli). None of the catheters had fibrin 
clots.
Discussion
The antiphlebitic mixture we used per­
mitted the infusion of dextrose-saline 
solutions for 4 to 7 days with very few 
restarts and a remarkably low frequency 
of phlebitis. This is an important advan­
tage on a busy general surgical unit where 
phlebitis causes patient discomfort, delays 
delivery of medications and may lead to 
unnecessary and expensive tests to rule 
out other causes of fever. Such an anti­
phlebitic mixture might also obviate the 
need for intravenous teams since frequent 
restarting is not necessary. This would 
account for a substantial reduction in 
cost.
Another consideration is the delivery of 
nutrients intravenously. Not all hospitals 
have nutrition support services and the 
insertion and care of subclavian catheters 
may become difficult if not impossible. 
Such hospitals use various methods of
peripheral parenteral nutrition. This is 
reasonably efficacious, but the hyper­
osmolar amino acid-dextrose solutions 
produce phlebitis even more frequent­
ly.10 Studies dealing with the prevention 
of phlebitis during peripheral parenteral 
nutrition are currently under way in our 
institution. The preliminary data are 
remarkably similar to those reported here, 
indicating that the mixture prevents phle­
bitis under these conditions as well.
Five factors have been directly cor­
related with the high incidence of post­
infusion phlebitis in hospitalized 
patients:1’2’11 the formation of clots 
around the catheter tip in 24 hours due 
to trauma from catheter insertion; the 
irritative properties of drugs; the low pH 
of most commonly used intravenous 
fluids; particulate matter from the 
intravenous bottle or other materials; and 
finally infection secondary to poor tech­
nique or contamination from the skin 
around the catheter insertion site. It has 
been recommended that the intravenous 
site be changed every 24 to 36 hours,2 
but phlebitis is not eliminated by this 
procedure which is impractical and pain­
ful, particularly when therapy is needed 
for more than 5 days.
It is essential to differentiate infiltra­
tion from phlebitis. A dislodged catheter 
results in the infusion of fluids into 
perivenous tissues. This produces an 
inflammatory response simulating phle­
bitis. It is important to eliminate factors 
that may promote phlebitis such as the 
type of intravenous catheter, insertion 
technique and drugs given through the 
catheter during and after operation. A 
large, poorly inserted plastic catheter 
through which medications are infused 
into a small vein results in phlebitis 90% 
of the time.3 Ours was the first study to 
control all of the variables involved in the 
development of phlebitis and to combine 
three different compounds known to have 
antiphlebitic effects in an effort to reduce 
the incidence of phlebitis.
Heparin is thought to prevent phlebi­
tis by effecting ionic changes in the vein 
wall, thereby setting up a protective 
hydrostatic barrier.8 Others believe that 
heparin prevents the deposition of fibrin 
which acts as a nidus for the accumula­
tion of bacteria, particulate matter or 
drug by-products. Fibrin accumulates on 
most catheters within 24 hours, including 
those inserted into large veins such as the 
subclavian.2 This is corroborated by the 
observation that local high concentrations 
of heparin, added to the intravenous infu- 
sate, reduce the incidence of phlebitis 
from 50% to 10%.5’8 Low-dose heparin 
given systemically reduces the incidence 
of phlebitis from 50% to 25%, presuma­
bly also by preventing the formation of 
fibrin clots.8 However, some authors 
have been unable to demonstrate a
favourable effect of heparin.3-12 Further­
more, those studies that did demonstrate 
salutary effects were either uncontrolled 
or used other compounds, such as buffers 
or steroids, as well.6,13 As previously 
noted, in our series no fibrin clots were 
found in any of the 24 catheter tips exa­
mined, suggesting either that heparin was 
not necessary in the antiphlebitic mixture 
or that it acted in some other manner. The 
homeopathic doses of heparin that were 
used did not produce any complications 
of note — only a single episode of 
hematemesis has been reported to date.5
The anti-inflammatory effects of 
steroids were assessed by Isaacs and 
associates.6 They infused an amino acid- 
dextrose-electrolyte mixture with an 
osmolarity of 900 mOsm/L for an aver­
age of 114 hours before phlebitis neces­
sitated a change. However, they did not 
regulate the pH and control subjects were 
not studied. Others have studied the com­
bined effects of heparin and cortisone. 
Although other factors were uncontrolled 
and infusion rates varied greatly, a reduc­
tion in phlebitis for 72 to 104 hours was 
observed.4’6,7
Hence, despite arguments for the 
beneficial effects of each of the antiphle­
bitic materials referred to, no previous 
study has combined heparin, steroid and 
buffers while at the same time using 
blinded control and study subjects and 
eliminating other causative variables.
We thank J. Garber, RN, for technical 
assistance and the surgical nursing staff of the 
seventh floor of the Ottawa General Hospital. 
We are also grateful to Ms. Catherine Oxley 
from the Infection Control Service who per­
formed the catheter cultures.
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Transabdominal Total Fundoplication Gastroplasty to 
Control Reflux: a Preliminary Report
Transthoracic total fundoplication gas­
troplasty has been reported as having a 
low mortality and a 1 .1%  recurrence 
rate and to produce excellent results in 
93 .1 %  of patients, moderate results in 
3 .7 %  and poor results in only 2 .8 %  of 
patients. In approximately 7 .0 %  inter­
costal neuritis is a serious residual 
problem. The transabdominal total fun­
doplication gastroplasty uses the identi­
cal repair technique but avoids the chest- 
wall pain. Previous esophageal or gastric 
surgery and major esophageal shortening 
are contraindications to an abdominal 
approach.
The authors report their results with 
50 patients who underwent transabdomi­
nal total fundoplication gastroplasty and 
were followed up for 6 to 20 months.
There was no mortality or major mor­
bidity. Clinical follow-up was complete, 
9 4 %  of patients were assessed by roent­
genography and 72%  by manometry. 
None had anatomic recurrence, 46 
(9 2 % ) were asymptomatic and 4 (8% ) 
had minor residual gastric symptoms of 
fullness or occasional epigastric pain. All 
were much improved and none had 
wound pain.
Long-term follow-up of transabdominal 
total fundoplication gastroplasty is 
necessary; however, since the technique 
of repair is identical to the thoracic 
approach, the results should be similar.
On reconnaft a la gastroplastie transtho- 
racique par plicature totale du fundus, 
une mortalite peu elevee et un taux de 
recidive de 1.1% seulement. Elle donne 
des resultats dans 93.1%  des patients.
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moyens dans 3 .7 %  et mediocres dans 
2 .8 % . Une nevrite :itercostale demeure 
un problbme residue! serieux chez envi­
ron 7 .0 %  des patients. La gastroplastie 
transabdominale par plicature totale du 
fundus fait appel a une technique de 
reflection identique sans causer de dou- 
leur de la paroi-thoracique. L'abord abdo­
minal est contre-indique chez les patients 
que ont deja subi une chirurgie oesopha- 
gienne ou gastrique, ou un raccourcisse- 
ment important de I'oesophage.
Les auteurs decrivent les resultats 
obtenus chez 50 patients qui ont subi 
une gastroplastie transabdominale par 
plicature totale du fundus. La surveil­
lance des suites therapeutique s'etale sur 
6 a 20 mois.
II n'y a eu ni mortalite ni morbidity 
importante. Tous les patients ont subi 
des examens cliniques de controle, 94%  
ont ete evalue par radiographie et 72%  
par manometrie. II n'y a eu aucune reci­
dive anatomique, 46 (92% ) sont deve- 
nus asymptomatiques et les 4 autres 
(8 % ) n'avaient plus que de symptomes 
gastriques mineurs: plenitude et douleur 
epigastrique occasionnelle. Tous furent 
considerablement ameliorer; aucun n'a 
souffert de douleur au niveau de la cica­
trice.
II est maintenant necessaire de faire 
une surveillance a long terme de la gas­
troplastie transabdominale par plicature 
totale du fundus. Cependant, comme la 
technique operatoire est la meme que 
pour l'abord thoracique, les resultats 
devraient etre similaires.
Gastroplasty was first described by Collis 
in 19611 for the management of the scar- 
shortened esophagus. Since then the oper­
ative technique has changed and a vari­
ety of operations have been described, 
including the Belsey gastroplasty,2 the 
uncut Belsey gastroplasty,3 the uncut 
total fundoplication (Nissen) gastroplas­
ty4 and the total fundoplication gas­
troplasty (TFG).5
In a personal series6 of transthoracic 
TFGs with a 5-year follow-up, the mor­
tality was 0% and the anatomic recur­
rence rate 1.1%. Excellent results were
achieved in 93.1%, moderately good 
results in 3.7% and poor results in 2.8%.
The most serious disadvantage o f the 
transthoracic approach is that it causes 
chest-wall discomfort. Although in most 
patients this becomes a minor irritant, in 
approximately 7% it is persistent and in 
a few patients intercostal neurectomy and 
wound revision are necessary. Transab­
dominal TFG was developed to eliminate 
this problem. The technique of hernia 
repair is identical to that used transtho- 
racically.
This is a preliminary report of the early 
results achieved with transabdominal 
TFG.
Patients and Methods
Fifty consecutive patients have been 
evaluated and treated surgically by trans­
abdominal TFG. There were 35 women 
and the average age was 45.9 years (rang­
ing from 18 to 67 years). The patients 
were studied by history, radiology, 
manometry with pH and with acid per­
fusion (Bernstein test) and esophagogas- 
troduodenoscopy.
A detailed history was obtained using 
a prepared format. This included a his­
tory of reflux, a diagrammatic display of 
pain distribution and an evaluation of 
past medical and surgical treatment. 
Follow-up roentgenography was con­
ducted by the same radiologists as 
preoperatively and included water-siphon 
tests for reflux.
Manometrie data were recorded using 
a Honeywell U.V. vesicorder (Honeywell 
Ltd., Toronto, Ont.). Constant water 
infusion at a rate per minute o f 6.8 
mL/tube was obtained using a direct- 
drive syringe pump and three fused poly­
ethylene catheters. A Beckman probe 
(Beckman Instruments Inc., Toronto, 
Ont.) and pH monitor were used to 
record pH change or reflux, using the 
common cavity test of abdominal com ­
pression.
Esophagogastroduodenoscopy was 
conducted under local anesthesia.
Following investigation, all patients 
underwent transabdominal TFG. A mid­
line upper abdominal incision is used. The
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sternum is elevated using a Goligher 
retractor. The left lobe of liver is mobi­
lized by dividing the triangular ligament. 
The lesser sac is entered and the hepatic 
branch of vagus preserved. The greater 
curvature is mobilized by dividing the 
proximal four short gastric vessels. When 
exposure is difficult the vessels are 
clipped. The esophagogastric junction is 
now fully mobilized by dividing the 
phrenoesophageal ligament. Care is taken 
to preserve the vagi and the peritoneal 
coverings of the crurae.
The esophagogastric fat pad is 
removed. Posterior crural sutures of no. 
1 silk are placed, taking care to make deep 
bites into muscle and to incorporate 
peritoneum. Three to four sutures are 
usually placed and tied later (Fig. 1).
A no. 60 French Maloney bougie is 
now passed into the stomach; great care 
is taken to place a right-angled DeBakey 
vascular clamp snugly along the bougie. 
Clamp placement incorporates the 
phrenoesophageal ligament. A second 
clamp is placed on the fundus for 
hemostasis and to prevent spillage of gas­
tric content. The 5-cm gastroplasty tube 
is now cut leaving a 4-mm cuff of 
stomach for suture closure.
The tube and gastric fundus are closed 
with continuous locked 00 chromic cat­
gut suture and, following clamp removal, 
with a continuous 000 silk inverting 
suture.
Posterior sutures are tied for loose 
crural approximation. The new fundus of 
the stomach is passed in a clockwise 
fashion posterior to the esophagus and 
the tip of fundus protrudes for 2 cm on 
the hepatic surface of the esophagus and 
tube. Positioning of the fundus is most 
important as it must be sutured to guaran­
tee only 1 cm of completion fundopli- 
cation.
The fundus of stomach is now sutured 
to the left lateral aspect of the distal 1.5 
cm of esophagus and 5 cm gastroplasty 
tube using five mattress double-eye 
sutures of 00 silk (Fig. 2). These sutures 
incorporate and support the gastroplasty 
suture line. An intra-abdominal segment 
of 6.5 cm is created.
The fundus is now approximated an­
teriorly with three mattress sutures of 00 
silk for a distance of 1 cm (Fig. 3). In 
patients with an adynamic esophagus, the 
completion fundoplication is reduced to 
0.25 cm to 0.5 cm. One suture is placed 
from the esophagus to the medial aspect 
of the fundoplication to prevent slipping 
and another suture is placed from the 
fundus to the diaphragm to add to the sta­
bility. The abdomen is closed in a routine 
fashion.
Results
The preoperative symptoms and signs 
noted in our 50 patients (Table I) were all
severe and unresponsive to medical 
management. The most diagnostic symp­
toms were reflux and dysphagia; 92% of 
patients had at least one of these. Radio- 
logically 34 had a hiatal hernia, 7 had 
reflux only and in 9 the findings were 
reported as normal.
Manometrically the mean tone of the 
high pressure zone was 13.4 cm HzO 
(normal 15 to 20 cm H20) and the mean 
percentage of lower esophageal disor­
dered motor activity in each examination 
was 38.2. Acid-perfusion studies (Bern­
stein test7) gave positive results in 31 and 
negative in 16; in 3 patients the test was 
not done.
Endoscopically no duodenal abnormal­
ities were seen. Two patients had moder­
ate gastritis and one had a superficial gas­
tric ulcer. All had an incompetent 
gastroesophageal junction, including nine 
who had gastroesophageal mucosal pro­
lapse. Twenty-one had localized eso­
phageal ulceration and 8 had a stricture.
Postoperative Follow-up
Follow-up ranged from 6 to 20 months 
(mean 12.1 months). There was no oper­
ative mortality or major morbidity. The 
anticipated complications of this proce­
dure were splenectomy, gastric fistula and 
wound infection. In the 50 patients 
reported here, none of these complica­
tions occurred. (Since this study was com­
pleted, a total of 150 transabdominal 
TFGs have been done. Splenectomy was 
required in one and there were no gastric 
fistulas.) Clinical follow-up was complete 
and radiologic studies were done in 47 
(94%) and manometry in 36 (72%).
Radiologically there was no evidence of 
anatomic recurrence or reflux.
Manometrically the tone of the high 
pressure zone rose from a preoperative 
level of 13.4 cm H20  to a postoperative 
level of 18.8 cm H20 , an increase of
FIG. 1—Gastroplasty tube, 5 cm long, is cut 
over no. 60 French Maloney bougie. Left gas­
tric artery is preserved. Both vagi and hepatic 
branch of vagus nerve are preserved.
40.3%. The percentage of disordered 
motor activity in the lower esophagus fell 
from 38.2 preoperatively to 28 post- 
operatively, a decrease of 26.7%.
The clinical result was staged as fol­
lows: stage I — asymptomatic, stage II
— minor residual symptoms and stage III
— major residual symptoms.
At present, in early follow-up, 46 
patients (92%) are asymptomatic and 4
FIG. 2—Fundus is sutured to distal 1.5 cm 
of esophagus and 5 cm of gastroplasty tube 
with five mattress sutures of 00 silk.
FIG. 3—Completed total fundoplication 
gastroplasty has 6.5 cm intra-abdominal 
esophagus which is responsible for operative 
stability. Completion fundoplication, tailored 
to 1 cm length, effectively controls reflux and 
avoids overcompetence.
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(8%) have minor residual gastric symp­
toms of fullness or occasional epigastric 
pain when they are guilty of dietary 
indiscretion, but all are much improved.
Dysphagia is the most serious disadvan­
tage of a total fundoplication procedure. 
Two patients who had persistent minor 
dysphagia 3 to 5 months after surgery had 
one dilatation with a no. 60 French 
Maloney bougie and both are now asymp­
tomatic.
Two of the eight patients who had a 
stricture preoperatively have required one 
dilatation postoperatively and are now 
swallowing normally. This is a lower inci­
dence of stricture than would be antici­
pated; however, these patients were 
selected for a transabdominal approach 
because they had no major associated 
ulceration.
None of the 50 patients have residual 
wound pain and none have ventral her­
niation.
Discussion
Total fundoplication gastroplasty 
(TFG) reduced the incidence of anatomic 
recurrence of a hiatal hernia to 1.1 % and 
produced satisfactory results in 96.8% of 
patients after a 5-year follow-up. These 
results have improved further with tech­
nical modifications to the operation that 
have much reduced the incidence of dys­
phagia. As with all thoracic operations, 
the incidence of post-thoracotomy pain 
is 7% and for this reason, without alter­
ing the design of the operation, it has been 
adapted for a transabdominal approach.
In the early stages the abdominal 
approach was restricted to thin patients 
without clinical evidence of esophageal 
shortening and without previous gastric 
or esophageal surgery. At this stage these 
are the only contraindications. Initially, 
gastroplasty was used only in patients 
with an esophagus shortened from reflux- 
induced panmural fibrosis. This remains 
the only absolute indication; however, the 
low incidence of anatomic recurrence is 
a substantial benefit and for a surgeon 
experienced in gastroplasty, long-term 
results will be improved.
The standard transabdominal Belsey or 
Nissen procedures need esophageal length 
to create stability. Approximately 4 cm 
of esophagus is reduced below the 
diaphragm to allow adequate fundoplica­
tion. With TFG, only 1.5 cm of esopha­
gus is reduced below the diaphragm. This 
reduced abdominal length of esophagus 
minimizes tension on the esophagus and 
allows effective, stable reflux control in 
patients with minor degrees of esophageal 
shortening.
The technique of TFG has been deve­
loped to produce a high degree of ana­
tomic stability and simultaneously to con­
trol reflux effectively. Stability is 
produced by having a 5-cm gastroplasty
tube and 1.5 cm of distal esophagus main­
tained below the diaphragm, instead of 
the 4 cm required by the Belsey,8 Hill9 or 
standard Nissen procedures.10 Thus, 
with TFG, minor degrees of esophageal 
shortening are accommodated. It is 
important to recognize that the esopha­
gus shortens by at least 2 cm when the 
relaxants wear off following anesthesia. 
This shortening is a causative factor in 
early anatomic recurrence.11
A further factor producing stability is 
the presence of the left gastric artery at 
the base of the gastroplasty tube. This is 
essential for vascularization of the tube 
and also provides natural support to pre­
vent anatomic recurrence.
In TFG, the completion wrap is 
reduced to 1 cm maximal length. The 
intra-abdominal segment is sutured 
separately to the fundus and indepen­
dently adds strength to the anatomic cor­
rection. With this separate suturing tech­
nique, stability and reflux control are 
independent and can be tailored to fit the 
patient’s problem. In the presence of 
severe shortening, the high pressure zone 
can be left in the chest. In patients who 
have an adynamic esophagus, a previous 
esophageal myotomy or very severe reflux 
motor damage, the total completion fun­
doplication length can be reduced to 0.25 
to 0.5 cm.
Although the results we report 
represent our early experience with trans­
abdominal TFG, they do show that the 
operative technique is safe. Since the 
long-term results of transthoracic TFG 
are well established, we anticipate that 
our early good results will be maintained.
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Congenital Cervical Salivary Fistula
A study of 35 lesions diagnosed as bran­
chial cleft sinuses or fistulas identified a 
homogeneous subgroup characterized by 
ectopic salivary tissue, draining serous or 
mucoid fluid through a short sinus tract 
to the base of the neck anteriorly.
These lesions should more properly be 
called congenital cervical salivary 
fistulas, since they may not arise from 
the branchial apparatus but rather from 
the embryonic placodal duct.
Une etude de 35 lesions auxquelles le 
diagnostic de sinus ou fistule branchiale 
a ete attribue a permis a I'auteur d'isoler 
un sous-groupe caracterise par une 
masse microscopique de tissu salivaire 
ectopique drainant un liquide sereux ou 
muqueux par un court trajet fistuleux a 
la base du cou.
L'auteur croit que le terme le plus 
approprie pour designer cette lesion 
serait celui de fistule salivaire cervicale 
congenitale et que son origine n'est pas 
de I'appareil branchial mais plutot du 
canal placodal embryonnaire.
The presence of a congenital sinus open­
ing along the anterior border of the ster­
nocleidomastoid is generally interpreted 
as being the external manifestation of a 
second-cleft branchial fistula. The sur­
geon operating on such a lesion expects 
to find a tract of substantial size extend­
ing to the lateral pharyngeal wall, along 
a predictable course that is well described
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in surgical texts. Histologic examination 
will show a squamous or columnar, cili­
ated epithelium with abundant underly­
ing lymphoid tissue. Mucous glands are 
said to be rare.1 Inflammatory cells and 
variable destruction of the wall are seen 
if the lesion has been infected (Fig. 1).
Incomplete tracts (sinuses) are said to 
be less common than complete fistulas.2
At the Children’s Hospital of Eastern 
Ontario, we recently encountered a child 
whose fistula did not fit this traditional 
concept. This led us, after a study of our 
patient material and of the literature, to 
revise our thinking about second-cleft 
fistulas.
Case Report
A 1-year-old girl presented with a tiny, con­
genital sinus opening in the midline, just above 
the sternal notch. The opening drained a clear, 
watery fluid, rather than the mucoid material 
usually associated with second-cleft branchial 
fistulas.
Probing with a fine ureteric catheter at oper­
ation showed only a very short sinus tract, and 
surgical exploration revealed only a short flim­
sy canal that petered out in the soft tissues of 
the neck. The histologic examination demon­
strated ectopic salivary tissue. We gave the le­
sion the descriptive name of “ congenital cer­
vical salivary fistula” .
Literature Review
A number of authors3-7 have described 
similar lesions although the standard 
reference texts give them only one line or 
no mention at all. The following facts 
emerge from their reports:
• Salivary tissue is found in a number 
of aberrant locations. The most frequent 
is the low anterior part of the neck, usual­
ly in association with a congenital sinus 
tract. These sinuses cluster in an area 
about the width of the manubrium sterni 
and at the most 2 to 3 cm above it. They 
may be found in the midline, along the 
anterior border of the sternomastoid, or
FIG. 1—Cross-section of branchial fistula. Respiratory type epithelium has been partially 
destroyed by infection. There is abundant lymphoid tissue and no glands in wall (hematoxylin 
and eosin, reduced by 31% from x 40).
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overlying the sternal origin of the mus­
cle. These aberrant salivary fistulas ap­
pear to be rare.
• Palpable masses of salivary tissue 
have been found close to the sinus open­
ing; in one instance a sialogram was 
obtained on injection of the tract with 
contrast material.
• The drainage is usually mucoid rather 
than serous; our case is an exception, and 
the histologic features are those of a 
mixed (seromucous) salivary gland. 
Drainage may be increased with any 
stimulus to salivation.
Patient Material
We then reviewed the findings in 35 
branchial sinuses and fistulas that we had 
operated on. The lesions fell into three 
distinct categories. In six cases the tract 
was lined by a stratified, squamous, ker­
atinizing epithelium, and in four of these 
the course of the tract was that of a first- 
cleft branchial fistula. Two tracts had 
courses that did not correspond to con­
ventional descriptions.
In 12 cases there was a complete 
second-cleft fistula to the pharynx, and 
in all the histologic findings were as 
expected. Two fistulas had a few seromu­
cous glands in the wall and one had a 
more substantial cluster of seromucous 
tissue that was labelled as ectopic salivary 
gland.
The third category consisted of 17 
sinuses, an unexpectedly high proportion 
of the total. Four sinuses had only a few 
seromucous glands in their walls but 
another eight were composed of substan­
tial masses of salivary tissue with an orga­
noid pattern, arranged in lobules with
FIG. 2—Ectopic salivary tissue and ducts. 
Serous units stain more deeply (hematoxylin 
and eosin, reduced by 50% from x 40).
intralobular ducts that in some instances 
were in continuity with the main sinus 
tract (Fig. 2). Clinically, these eight chil­
dren all presented with a low anterior cer­
vical sinus present since birth, draining 
clear mucoid or serous fluid. The longest 
tract extended to the level of the bifurca­
tion of the carotid artery. Most were only 
1 to 2 cm long.
It is evident that the clinical and 
histopathologic features of these eight 
patients are similar or identical to those 
of other cases reported as cervical salivary 
fistulas, and that the lesion is much com­
moner than was previously thought.
Discussion
Is this a distinct lesion that is not of 
branchial origin, or is it simply a histo­
logic variant of the branchial sinus?
Most authors support the theory of het- 
eroplasia, that is, anomalous differenti­
ation to salivary tissue of cells within the 
wall of a branchial sinus.
In favour of this theory is the fact that 
the sinus opening is generally in the same 
location as a typical branchial sinus, the 
tract usually follows the same course 
upwards and, as we noted, the main sinus 
tract may be lined by ciliated epithelium, 
which is not a feature of normal salivary 
gland ducts. In addition we have 
documented one case of a complete 
fistula to the pharynx containing ectopic 
salivary glands.
Against the theory of heteroplasia and 
in favour of the theory that the lesion is 
an entity distinct from branchial sinuses 
is the fact that on a number of occasions 
the sinus opening was not at the anterior 
border of the sternomastoid, and dipped 
downwards rather than led upwards. The 
frequency of this process and its singular 
predilection for low neck sinuses is also 
surprising.
Himalstein,8,9 based on the studies of 
Fraser10 and G arrett,11 proposed an 
intriguing theory to explain the occur­
rence of low cervical sinuses. In the 
human embryo, in the area just dorsal to 
the arch field, contiguous with but not a 
part of the branchial apparatus, ectoder­
mal thickenings form in relation to the 
underlying ganglia of the 7th, 9th and 
10th cranial nerves. These are called 
epibranchial placodes.
As the ganglia sink in deeper, the pla­
codes become invaginated as ducts that 
follow the ganglia. The area bearing the 
opening of these ducts is closely related 
to the embryonic cervical sinus of His, the 
persistence of which has been said to 
account for second-cleft branchial 
anomalies, and it corresponds to the 
inferior apex of the anterior triangle of 
the neck in the mature fetus.
Himalstein has suggested that the 
placodal duct of the 10th ganglion is a
logical source of blind low cervical sinuses 
composed of ectodermal derivatives such 
as salivary tissue.
Why the ectoderm lining of this placo­
dal duct would have a particular propen­
sity for differentiation into salivary tis­
sue, though, remains unexplained.
Summary
We propose that there is a distinct 
entity that is best called congenital cervi­
cal salivary sinus or fistula. It mimics 
branchial sinus, but can be distinguished 
from it by its presence very low in the 
neck, its inconstant relation to the 
anterior border of the sternomastoid mus­
cle and its drainage occasionally of ser­
ous rather than mucoid material.
A fistulogram shows a short tract and 
may in fact have the appearance of a 
sialogram. At operation the tract is short 
and flimsy and may not extend upwards.
The sinus tract drains a microscopic or 
grossly visible mass of salivary gland tis­
sue, usually with a mixed, seromucous 
pattern.
This lesion may not arise from hetero­
plasia within a branchial sinus, as is com­
monly proposed, but may represent per­
sistence of the placodal duct with 
differentiation of its cells into salivary 
tissue.
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Correction
In the paper “ Winnipeg Orthopaedic 
Society, a Short History” , which appeared 
in the January 1985 issue, the sentence on 
page 93 (left-hand column) “ Others served 
as chairman of the local arrangements com­
mittee for the Association’s annual meet­
ing: Dr. W.B. MacKinnon — 1962, Dr. 
D.R. Bigelow — 1973, Dr. R. Macoomb
— 1964.” should read “ Others served as 
chairman of the local arrangements com­
mittee for the Association’s annual meet­
ing: Dr. W.B. MacKinnon — 1962, Dr. 
D.R. Bigelow — 1973, Dr. R. Macoomb
— 1984.”
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Necrotizing Enterocolitis: a Chronic Colonic Disease
W hile acute necrotizing enteroco litis  is a 
comm on neonatal cond ition , the chroni- 
c ity  o f the  pathologic process is often 
overlooked.
Between 1979  and 1 9 8 3  at the 
Foothills Hospital in Calgary, a diagnosis 
o f acute necrotizing enteroco litis  was 
made in 211 in fants. Seventeen infants 
(8% ) required urgent surgical treatm ent 
in addition to  standard m edical manage­
m ent. Overall, 2 0 6  (98% ) in fants  sur­
vived the acute episode. Long-term  sur­
vival was 92%  (19 4  children). The 12 
late deaths w ere ascribed to  chronic 
cardiovascular, pulm onary and cerebral 
diseases and "s h o r t gut synd rom e".
Colonic s tric tu res developed in 9%  of 
those treated m edically; s tric tu res distal 
to  the m ucous fis tu la  developed in 50%  
o f those requiring urgent resection and 
exteriorization. None o f the strictures, 
w h ich  form ed between 14 days and 18 
m onths a fte r the diagnosis w as made, 
resolved spontaneously. They tended to 
be m ultip le  and to  involve longer seg­
m ents in in fants  w ho  required surgery. 
Diarrhea prolonged the m orb id ity  in these 
children.
The tim e course and varied presenta­
tion  o f s tric tu res in th is series suggests a 
rationale fo r managem ent o f in fants who 
survive acute necrotizing enterocolitis.
L 'entero-colite  necrosante aigiie est un 
frequent diagnostic en periode neonatale 
et la chronic ite  du processus pathologi- 
que est souvent negligee.
Entre 1979  et 1983, les auteurs ont 
diagnostique I'en td ro -co lite  necrosante
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aigiie chez 211 enfants. Un traitem ent 
chirurgical d 'urgence a 6te requis en plus 
du tra item ent medical standard chez 17 
(8% ) d 'en tre  eux. La survie a ete de 
98%  (206). La survie a long terme a ete 
de 92%  (1 9 4  enfants); les causes de 
m ortalite d tan t a ttrib u te s  aux maladies 
cardiovasculaires, pulmonaires et cere­
brates et le syndrom e de " in te s tin  
c o u rt" .
Des stric tures intestinales se sont 
developpees chez 9%  de ceux traites 
medicalem ent bien que 50%  de ceux 
ayant requis une resection et une exte- 
riorisation developperent des strictures 
distales k la fis tu le. Le tem ps de form a­
tion  des stric tures varia de 14 jours a 18 
mois. Aucune resolution spontanee des 
strictures n 'a  ete notee. Les strictures 
avaient tendance a etre m ultiples et a 
impliquer de plus longs segments intesti- 
naux chez ceux ayant requis de la chirur- 
gie. La diarrhee prolongea la m orbidity de 
ces enfants Id.
L 'evolution et la v a rie tt des presenta­
tions de stric tu res dans ce tte  serie sug- 
gerent une approche rationelle des 
enfants survivants a I'entdro-colite  necro­
sante aigiie.
Although necrotizing enterocolitis was 
first described as a clinical entity over 90 
years ago,1 the etiology and pathology 
are still not clear. Advances in neonatal 
care have not only resulted in increased 
survival o f infants with this condition, but 
have altered the natural history of the dis­
ease. This study shows that acute 
necrotizing enterocolitis is a chronic proc- 
tocolonic disease requiring long-term 
medical and surgical management.
Patients and M e th o d s
From June 1979 to December 1983, 211 
infants with acute necrotizing enteroco­
litis were treated in the Intensive Care 
Nursery at the Foothills Hospital in 
Calgary.
The diagnosis was made using a com­
bination o f clinical, laboratory and radi­
ologic investigations. The infants had sep­
sis associated with an ileus, hematochezia 
and radiologic evidence of pneumatosis
intestinalis. Medical management, which 
consisted o f total parenteral nutrition, 
systemically administered antibiotics, 
nasogastric decompression, no oral intake 
and correction of electrolyte, acid-base 
and ventilatory abnormalities, was con­
tinued for at least 10 days.
The indications for surgery were clini­
cal and radiologic signs of frank intesti­
nal perforation or failure of medical treat­
ment. At operation, each necrotic bowel 
loop was resected and the adjacent via­
ble ends were exteriorized. In three 
infants the whole intestine was involved. 
Ileostomy, with or without ileocolic resec­
tion, was performed, but had no effect 
on the rapid downhill course of the 
infants who all died.
All surviving children have been fol­
lowed up for periods extending from 6 
months to 5 years. Clinical examination 
was supplemented by appropriate labora­
tory and roentgenographic studies. 
Retrospective analysis of records and tests 
of statistical significance were performed.
Results
Of the 211 infants, 194 (92%) with a 
mean gestational age of 30 weeks and a 
mean birth weight o f 1700 g received med­
ical treatment only (Fig. 1). In two, the 
course of the disease was fulminant and 
death occurred within 6 hours of admis­
sion, without the opportunity for
211 infants who had necrotizing enterocolitis. 
BPD = bronchopulmonary dysplasia, CHD 
=  congenital heart disease, IV H  = intraven­
tricular hemorrhage.
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laparotomy. Seventeen patients (8%) 
required surgery in addition to medical 
treatment. These infants had a mean 
gestational age of 30 weeks and a mean 
birth weight of 1510 g. There were three 
deaths in this group due to intractable 
necrotizing enterocolitis. The overall sur­
vival was 206 of 211 infants (98%).
Among the 192 survivors who received 
medical treatment alone, 10 died later of 
causes unrelated to the necrotizing 
enterocolitis (bronchopulmonary dyspla­
sia 7, congenital heart disease 2, intraven­
tricular hemorrhage 1). Two of the 14 sur­
vivors who received medical and surgical 
treatment died later of short gut syn­
drome. Thus, 182 of 194 infants (94%) 
treated medically and 12 of 17 (71%) who 
received medical and surgical therapy sur­
vived.
Colonic stricture represented the most 
important long-term complication. After 
medical treatment, only 16 of 182 children 
(9%) had colonic strictures, but surgery 
was followed by strictures in 6 of the 12 
surviving infants. In five of these six 
babies the fibrosis was pancolonic, 
including the submucosa of the rectum. 
All strictures developed within 18 months 
of the acute episode of necrotizing 
enterocolitis. The most frequently 
involved sites were the transverse and 
descending portions of the colon. Stric­
tures were localized, multiple or segmen­
tal. No colonic strictures resolved spon­
taneously.
Discussion
A number of factors are likely involved 
in the etiology of necrotizing enterocoli­
tis. It is seen most commonly in the 
stressed premature infant. Proposed con­
tributory factors relate most directly to 
mucosal ischemia.2 Resultant tissue 
edema and damage may predispose to 
colonization of the gut wall, especially in 
the presence of an immature immune sys­
tem unable to resist local invasion.3’4
In this study, once acute necrotizing 
enterocolitis was diagnosed the infant 
received a standard treatment protocol 
for a minimum of 10 days.2’5’6 Survival 
was 98%, similar to that reported by
FIG. 2—Treatment algorithm for infants 
with acute necrotizing enterocolitis, adapted 
from Schwartz and associates.6
Schwartz and associates6 and substan­
tially better than the 45% to 75% survival 
reported previously.7-9 The successful 
outcome of medical treatment is proba­
bly related to general improvement in the 
medical management of sick neonates, 
earlier diagnosis and more stringent indi­
cations for surgical intervention.
Surgery is performed in 9% to 50% of 
cases of acute necrotizing enterocolitis.6,8 
Only 8% of infants in our series under­
went surgery. Irrespective of the indica­
tion for surgery, infants survived the 
operation only if the gross pathologic fea­
ture was localized intestinal necrosis and 
perforation. The disease in all infants 
involved the terminal ileum, cecum and 
proximal ascending colon. The necrotic 
intestine was resected and the infant was 
left with an ileostomy and an ascending 
or transverse colostomy (mucous fistula).
Colonic strictures developed in 22 
(11%) of 194 children after successful 
m anagem ent of acute necrotizing 
enterocolitis. The reported incidence of 
stricture formation varies from 3% to 
44%.2,6,8,i°,ii jn thjs stuciy a significant 
difference was noted (9% versus 50%) in 
stricture formation between those infants 
treated medically and those requiring sur­
gery (x2 = 19, p < 0.001). Our 
experience confirms that colonic strictures 
may develop at variable intervals follow­
ing an acute episode of necrotizing 
enterocolitis,2,6,11 in our series from 14 
days to 18 months. Most frequently the 
stricture was diagnosed within the first 6 
months. Thus, a normal roentgenogram 
after barium enema 4 to 8 weeks follow­
ing the acute episode does not exclude 
stricture formation later. In contrast to 
others,2,6,11 we failed to observe spon­
taneous resolution of such a stricture. 
Moreover, the small intestine was never 
involved in the chronic pathologic 
process.
Strictures that developed in children 
whose acute necrotizing enterocolitis 
required medical treatment only were 
localized and single. These infants 
presented with symptoms and signs of a 
partial obstruction of the distal bowel. 
Roentgenography after a barium enema 
indicated the site of the stenosis. Stric­
tures were most commonly seen in the 
transverse colon.2’9,12’13 Excision of the 
involved length of colon with primary or 
staged colocolic anastomosis was uni­
formly successful.
Whereas one of the six infants who 
underwent surgery for acute necrotizing 
enterocolitis had multiple strictures local­
ized to the transverse and descending 
colon, the remaining five had extensive 
fibrotic narrowing involving all the colon, 
including the rectum as far distal as the 
dentate line. The gross morphology of 
lengthy strictures frequently resembled 
multiple atresias with intraluminal mem­
branes seemingly unrelated to colonic ste­
nosis elsewhere. However, histologic 
examination revealed continuous fibrotic 
and chronic inflammatory changes in the 
colonic wall without skip areas. The more 
extensive involvement in those infants 
who required surgery probably reflects 
the severity of the disease. However, the 
rectum should be spared by virtue of its 
systemic blood supply. The histologic fea­
tures of necrotizing enterocolitis suggest 
that the rectal submucosal fibrosis and 
chronic inflammation are similar to the 
pathologic findings in the more proximal 
large intestine. Diffuse and progressive 
small-vessel disease of the colon not 
associated with variations in major 
arterial blood supply14 may account for 
the pancolonic involvement and subse­
quent stricture formation.
Loss of terminal ileum, ileocecal valve, 
colon and rectum with an ileoanal anasto­
mosis, while at first associated with gross 
diarrhea and a perineal rash, has 
responded to dietary manipulation, oral 
administration of loperamide hydrochlo­
ride (0.25 mg to 1 mg/kg daily) and appli­
cation of karaya-zinc oxide-glycerine 
paste to the perineum. Long-term follow­
up in these children has shown a gradual 
return to normal stools with normal nutri­
tional status. All bouts of diarrhea should 
be energetically treated to prevent 
dehydration and the appearance of a 
perineal excoriating dermatitis.
Conclusions
Since more neonates survive the acute 
episode of necrotizing enterocolitis, stric­
ture formation must be recognized as a 
potential long-term complication. Ex­
perience dictates that strictures may 
present as late as 18 months following the 
acute episode, long after the child has 
been discharged from the hospital. A nor­
mal barium enema before discharge does 
not exclude development of a stricture 
later.
If a clinical diagnosis of incomplete 
large-bowel obstruction is suspected in 
children treated medically for acute 
necrotizing enterocolitis, then roent­
genography after a barium enema is 
essential in planning the appropriate oper­
ative procedure (Fig. 2). When the infant 
has had emergency surgery, a contrast 
enema and a stomagram must be 
obtained before closing the stomas to 
ensure that no additional strictures have 
formed. Careful operative intra- and 
extraluminal examination to ensure that 
multiple or atypical strictures are not 
present must be performed.
Cooperation between the neonatolo- 
gist, pediatric surgeon and radiologist in 
the long-term management of infants who 
have had acute necrotizing enterocolitis 
is essential to avoid the added morbidity
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should be employed and it is advisable to 
monitor serum levels in patients with severe 
impairment.
In adults with renal insufficiency, an initial 
loading dose of 1 g to 2 g should be given. 
A fte r  a lo a d in g  dose, the  fo llo w in g  
recommendations for maintenance dosage 
may be used as a guide:
RENAL CREATININE
FUNCTION CLEARANCE D O SE FR EQ U EN C Y
2.m L /m in
M ild
im p a irm e n t
M odera te
50-30 1-2 g eve ry  8-12 h 3.
im p a irm e n t
Severe
29-10 1-2 g eve ry  12-24 h
4.im p a irm e n t
E sse n tia lly
9-5 0.5-1 g eve ry  12-24 h 
every  24-48 hno  fu n c tio n < 5 0.5-1 g
In the patient undergoing hemodialysis, the 
loading dose of 1 -2 g  should be given after 
each hemodialysis, and the maintenance dose 
should be given as indicated in the Table 
above.
Neonates (Including Premature Infants), 
Infants and Children (See WARNINGS for 
Neonates under ADMINISTRATION in the 
complete monograph.)
Premature Infants 
with Body Weights 
Above 1500 g 2 0 -4 0  m g /k g  e v e ry  1 2  h I.V.
Neonates
0 -  1 w e e k  o f  a g e
1 - 4  w e e k s  o f  a g e
2 0 -4 0  m g /k g  e v e ry  12  h I.V. 
2 0 -4 0  m g /k g  e v e ry  8 h  I.V.
Infants
1 m o n th  to  2  ye a rs  
o f  a g e
2 0 -4 0  m g /k g  e v e ry  6  h  o r 
e v e ry  8 h  I.M . o r  I.V.
Children 2 0 -4 0  m g /k g  e v e ry  6  h o r 
e v e ry  8  h  I.M . o r  I.V.
In severe infections, the total daily dosage in 
infants and children may be increased to 
200 mg/kg, but not to exceed 12 g per day. 
MEFOXIN* is not recommended for the ther­
apy of meningitis. If meningitis is suspected, 
an appropriate antibiotic should be used.
At present there is insu ffic ien t data to 
recommend a specific dosage for children 
with impaired renal function. However, if the 
administration of MEFOXIN* is deemed to be 
essential the dosage should be modified 
consistent with the recommendations for 
adults (see Table above).
PROPHYLACTIC USE
For prophylactic use, a three-dose regimen of 
MEFOXIN4 is recommended as follows: 
Vaginal or abdominal hysterectomy and 
abdominal surgery
2 g a d m in is te re d  in tra m u s c u la r ly  or 
in tra v e n o u s ly  Just p r io r  to  su rg e ry  
(approximately one-half to one hour before 
initial incision).
The second and third 2 g doses should be 
administered at 2-6hour intervals after the 
initial dose.
Cesarean Section
The first dose of 2 g should be administered 
intravenously as soon as the umbilical cord 
has been clamped. The second and third 
2 g doses should be given intravenously or 
intramuscularly four hours and eight hours 
after the first dose.
AVAILABILITY
MEFOXIN* (sterile cefoxitin sodium, Frosst 
Std.) is supplied as sterile powder in boxes of 
10 vials:
No. 3356 1 g cefoxitin as sodium salt 
No. 3357 2 g cefoxitin as sodium salt
Storage
MEFOXIN* in the dry state should be stored 
below 30° C.
PRODUCT MONOGRAPH AVAILABLE 
ON REQUEST
associated with delay in diagnosis of 
colonic obstruction.
References
1. GENERISCH A: Bauchfellentziindung beim Neugebore- 
nen in Folge von Perforation des Ileums. Arch Pathol 
Anat 1981; 126: 485-94
J anik JS, Ein SH, MANCER K: Intestinal stricture after 
necrotizing enterocolitis. J Pediatr Surg 1981; 16: 438-43 
WlJESlNHA SS: Neonatal necrotising enterocolitis: new 
thoughts for the ’eighties. Ann R Coll Surg Engl 1982; 
64: 406-9
SANTULLI TV, SCHULLINGER JN, HE1RD w c , Gonga- 
WARE RD, WIGGER J, BARLOW B, BLANC WA, BER- 
DON WE: Acute necrotizing enterocolitis in infancy: a 
review of 64 cases. Pediatrics 1975; 55: 376-87
5. KOSLOSKE AM: Necrotizing enterocolitis in the neonate. 
Surg Gynecol Obstet 1979; 148: 259-69
6. Schw artz MZ, H ayden CK, Richardson CJ, 
TYSON KR, Lobe TE: a  prospective evaluation of intes­
tinal stenosis following necrotizing enterocolitis. J  Pedi­
atr Surg 1982; 17: 764-70
7. Gregory JR, Campbell JR, Harrison m w , Ca m p­
bell TJ: Neonatal necrotizing enterocolitis. A 10 year 
experience. A m  J  Surg 1981; 141: 562-7
8. SCHULLINGER JN, MOLLITT DL, VlNOCUR CD, SAN­
TULLI TV, DRISCOLL JM JR: Neonatal necrotizing 
enterocolitis. Survival, management, and complications: 
a 25-year study. Am  J  Dis Child 1981; 135: 612-4
9. KRASNA IH, BECKER JM, SCHNEIDER KM, BECK AR: 
Colonic stenosis following necrotizing enterocolitis of the 
newborn. J  Pediatr Surg 1970; 5: 200-6
10. KOSLOSKE AM, BURSTEIN J, BARTOW SA: Intestinal 
obstruction due to colonic stricture following neonatal 
necrotizing enterocolitis. Ann Surg 1980; 192: 202-7
11. POKORNY W J, Harr VL, McG ill CW, Harberg FJ: 
Intestinal stenosis resulting from necrotizing enterocoli­
tis. Am  J  Surg 1981; 142: 721-4
12. Schw artz  MZ, Richardson CJ, H ayden CK, 
SwiSCHUK LE, TYSON KR: Intestinal stenosis following 
successful medical management of necrotizing enteroco­
litis. J  Pediatr Surg 1980; 15: 890-9
13. Stein H, Kavin I, Faerber EN: Colonic strictures fol­
lowing nonoperative management o f necrotizing 
enterocolitis. J  Pediatr Surg 1975; 10: 943-7
14. GEBER WF: Quantitative measurement of blood flow in 
various areas of small and large intestine. A m  J  Physiol 
1960; 198: 985-6
BOOK REVIEWS
5-739
3ncmt
P.O. BOX 1005, POINTE-CLAIRE 
DORVAL, QUEBEC H9R 4P8
AESTHETIC BREAST SURGERY. Edited by
Nicholas G. Georgiade. 408 pp. Illust. Wil­
liams & Wilkins, Baltimore, 1983. $84
(US). ISBN 0-683-93450-2.
Dr. Georgiade has convened a distinguished 
group of well-known plastic surgeons to contri­
bute to this textbook on aesthetic breast surgery. 
Two thirds of the contributors are from the 
United States with the remainder representing 
Brazil, Canada, Great Britain, France, Spain, 
Sweden and Switzerland. They were selected 
for their interest in a particular aspect of the 
subject. Although the book contains more than 
400 pages, it is easily read, since a large propor­
tion is devoted to black and white photographs 
and line drawings. The quality of the illustra­
tions is excellent.
The book begins with the usual introductory 
chapters on anatomy, physiology and the psy­
chological aspects of aesthetic breast surgery. 
Following these are chapters devoted to breast 
augmentation, correction of breast asymmetry, 
hypertrophy and ptosis. The final chapters deal 
with management of gynecomastia, common 
congenital anomalies of the nipple and areola, 
with the last one covering problem cases.
Multiauthored texts are unavoidably repe­
titive, especially when so many give their indi­
vidual points of view on a relatively narrow 
subject. The editor does succeed, however, in 
presenting “ the extensive experience of the 
foremost international authorities in the field 
of aesthetic surgery” , as stated in his preface. 
The format is straightforward, and the text and 
illustrations are well synchronized, with the 
exception of the final chapter, where it would 
have been advantageous to have the photo­
graphs on the same page as the case summaries.
Dr. Georgiade’s book is a complete, well- 
written and illustrated overview of the current 
status of aesthetic breast surgery and I recom­
mend it as a valuable addition to the plastic 
surgeon’s library.
G . A l l a n  T a y l o r , m d , frcsc
Chief, Division of Plastic Surgery,
Ottawa Civic Hospital,
Ottawa, Ont.
K1Y 4E9
PLASTIC RECONSTRUCTIVE BREAST 
SURGERY. Gaston F. Maillard, Denys 
Montandon and Jean-Louis Goin. 317 pp. 
Illust. Masson, Paris, 1983. (Price not sta­
ted). ISBN 2-225-80076-6.
This bilingual textbook updates reconstructive 
breast surgery. It is particularly valuable to the 
surgeon with extensive experience in this field. 
The authors have deliberately kept their com­
ments concise so that they would be read; their 
analysis of various techniques is generally based 
on their experience and often is lacking in 
depth. Their reasons for choosing a technique 
are outlined along with their comments.
The discussion on augmentation mamma- 
plasty, listing its advantages and disadvanta­
ges, is good. I disagree with the authors’ 
mastectomy technique for gynecomastia; I 
believe that most surgeons would not leave a 
1.0 to 1.5-cm platform under the nipple areo­
lar complex. The section on subcutaneous 
mastectomy is nicely handled. The general sur­
gery and pathologic features of malignant 
lesions of the breasts are well discussed and I 
agree that a 3- to 12-month waiting period 
should follow mastectomy before breast recon­
struction is begun. The various techniques of 
subcutaneous mastectomy are discussed and 
analysed. The section on breast implants is well 
presented and the complications are mentioned 
in sufficient detail. I believe that manual rup­
ture of the capsular contracture following 
implants is still a questionable procedure.
The pathologic aspects of malignant lesions, 
as presented by Dr. Larue Charlus, are brief 
but to the point. The alarming figure of 67 000 
new cases of breast carcinoma annually in 
Europe is noted, as well as 30 000 deaths 
annually from this disease.
The authors mention that three out of five 
women who undergo mastectomy are interested 
in reconstruction, and the indications and con­
traindications are reasonably presented. Breast 
reconstruction, using direct prosthetic implan­
tation, musculocutaneous flaps, such as the 
rectus abdominis and the latissimus dorsi, and 
local de-epithelialized flaps, is well presented
continued on page 187 
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Delay in Diagnosing Gastrointestinal Injury 
After Blunt Abdominal Trauma in Children
Intestinal perforation after blunt abdomi­
nal trauma in children is rare and thus 
the diagnosis may be delayed. For this 
reason the authors reviewed their 
experience with 12 children to recom­
mend a protocol for investigation that 
would reduce the delay in diagnosis. Of 
the 12 perforations, 2 were gastric, 2 
duodenal, 7 jejunal and 1 colonic. The 
diagnosis of jejunal perforation, in partic­
ular, was usually delayed because free 
air was not seen radiologically in the first 
few hours after injury. This may be 
because of delayed rupture or spasm of 
the injured intestine. Serial films were 
valuable in aiding the diagnosis and are 
recommended, together with assessment 
of solid organ injury by radionuclide 
scanning. In this series peritoneal lavage 
was not used. No child died.
Chez I'enfant, la perforation intestinale 
consecutive a une contusion abdominal 
est rare, ce qui peut done en retarder le 
diagnostic. En consequence, les auteurs 
ont analyse leur experience personnels 
chez 12 enfants dans le but de degager 
un protocole d’examen qui permettrait de 
reduire les delais de diagnostic. Des 12 
perforations, 2 etaient gastriques, 2 duo- 
denales, 7 jejunales et 1 colique. Le 
diagnostic de perforation jejunale a ete 
particulierement retarde du fait qu'il etait 
impossible de visualiser Fair libre a la 
radiographie dans les premieres heures 
qui suivaient le traumatisme. Ceci peut 
etre le fait d'un delai de rupture ou d'un
From the Department o f  Surgery, Chil­
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spasme de I'intestin. Les radiographies 
seriees ont contribud au diagnostic et 
sont done recommandees en association 
avec revaluation des blessures des orga- 
nes solides par scintigraphie isotopique. 
On n'a pas eu recours au lavage perito­
neal dans cette serie. Aucun enfant n'est 
decede.
Blunt abdominal trauma in children 
usually results in solid organ injury and 
much more rarely in hollow visceral per­
foration.1,2 Since trauma to solid organs 
is treated nonsurgically, if possible, in 
most pediatric centres, the presence of 
blood on peritoneal lavage is not itself an 
indication for surgery, so lavage is often 
not performed except in unconscious 
patients. The diagnosis of hollow visceral 
perforation is made by the disclosure of 
free or retroperitoneal air on roentgeno­
graphy. Often this cannot be seen in the 
first few hours after injury and may never 
appear. Thus, the diagnosis may be 
delayed unduly. Also, abdominal findings
are often neither marked nor characteris­
tic.3,4 We have investigated 12 patients 
with intestinal perforation seen at the 
Children’s Hospital of Eastern Ontario, 
Ottawa, between 1974 and 1984. This 
review has led us to recommend a plan 
of investigation to reduce the delay in 
diagnosis.
Patients and Methods
Twelve children, ranging in age from 
14 months to 14 years (mean 6.8 years), 
with gastric, duodenal, jejunal and 
colonic perforations after blunt abdomi­
nal trauma, were seen in the study period. 
We reviewed their records from the stand­
point o f the viscus involved, the type of 
trauma suffered and associated injuries 
(Table I), delay in diagnosis and its rela­
tion to radiologic studies (Table II), 
peritoneal lavage and peritoneal soiling at 
the time of surgery, the presence or 
absence of solid organ injury, postoper­
ative complications as they relate to delay 
in diagnosis and the viscus perforated 
(Table III).
T a b le  l - A s s o c ia t e d  In ju rie s
T y p e  of P a t ie n t C a u se  o f
p e rfo ra tio n no. A s s o c ia t e d  in ju r ie s in ju ry
G a s tr ic 1 F a c ia l la c e r a t io n s , 
c o n c u s s io n , f ra c tu r e d  r ib s
A b u se
2 F ra c tu re d  fe m u r, ru p tu re d  
sp le e n  and k id n e y , h ead
M o to r v e h ic le  
a c c id e n t
D uodenal 3 C o n c u s s io n , p a n c r e a t it is M o to r v e h ic le  
a c c id e n t
4 F ra c tu re d  p e lv is  an d  a n k le , 
k id n e y  co n tu s io n
M o to r v e h ic le  
a c c id e n t
Je ju n a l 5 F ra c tu re d  rib s  an d  ra d iu s , 
fa c ia l  in ju ries
A b u se
6 — F a ll
7 — H a n d le b a r
8 F ra c tu re d  p e lv is M o to r v e h ic le  
a c c id e n t
9 F ra c tu re d  h u m e ru s, 
p n e u m o th o ra x
M o to r v e h ic le  
a c c id e n t
1 0 — B lo w
C o lo n ic
11 — M o to r v e h ic le  
a c c id e n t
1 2 F ra c tu re d  v e rte b ra e , 
p a ra p le g ia
M o to r v e h ic le  
a c c id e n t
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Findings
Gastric Perforation
Two children had gastric perforation. 
One was secondary to child abuse (case 
1); the other child (case 2) was a pedes­
trian involved in a motor vehicle accident. 
Both perforations were diagnosed within 
2 hours of injury. In each, the laceration 
was on the greater curvature and there 
was gross intraperitoneal soiling. Free air 
was seen on the roentgenogram in one. 
These cases presented no diagnostic 
problem. They had gross abdominal find­
ings and were in shock. Postoperatively, 
one child had bowel obstruction from 
adhesions and remained in hospital for 17 
days. The other had a pleural effusion 
and atelectasis and remained in hospital 
for 27 days.
DuodenaI Perforation
Two cases of duodenal perforation 
were seen. Both resulted from motor vehi­
cle accidents. One child (case 3) was a pas­
senger wearing a seat belt and the other 
(case 4) was riding a motorcycle. In 
neither case did the initial films show free 
air. In case 3, a child who had a perfora­
tion of the first part of the duodenum, 
free air was apparent 18 hours after 
injury. In the second child, who had a 
perforation in the second part of the 
duodenum, there was only a retro­
peritoneal air leak and the diagnosis was 
not suspected until the leak was noted 31 
hours after injury.
The first child was treated with simple 
suture and was discharged from hospital 
after 25 days. He returned 6 weeks after 
discharge with a chronic duodenal fistula. 
This closed spontaneously after jejunal 
feeding for 3 weeks through a catheter 
passed nasally under radiologic control. 
The second child was treated by simple 
suture and pyloroplasty.
Jejunal Perforation
There were seven cases of jejunal per­
foration in children ranging in age from
214 years to 12 years (mean 6.8 years). 
Supine and erect abdominal films were 
obtained in all cases within 2 to 3 hours 
of injury; none showed free air.5 Free air 
was seen in four cases (nos. 5, 6, 8 and 
11) at 11 to 96 hours after injury (mean 
41 hours). In three patients (nos. 7, 9 and 
10) free air was never present. In case 7 
the diagnosis preoperatively was perito­
nitis of unknown cause but laparotomy 
revealed a 1-cm long rupture of the jeju­
num. In patients 9 and 10, the preopera­
tive diagnosis was bowel obstruction; in 
case 9, the diagnosis was only made 96 
hours after injury although the jejunum 
was completely transected and in case 10 
the perforation sealed spontaneously, giv­
ing rise to a stricture with subacute 
obstruction and the condition was finally 
diagnosed 40 days after injury.
Colonic Perforation
One child (case 12) had spontaneous 
drainage of an abscess around a fistula 
in the mid-ascending colon 14 days after 
injury. Neither free intraperitoneal air nor 
retroperitoneal air was seen at any time. 
The diagnosis was complicated by para­
plegia due to a fracture-dislocation of the 
lumbar spine with consequent loss of sen­
sation below the umbilicus.
Discussion
Usually gastric perforation is diagnosed 
easily, soon after injury. There are gener­
ally signs of gross peritoneal irritation 
from leakage of gastric content, and early 
shock. Immediate laparotomy is indi­
cated.
Duodenal perforation may be diag­
nosed quite early after injury if the leak 
is into the general peritoneal cavity, as in 
our case 3, but even so no free air was 
seen until 18 hours after injury. In case 
4, the rupture was in the second part of 
the duodenum and the leakage of fluid 
and air remained retroperitoneal. The 
diagnosis was delayed for 31 hours.
Jejunal perforation is more difficult to 
diagnose early. Free air may not be seen
for several hours or indeed may never be 
seen. Clear abdominal findings that 
would lead at least to an exploratory 
laparotomy are often absent. The perfo­
ration may be due to a blow-out of dis­
tended or air-filled jejunum. This appears 
to be the commonest injury but the jeju­
num also has considerable capacity to go 
into spasm so that peritoneal soiling is 
minimal. In addition, jejunal contents are 
not very irritating and are essentially 
sterile, at least in the upper part. In one 
case (no. 8) complete transection of the 
upper jejunum occurred with minimal 
soiling of the peritoneal cavity and with 
functional closure of the transected ends 
of the bowel by spasm and by omentum. 
All our jejunal perforations occurred in 
the upper half. Less severe trauma may 
cause only localized injury to the bowel 
wall or its mesenteric blood supply. This 
may result in either a very small perfora­
tion or delayed perforation. In our patient 
10, it may have been responsible for the 
jejunal stricture that followed a direct 
injury to the abdomen but was diagnosed 
only after 40 days.6 It was a factor in 
case 5 in which free air was seen, but the 
tiny perforation was not clear at opera­
tion and was seen only on pathological 
examination. In no case was peritoneal 
lavage carried out. We do not believe that 
it would have helped diagnostically since 
there was little or no peritoneal soiling at 
operation in any of our children.
In the child with colonic perforation, 
the absence of peritoneal signs was, of 
course, related to the retroperitoneal posi­
tion of the injured colon and to abdomi­
nal anesthesia secondary to the spinal 
cord injury.
Of interest is that in none of the seven 
patients with perforated jejunum was 
there solid organ injury involving spleen 
or liver. This is probably related to the 
level of injury, which was below the costal 
margin and directed to the central abdo­
men, resulting from direct seat-belt
T a b le  I I I — D e la y  a n d  P o s t o p e r a t iv e  
C o m p lic a t io n s  ( 4 2 % )
P a t ie n t
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2 2 P le u ra l e f f u s io n ,  w o u n d  
a b s c e s s
3 1 8 N o n e
4 4 8 D u o d e n a l f is t u la
5 4 8 N o n e
6 1 1 N o n e
7 2 4 N o n e
8 9 6 N o n e
9 9 6 P n e u m o n it is ,  w o u n d  
in fe c t io n
1 0 4 0  d N o n e
1 1 1 1 N o n e
1 2 1 4  d S m a ll -b o w e l  o b s t r u c t io n  
b y  a d h e s io n s
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T y p e  o f  
p e r fo ra t io n
P a t ie n t
n o .
P re s e n c e  ( +  ) or 
a b s e n c e  ( - )  o f  a ir
M e a n  
d e la y , h
G a s tr ic i + 0
2 -
D u o d e n a l 3 + 3 3
4 +  ( r e t r o p e r ito n e a l o n ly ) 4 1 *
J e ju n u m 5 +
6 +
7 -
8 +
9 -
1 0 -
1 1 +
C o lo n ic 1 2 -
* l n  4  p a t ie n ts .
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trauma. In the second case of gastric per­
foration, the patient had a splenic lacer­
ation resulting from a motor vehicle acci­
dent. This is the only example of proven 
splenic laceration associated with gas­
trointestinal injury in our hospital over 
a 10-year period in which 64 ruptured 
spleens and 17 ruptured livers were diag­
nosed. While this series o f gastrointesti­
nal perforations is small, it is compara­
ble to or larger than others in the 
literature. We did not see a case of ileal 
perforation.
As a result o f  this investigation, we 
recommend that immediate supine and 
erect or decubitus films of the abdomen 
be taken on admission and at regular 
intervals o f 6 to 8 hours thereafter for at 
least 48 hours. If abdominal signs wor­
sen, roentgenography should be per­
formed earlier. If abdominal signs persist 
after 48 hours, roentgenography should 
be repeated at the same intervals. Liver 
and spleen radionuclide scanning should 
be performed at the outset on all closed 
abdominal injuries when there are abnor­
mal abdominal signs. However, positive 
findings are rarely associated with duo­
denal or jejunal perforation. Serum amy­
lase levels should also be measured but 
are of little diagnostic value in bowel per­
foration. Peritoneal lavage has not been 
o f diagnostic value and we do not recom­
mend it except in unconscious patients.7 
We have been particularly impressed by 
the lack of peritoneal soiling in jejunal 
perforations. Two cases of jejunal perfo­
ration have been diagnosed using our 
regimen, but even then diagnosis was not 
made until 11 hours after injury. A diag­
nosis of intestinal obstruction following 
abdominal injury suggests complete or 
incomplete bowel perforation, as in two 
of our cases. Contrast roentgenography 
may then be indicated.
Finally, child abuse must always be sus­
pected in cases of abdominal trauma; this 
was the cause o f injury in 2 of our 12 
patients. In all three cases where the 
patient was a passenger in an automobile, 
a transverse seat belt was worn and was 
the cause of the injury as shown by skin 
bruising.8 The belts were o f the lapstrap 
type and not o f the preferred shoulder 
harness types, but they may well have 
saved the children’s lives. Serious 
associated injuries were seen in eight cases 
(66%) but in only 41% of the cases of 
jejunal perforation. This may be due to 
a more localized area of injury in this 
group.
We used the simplest procedure avail­
able to close the perforation. If possible, 
the edges were freshened and simply 
sutured. If not, resection and suture were 
performed. Recovery was rapid in all 
cases but one (no. 4). The complication 
rate o f 42% was high; two patients had 
small-bowel obstruction by adhesions that I
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required lysis. The complication rate is 
similar to that in other series, but did not 
seem related to a delay in diagnosis9 
(Table III). In the five cases with compli­
cations, the mean delay was 94.5 hours 
and in the seven uncomplicated cases, the 
mean delay was 167 hours. There were no 
deaths in the series and no lasting 
problems related to the perforation.
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Anorectal Therapy
INDICATIONS
1. For the relief of pain and discomfort associated with the 
acute phase of common anorectal disorders, including, 
-hemorrhoids, internal and external (including those
accompanying pregnancy), whether or not compli­
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Catheterization of the Umbilical Artery in Neonates: 
Surgical Implications
Catheterization of the umbilical artery is 
a common procedure in neonatal inten­
sive care units. The authors studied the 
records of 100 consecutive newborns 
who underwent this procedure to review 
the indications for and complications of 
umbilical artery catheterization and to 
discuss preventive measures and alterna­
tive techniques. Only polyvinylchloride 
barium-impregnated catheters were used 
(nos. 3.5 and 5.0 French). The com­
monest indications were respiratory dis­
tress syndrome, asphyxia and congenital 
heart disease. Of the 100 infants, 75 
weighed less than 2500 g.
Ampicillin and calcium were the com­
monest medications infused (70 and 65 
babies respectively). There were three 
major complications, two of which were 
gangrene of the lower extremity. Ampu­
tation of the foot was necessary in one 
and amputation of the toes in the other. 
The third complication was the develop­
ment of gluteal necrosis. In all three 
cases, catheter placement was low and 
the infusion was ampicillin. In two of the 
babies, calcium was also administered. 
Minor complications were seen in 32 
cases, with vascular spasm in the lower 
limb being the most common.
All catheter tips were cultured; there 
was bacterial colonization in 13% , 
Staphylococcus epidermidis being the 
commonest organism. Proven necrotizing 
enterocolitis was seen in eight infants
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and was suspected in eight others.
Blanching is a serious sign and was 
seen in the three infants with major com­
plications. The infusion should be 
stopped immediately. When necrotizing 
enterocolitis is suspected, the catheter 
should be removed.
Le catheterisme de I'artere ombilicale est 
une intervention courante dans les unites 
neo-natales de soins intensifs. A I'etude 
des dossiers de 100 nouveau-nes qui ont 
subi consecutivement cette intervention, 
les auteurs revoient les indications et 
complications du catheterisme de I'artbre 
ombilicale et commentent les mesures 
preventives ainsi que les techniques 
alternatives. Seules des sondes de chlo- 
rure de polyvinyle marquee au barium 
(sonde French no. 3,5 et 5.0) ont ete 
utilisee. Les indications les plus frequen- 
tes etaient le syndrome de detresse res- 
piratoire, I'asphyxie et les maladies car- 
diaques congenitales. Des 100 bebes, 75 
pesaient moins de 2500 g.
Les medicaments les plus frequem- 
ment perfuses par cette voie sont I'ampi- 
ciline et le calcium (chez 70 et 65 bebes 
respectivement). On a enregistre trois 
complications serieuses. dont deux cas 
de gangrene des membres inferieurs 
necessitant I'amputation d'un pied dans 
un cas et celle des orteils dans I’autre.
La troisieme complication fut I'apparition 
d'une necrose du muscle fessier. Dans 
ces trois cas, le catheter etait place bas 
et il s'agissait d'une perfusion d'ampicil- 
line. Du calcium etait aussi administre a 
deux de ces enfants. Des complications 
benignes ont aussi ete observees dans 
32 cas, les spasmes vasculaires des 
membres inferieurs etant les plus fre- 
quentes.
Toutes les extr6mites de catheters ont 
ete cultivees; on a constat^ une coloni­
sation bacterienne dans 13%  des cas. Le 
Staphylococcus epidermidis fut le 
microorganisme le plus frequemment 
isole. Une enterocolite necrosante fut 
diagnostiqube positivement chez huit 
enfants et soupgonn£e chez huit autres. 
La paleur de la peau est un signe serieux 
qui fut observe chez les trois bebes qui 
ont souffert de complications graves.
Dans ce cas, la perfusion doit etre arre- 
t6e immediatement. Le catheter devrait 
etre retire dfes qu'on soupconne une 
enterocolite necrosante.
Umbilical artery catheterization has 
become a common procedure in neona­
tal intensive care units. It is easily per­
formed and provides a useful access for 
blood sampling, blood-pressure monitor­
ing, infusion of fluid and medications, 
exchange transfusion, cardiac catheteri­
zation and angiography.1-5
Complications of the procedure are 
being reported increasingly frequently. 
They include death,6 throm bosis,7’8 
infection,3 visceral gangrene and perfo­
ra tion ,6 hemorrhage,9,10 em bolism ,11 
hypertension,12,13 necrotizing enterocoli­
tis,114 aortic aneurysm,15,16 peritoneal 
perforation with bleeding,17 paraplegia,18 
foot drop,19 osteomyelitis,20 refractory 
hypoglycemia,21 vesicoumbilical fistula,22 
visceral herniation through the umbilical 
ring,23,24 urinary ascites,25 and gluteal 
necrosis and others.26,27 The incidence of 
major complications is reported to be 
from 1.5% to 30%.1,11,14 Minor compli­
cations such as blanching from vascular 
spasm are more common.28
We reviewed the records of 100 con­
secutive newborns who underwent umbil­
ical artery catheterization. Our purpose 
is to discuss the indications for the proce­
dure and its complications, the warning 
signs of major complications and preven­
tive measures and alternative techniques.
Methods
At the Children’s Hospital o f Eastern 
Ontario in Ottawa, 100 consecutive 
infants (41 girls, 59 boys) who had umbil­
ical artery catheterization were reviewed. 
Of these, 75 infants weighed less than 
2500 g. The most common indications for 
the procedure were for sampling of blood 
and infusion of fluids and medications 
(Table I). The most common conditions 
requiring catheterization were respiratory 
distress syndrome, asphyxia, congenital 
heart disease, pneumothorax, sepsis, 
hyperbilirubinemia and meconium aspi­
ration (Table II).
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In all cases polyvinylchloride barium- 
impregnated catheters (Argyle; Sherwood 
Medical Industries, Inc., St. Louis, Mo.) 
were used. In 81 cases the size of catheter 
was not recorded, but in 10 infants no. 
3.5 French was used and in 9, no. 5 
French.
The position of the catheter was low 
(below L2) in 60 infants, intermediate 
(from T12 to L2) in 28 and high (above 
T12) in 12.
Cultures of the catheter tip grew organ­
isms in 13 cases: Staphylococcus epider- 
midis in 9, Enterococcus in 2, Staphy­
lococcus aureus in 1 and a-hemolytic 
streptococcus in 1.
There were 3 major and 32 minor com­
plications. Major complications included 
gangrene o f the right foot and the right 
leg and left gluteal necrosis. Minor com­
plications included blanching cyanosis 
and discoloration of foot and toes. All 
resolved completely after removal o f the 
catheter.
In one case, minor umbilical bleeding 
was easily controlled.
Findings
M ajor Complications
Case 1.—A boy born after 40 weeks’ gesta­
tion had Down’s syndrome, respiratory distress 
syndrome and meconium aspiration. The birth 
weight was 3140 g. A no. 5 French umbilical 
artery catheter was introduced at 12 hours of 
age. It was initially positioned at T il (high 
position) but was repositioned at L3-4. A 10% 
dextrose solution with calcium and ampicillin 
added was infused through the catheter, which 
was also used for blood sampling. After 12 
hours, blockage and persistent blanching in the 
right foot prompted removal of the catheter. 
A second catheter was introduced, and the 
same medications and solution were infused 
when the blanching had subsided. A few hours 
later recurrent blanching of the right foot 
occurred with increasing cyanosis. Because of 
decreased pulses in the right leg with ischemia, 
the catheter was removed. Angiography was 
not done. Despite removal of the catheter, 
there was progressive ischemia. Thrombectomy 
was not considered to be indicated. The 
catheter tip was sterile on culture. Gangrene 
of the right foot (Fig. 1) necessitated below- 
knee amputation. Heparinization was not con­
sidered desirable because of the risk of cerebral 
hemorrhage.
Case 2.—This girl was born at 31 weeks’ 
gestation. She weighed 1680 g and was the 
first of twins. She had severe respiratory dis­
tress syndrome, congenital heart disease and 
bilateral pneumothorax. Umbilical artery 
catheterization was performed for blood sam­
pling and infusion of fluids at 3 hours of age. 
The catheter was initially positioned at T9. It 
was later positioned lower, just below the aortic 
bifurcation in the left iliac artery. A few hours 
later it was again repositioned at L3. All the 
while, 10% dextrose solution with calcium and 
ampicillin was infused. Sodium bicarbonate, 
packed cells and fresh frozen plasma were also 
infused. Two days later the catheter became 
completely blocked. It was changed and posi­
tioned at L3-4. Persistent blanching and cya­
nosis developed in both legs. Twenty-four 
hours later, decreased pulses in the right leg 
and definite ischemia required removal of the 
catheter; gangrene in the right fourth and fifth 
toes (Fig. 2) necessitated amputation. Contrac­
tures of the calf with foot drop subsequently 
improved with physiotherapy.
Angiography was not done. The tip of the 
catheter was sterile on culture.
Case 3.—This male infant of 42 weeks’ 
gestation had a birth weight of 3160 g. Meco­
nium aspiration developed with severe 
asphyxia, right pneumothorax, seizures and 
myotonic dystrophy. An umbilical artery 
catheter (no. 5 French) was inserted at 2 hours 
of age. Initially the catheter was found to be 
in the left side but it had not reached the com­
mon iliac artery. It was advanced to L5-6 some 
hours later. The next day the catheter became 
blocked so a new one (no. 3.5 French) was 
inserted. Initially the catheter was at T11 and 
was repositioned at L3.
From the beginning there was recurrent 
blanching in the left buttock.
The catheter remained in position for 3 days, 
during which time 10% dextrose solution, 
ampicillin, calcium, sodium bicarbonate, 
Lasix, phenobarbital and fresh frozen plasma 
were infused through it. When it became obvi­
ous there was ischemia of the left buttock, the 
catheter was removed.
An ulcer developed in the buttock (Fig. 3) 
and subsequently healed slowly. The tip of the 
catheter was sterile on culture.
Table 1-Medications and Solutions 
Infused in Umbilical Artery Catheter
Medicationfsolution
No. of 
cases
10% dextrose 100
Ampicillin 70
Calcium 65
Fresh frozen plasma 24
Potassium chloride 12
Sodium bicarbonate 17
Packed red cells 16
Furosemide 5
Aminophylline 5
Cloxacillin 2
Prostaglandin E, 2
Phenytoin 1
Table 11-Diagnoses in 100 Cases of
Umbilical Artery Catheterization
No. of
Diagnosis cases
Respiratory distress syndrome 81
Asphyxia 25
Congenital heart disease 21
Pneumothorax 15
Sepsis 11
Hyperbilirubinemia 8
Meconium aspiration 6
Hypoglycemia 3
Hypocalcemia 3
Disseminated intravascular
coagulation 2
Hydrocephalus 2
Hemangiomatosis with heart failure 1
Diaphragmatic hernia 1
Di George syndrome 1
Necrotizing Enterocolitis
Of the 100 cases, 8 had proven 
necrotizing enterocolitis with a typical 
clinical picture and pneumatosis intes- 
tinalis. Eight cases o f necrotizing 
enterocolitis were suspected clinically but 
not confirmed radiologically. In all 16, 
the catheters were in the low position at 
L3-4 and were removed promptly.
Discussion
About 300 newborns are admitted to 
our neonatal intensive care unit each year. 
About one third require intubation and 
assisted ventilation. On average, 66 
umbilical artery catheters are inserted 
each year, mostly by residents and fellows 
in neonatology. Careful aseptic technique 
is used and care is taken not to damage 
the arterial intima. All catheter positions 
are checked radiologically.
Sometimes catheters are placed 
between T8 and T12 but we prefer to 
place them between L3 and L5. Twenty- 
eight of our catheters lay between T12
FIG. 1—Case 1. Gangrene of right foot 
which required below-knee amputation.
FIG. 2—Case 2. Gangrene of right fourth 
and fifth toes required amputation. Contrac­
ture of calf improved with physiotherapy.
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and L2 and their position was classed as 
intermediate.
There has been discussion as to the best 
position of umbilical artery catheters.4,5 
Most reports suggest that while compli­
cations are fewer with a high position of 
the catheter tip, they are more serious 
since thrombosis may affect the celiac, 
mesenteric and renal arteries.2,14,28
Low placement results in more compli­
cations but they tend to be less serious. 
They may be due to differences in blood 
flow and velocity in the thoracic and 
abdominal aorta. Upward propagation of 
a low thrombus has been reported.2,4 It 
is of interest that in our three babies with 
major complications, the catheter was ini­
tially in the high position before being 
changed to the low position. Of the 32 
infants with minor complications, 5 
catheters were in the high position, 6 in 
the intermediate and 21 in the low 
position.
We did not see any visceral or aortic 
thromboses nor have we seen any cases 
of renal thrombosis or of hypertension.
We do not use heparin since it has not 
been shown to affect the incidence of 
thrombosis or embolism.7,14,28 Also, we 
do not use antibiotics prophylactically 
because they have not been shown to 
decrease the frequency of positive blood 
culture or of catheter-tip infection.28 
They may result in the development of 
resistant strains and may delay normal 
colonization of the intestine and increase 
the risk of fungal infections. In 13 
catheter tips, organisms were cultured. 
The frequency of positive cultures has 
been reported to range from 6% to 
55%.3,20 We routinely cultured all the 
catheter tips when they were removed or
FIG. 3—Case 3. Gluteal ulcer healed slowly 
with conservative management.
changed. Cultures were negative in our 
three cases of major complications.
We continue to use the commercially 
available polyvinylchloride umbilical 
catheters in sizes 3.5 and 5 French. The 
throm bogenicity of these barium - 
impregnated catheters is well known but 
no other practical type of catheter is avail­
able for umbilical artery catheteriza­
tion2,29 and about 120 000 of these 
catheters are sold each year in the United 
States alone.30
The barium impregnation for radio- 
logic identification of the catheter seems 
to be the major factor in thrombus for­
mation.29 It is surprising that while bet­
ter catheters of Silastic are available for 
central venous cannulation , ven­
triculoperitoneal shunts and nasogastric 
tubes, they are not for umbilical artery 
catheterization, particularly when this 
catheter is placed in a vessel as important 
as the aorta.
Nasogastric tubes (infant type) should 
never be used for umbilical artery 
catheterization because of a higher inci­
dence of thrombus formation. An end- 
hole catheter is preferred because there is 
no dead space at the dp .2
The size of the catheter is not crucial. 
Indeed, higher complication rates have 
been reported with the no. 3.5 French 
than with the size 5 French catheter.5,17
The infusion of medications and hyper­
osmolar solution is an important factor 
in producing complications.4,5,8,14,26,28,29 
Our three infants with major complica­
tions all had several medications infused. 
Ampicillin, calcium and sodium bicar­
bonate are especially dangerous when 
injected intra-arterially.31 In fact, these 
medications are the commonest to be 
infused through umbilical artery catheters 
in neonatal nurseries. All our infants who 
had minor complications had ampicillin, 
calcium and sodium bicarbonate infused 
alone or in combination with other drugs.
In view of the possible complications, 
the indications for umbilical catheteriza­
tion should be carefully assessed. The 
umbilical arteries in a newborn infant are 
readily available and because cannulation 
is easy, this procedure is often overused 
and its dangers are underestimated. It is 
true that it provides quick access for 
monitoring, sampling arterial blood and 
infusing medications. While the benefits 
may outweigh the risks,1,28,30 in general 
a safer way to sample arterial blood 
should be used. New, improved, per­
cutaneous catheters (Angiocath, Medi- 
cath) are now available in small sizes. It 
is possible to cannulate the radial and 
posterior tibial arteries, the dorsalis pedis 
artery and small branches of the temporal 
arteries in even premature babies. Cer­
tainly these procedures are not without 
complications and are technically more 
difficult; nevertheless, they should be
used instead of umbilical artery catheteri­
zation if possible.
The infusion of hyperosmolar solutions 
and medications should be reserved only 
for cases in which a vein cannot be can- 
nulated. This almost never occurs in a 
recently born baby with unused veins.
There is no place for infusion of total 
parenteral solutions through an umbili­
cal artery catheter.2,29,31
Umbilical artery catheterization should 
never be maintained for longer than 
necessary. When other routes are avail­
able, the catheter should be removed. 
Manipulation of the catheter should be 
avoided. In our three babies with major 
complications, the catheter had been 
repositioned. The catheter should also be 
removed promptly when a complication 
is suspected, for example when there is 
blanching, if necrotizing enterocolitis is 
present or suspected, or if the catheter is 
blocked or the flow has decreased.
When thrombosis is suspected, it is use­
ful to perform angiography through the 
umbilical artery catheter before it is 
removed.4,6,14
Pediatric surgical consultation should 
be requested early if thrombosis or bleed­
ing is suspected. In some cases thrombec­
tomy or embolectomy can be performed. 
The pediatric surgeon can also help when 
vascular access is difficult and is urgently 
required. Peripheral venous cutdowns are 
safer than umbilical artery catheterization 
for infusion of medications or intra­
venous solutions. When peripheral hyper­
alimentation is not possible, a central 
venous line can be inserted and when 
arterial blood gases cannot be measured 
percutaneously or through a capillary ves­
sel, a peripheral arterial cutdown can be 
performed.
With the advent of new and more effi­
cient percutaneous oxygen and carbon 
dioxide monitoring, arterial blood sam­
pling for gases in the newborn may 
become unnecessary.
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SESAP IV Critique
I T E M  151
A postmenopausal woman with a pelvic mass will require early opera­
tion. Uterine endometrial sampling, barium enema, and the cervical 
Pap smear are steps used to determine whether the tumor is arising 
primarily in an ovary, or whether the mass could represent metastatic 
disease from colon, cervix, or endometrium. Pyelography is used to 
identify possible ureteral compression or deformity of the urinary blad­
der secondary to the mass. Laparoscopy is not indicated because it will 
not add important information. Biopsy through the laparoscope would 
not be indicated.
m
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Single-Layer Large-Bowel Anastomosis: 
a Report of 250 Cases
Single-layer mucosa-excluding intestinal 
anastomoses involving the large bowel 
were evaluated in 249 patients (250 
procedures). All patients operated on 
electively had mechanical bowel prepara­
tion but not all received antibiotics. 
Forty-nine anastomoses were performed 
as part of emergency procedures in 
which antibiotics were given 
intravenously. Three leaks were noted in 
two patients, a rate of 1.2%. There 
were no deaths attributable to anasto­
motic dehiscence. These results compare 
favourably with both hand-sewn and sta­
pled anastomoses described in the liter­
ature.
L'anastomose du gros intestin par suture 
en monocouche (excluant la muqueuse) 
a ete evaluee chez 249 patients (dans 
250 interventions). Tous les patients 
operes de facon non urgente ont subi 
une preparation mecanique de I'intestin 
mais tous n'ont pas recu d'antibiotiques. 
Quarante-neuf anastomoses ont ete 
effectuees en urgence sous la couverture 
d'antibiotiques intraveineux. Trois fuites 
ont ete notees chez deux patients pour 
un taux de 1.2%. Aucun deces attribua- 
ble a une desunion des sutures n'a ete 
enregistre. Ces resultats se comparent 
favorablement avec ceux des anastomo­
ses avec suture manuelle ou a I'agraffe 
decrits dans la presse medicale.
Anastomotic dehiscence in colorectal sur­
gery is a dreaded complication. Morbidity 
is increased and approximately one third
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of deaths following colorectal procedures 
are the result of leaking anastomoses.1,2 
Factors contributing to dehiscence are 
both local and systemic. Adequate 
mechanical preparation, good blood sup­
ply and absence of tension rank as the 
most important prerequisites for uncom­
plicated healing.3-5 Anemia, jaundice, 
advanced age and poor nutritional status 
militate against satisfactory healing.1-4 A 
further factor, having nothing to do with 
technical expertise is the method of 
anastomosis used.
Multiple-layered serosa-to-serosa appo­
sition has remained the standard method 
of intestinal anastomosis since it was first 
popularized by Lembert in 1825. Hal- 
sted6 and others have encouraged use of 
single-layer techniques but they have 
not been widely accepted in North 
America.7 Reported here is our experi­
ence with a one-layer mucosa-excluding anastomosis of the large bowel.
Patients and Methods
The case records of 249 patients (148 
male, 101 female) who underwent 
colorectal surgical procedures (Table I) 
between 1969 and 1982 were analysed. 
The patients ranged in age from 1 month 
to 94 years with over 50% being more 
than 60 years old. Twelve patients were
T a b le  1— Proced ures  P erform ed
Procedure No.
R ig h t hem ico lecto m y 6 7
Tran sverse  co lec to m y 1 4
S u b to ta l c o le c to m y
lleo recta l a n asto m o sis 11
Cecosigm oid a n asto m o sis 5
L e ft  co lecto m y
Prim ary an a s to m o s is 1 2 2
H a rtm a n n 's  c losure 2 9
C olo tom y 2
T o ta l 2 5 0
under 1 year of age. Forty-nine proce­
dures were performed as emergencies for 
bleeding, obstruction or acute inflamma­
tory process. Carcinoma was present in 
189.
Not all patients operated on electively 
received antibiotics before operation. 
From 1976 an antibiotic regimen was 
instituted in which orally administered 
antibiotics were included with mechani­
cal preparation. This included a bulk-free 
diet for 3 days, cleansing enemas until 
return was clear 2 days before operation 
and preoperative sigmoidoscopic cleaning 
of the rectosigmoid region. When semi- 
obstructing or emergency situations 
prevented adequate and thorough 
mechanical cleansing, broad-spectrum 
antibiotics, covering both aerobic and 
anaerobic organisms, were given 
intravenously.
Silk and cotton sutures were used for 
the first 4 years. Polyglycolic acid deriva­
tives have been used exclusively since 
then.
The technique is illustrated in Fig. 1. 
The mucosal layer is excluded, but 
meticulous care is taken to ensure that the 
muscularis mucosae is included in each 
bite. Sutures are placed 4 to 5 mm apart, 
at a depth of 5 to 8 mm from the cut edge. 
Sutures are tied only after all in the 
posterior row are in place. This ensures 
precise alignment, limiting discrepancies. 
Anterior sutures are tied as they are
FIG. 1—One-layer mucosa-excluding anastomosis.
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placed. After the occlusion clamps are 
removed, the large bowel is filled with air 
to evaluate the integrity of the anastomo­
sis. Drains have not been used routinely. 
Sump drains have been placed in the 
pelvis following a low anterior resection, 
taking care to avoid direct contact with 
the anastomosis. An 84-year-old man, 
who underwent a low anterior resection, 
had a proximal colostomy for decom­
pression.
Anastomotic dehiscence was diagnosed 
when there was fecal drainage from the 
sump tube or through the incision. A 
fever, unexplained by respiratory, urinary 
or wound infection was thought to be an 
anastomotic dehiscence until proven 
otherwise. Contrast studies with either 
barium or Gastrografin were not per­
formed unless the possibility of an anasto­
motic leak had to be excluded.
Results
Clinically, three leaks (1.2%) occurred 
in two patients; one patient experienced 
two leaks in separate operations. All leaks 
involved operation on the left colon or 
rectum. Spontaneous closure on two 
occasions resulted from nonoperative 
measures. Feculant drainage through 
sump drains was the initial manifestation 
of dehiscence in two instances while in the 
third a fecal fistula developed through the 
wound. One year after closure of a fistula 
a 50-year-old man experienced constipa­
tion which was secondary to anastomotic 
stenosis as confirmed by roentgenography 
after barium enema. Subsequent revision 
of the anastomosis by a longitudinal tran­
section across the stenosis led to further 
breakdown. This was an obvious error in 
choice of procedure. A diverting left 
transverse colostomy was performed sub­
sequently with a smooth recovery and 
closure of the colostomy 3 months later. 
The two patients who had anastomotic 
dehiscence are well 6 and 9 years later 
respectively.
No complications attributable to 
anastomotic leak occurred in the remain­
ing 247 patients. There were eight deaths 
within 3 months of operation: two 
octogenarians died of myocardial infarc­
tion within 1 week of operation. Cardiac 
disease was confirmed at autopsy as was 
the integrity of intestinal anastomosis. Six 
patients died of malignant disease with 
extensive liver metastases, inanition and 
pneumonia.
The wound infection rate was 10.6%; 
two cases were classified as having major 
wound infections with abscess formation. 
Delayed primary closure has been prac­
tised increasingly since 1977, with a result­
ing decrease in wound infection. This 
coincided with widespread use of paren­
teral antibiotics preoperatively. One 
patient had a gunshot wound to the abdo­
men which necessitated transverse colec­
tomy, proximal colostomy and distal 
mucosal fistula. Following this, a left sub- 
phrenic abscess developed; this was 
drained. Continuity of the colon was re­
established without complication 6 
months later. Of three patients with 
splenic injuries one required splenectomy 
and the others were controlled by 
hemostatic means. Postoperatively acal- 
culous cholecystitis developed in a 
78-year-old woman who had done well 
following colectomy. A small-bowel 
obstruction secondary to adhesions 
required operation for lysis. Culture­
positive pneumonia developed in 8 
patients while significant urinary tract 
infection occurred in 10 patients, who all 
had indwelling catheters.
Discussion
The long-practised method of inverting 
cut edges of bowel in anastomosis presup­
poses that the junction of the two serosal 
layers provides the most secure healing. 
German surgeons in the late 1800s took 
Lembert’s concept in stride and the 
inverting two-layer anastomosis became 
standard surgical practice. It was Flalsted6 
who recognized that the submucosa of the 
intestine is the only layer of the intesti­
nal wall that has sufficient tensile strength 
to maintain an anastomosis. Fie suggested 
that a single-layer anastomosis, including 
all coats except mucosa, was the ideal. 
Interest in the one-layer technique was 
sporadic for the next 50 years. Gambee 
and associates,8 in 1956, reported on 10 
years’ experience with the single-layer 
through-and-through technique that now 
bears his name. Emphasis, however, was 
placed on inversion of the cut edges and 
on the serosa-to-serosa approximation.
The end-on mucosa-excluding anasto­
mosis we describe was first reported by 
Jourdan.9 Evidence that this technique 
compares favourably, in terms of leakage 
rates, with the traditional two-layer 
anastomosis is accumulating.7,10'14 Evalua­
tion in the laboratory has clearly demon­
strated the superiority of the one-layer 
technique. Earlier revascularization, 
increased collagen concentration and ten­
sile strength after postoperative day 5 are 
all factors considered conducive to heal­
ing.15'21 The single-layer technique results 
in less tissue strangulation, and dec­
reases in edema and inflammatory re­
sponse.15"17,22 Reduction of luminal 
diameter is less with the single-layer than 
with the two-layer anastomosis.15'18 Fur­
thermore, the one-layer anastomosis can 
be carried out more expeditiously with 
less tissue trauma and vascular interfer­
ence.17 Anastomotic edges are approxi­
mated more accurately, favouring earlier 
secure healing.
Conclusions
The clinical leak rate with single-layer
mucosa-excluding anastomosis in our ser­
ies was 1.2%. To our knowledge this is 
the lowest rate reported that was of clin­
ical importance. We believe that the use 
o f this technique should be encouraged.
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Transluminal Angioplasty: Results in High-Risk Patients With 
Advanced Peripheral Vascular Disease
The role of percutaneous transluminal 
angioplasty in treating advanced 
peripheral vascular disease is unknown. 
The authors therefore reviewed the 
experience of Sunnybrook Medical 
Centre in Toronto with 85 consecutive 
patients who had rest pain, ulceration, 
pregangrene or gangrene as a result of 
peripheral vascular disease and who 
underwent percutaneous transluminal 
angioplasty. Seventy-four percent were 
smokers and 91% were at increased risk 
due to one or more of the following: 
coronary or cerebral ischemic disease, 
diabetes mellitus, obesity and hyperten­
sion. Thirty-six patients underwent dila­
tation of iliac lesions, 46 of superficial 
femoral or popliteal and 3 of more distal 
lesions. In nine patients angioplasty was 
repeated on the same lesion. In 16 
patients, the procedure was technically 
unsatisfactory. The morbidity and 30-day 
mortality were 5% and 2%, respectively. 
When the procedure was technically 
satisfactory, surgery was avoided and 
the limb was salvaged at 1, 2 and 5 
years in 69% , 62% and 54%  of cases, 
respectively (life-table analysis). The 
authors conclude that percutaneous 
transluminal angioplasty is acceptable 
treatment for patients with advanced 
peripheral vascular disease, because the 
morbidity and mortality are low and the 
long-term results are good.
On ignore quel role exact peut jouer 
I'angioplastie transluminale percutanee 
dans le traitement des maladies vasculai- 
res peripheriques avancees. En conse­
quence, les auteurs ont analyse I'expe- 
rience accumulee au Sunnybrook Medical
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Centre de Toronto lors du traitement de 
85 patients consecutifs qui souffraient 
de douleur au repos, d'ulceration, d'un 
etat pre-gangreneux ou de gangrene, 
consecutivement a une maladie vascu- 
laire peripherique, et qui subirent une 
angioplastie transluminale percutanee. II 
s'agissait de fumeurs dans 74% des cas 
et 91% presentaient un risque accru relie 
a une maladie coronarienne ou & une 
ischemie cerebrate, au diabete, et a 
I'obesite ou I'hypertension, ou les deux. 
Trente-six patients ont subi une dilata­
tion d'une lesion iliaque, 46 de lesions 
superficielles femorales ou poplitees et 3 
de lesions plus distales. Chez neuf 
patients, une deuxieme intervention fut 
necessaire pour la meme lesion, [.'inter­
vention fut techniquement insatisfaisante 
dans 16 cas. La morbidite et la mortalite 
a 30 jours furent de 5% et 2% respecti- 
vement. Avec une intervention techni­
quement correcte, la chirurgie put etre 
evitee et le membre sauvegarde pendant 
1, 2 ou 5 ans dans 69% , 62% et 54%  
des cas respectivement (analyse par la 
methode des tables actuarielles). Les 
auteurs concluent que I'angioplastie 
transluminale percutanee doit etre envi- 
sagee pour tout patient souffrant de 
maladie vasculaire peripherique avancee 
puisque la morbidite et la mortalite sont 
faibles et que les resultats a long-terme 
sont bons.
Although the technique of percutaneous 
transluminal dilatation of arterial 
stenoses, using a series of coaxial 
catheters, was introduced by Dotter and 
Judkins in 1964,1 it was not until 10 
years later, when Griintzig and Hopff2 
developed the double-lumen balloon 
catheter, that the procedure gained 
widespread acceptance. Since then, per­
cutaneous transluminal angioplasty has 
been shown to reduce symptoms in 
patients with peripheral vascular dis­
ease.3'5 It compares favourably in the 
short-term with surgical bypass.6 It has 
also been advocated as an adjunct to sur­
gery.7 However, its role in the treatment 
of peripheral vascular disease is not yet 
clearly defined. Many studies report only 
short-term follow-up, results have been 
inconsistent and the usefulness of the
procedure for limb salvage in patients 
with advanced ischemic changes has not 
been specifically studied.
The purpose of this study was to review 
the experience at Sunnybrook Medical 
Centre, University of Toronto, with per­
cutaneous transluminal angioplasty per­
formed over 5 years in 85 consecutive 
patients with advanced peripheral vascu­
lar disease.
Methods
The hospital and office charts of 85 
consecutive patients (55 men, 30 women) 
who underwent percutaneous translumi­
nal angioplasty for advanced peripheral 
vascular disease at Sunnybrook Medical 
Centre between December 1978 and July 
1983 were reviewed. The mean age of the 
patients was 67 years (ranging from 43 to 
91 years). Advanced disease was defined 
by the presence of rest pain, ulceration, 
pregangrene or gangrene in the affected 
limb. Patients who were living at the time 
of follow-up returned to the vascular 
clinic for assessment. Follow-up history 
for patients who died was obtained from 
family members.
Transluminal angioplasty was per­
formed by one of two radiologists (E.S. 
or S.W.) using a standard no. 7 or 9 
French balloon dilatation catheter and 
standard technique. Balloon diameter 
ranged from 4 mm to 10 mm, depending 
on the size of the vessel to be dilated. 
Heparin sodium, 5000 units, was 
administered intra-arterially after the 
catheter was passed through the lesion. 
For 2 days before and for 6 months after 
the procedure, all patients received acetyl- 
salicylic acid (325 mg twice daily) and 
dipyridamole (50 mg twice daily). Acetyl- 
salicylic acid (325 mg twice daily) was 
then prescribed indefinitely.
Angioplasty was repeated as required 
at the discretion of the attending physi­
cian. Every angiogram was reviewed 
retrospectively by a radiologist who was 
unaware of the clinical findings. Note was 
made of the site of the lesion, percent ste­
nosis, length of the lesion, pressure gra­
dient across the lesion before and after 
angioplasty (when measured) and any 
complications.
Immediate technical failure occurred
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when the artery could not be cannulated, 
the catheter could not be advanced to the 
site of the lesion or across it, or when 
there was immediate thrombosis.
Clinical failure of the procedure was 
accepted when the patient underwent sur­
gery (sympathectomy, endarterectomy, 
bypass or amputation). Repeat angio­
plasty of the lesion(s) originally treated 
was not considered to be failure as long 
as surgery was avoided.
The difference between the pressure 
gradient across the lesion before and after 
dilatation was evaluated by Student’s t- 
test. Discriminant analysis was used to 
predict technical success, based on the site 
of the lesion, length of the lesion dilated 
and degree of stenosis. Life-table curves 
were compared for patients with stenoses 
versus occlusions, iliac versus femoro- 
popliteal lesions, lesions less than versus 
greater than 10 cm long, smokers versus 
nonsmokers and diabetics versus nondi­
abetics, using the generalized Savage 
(Mantel-Cox) test.
Findings
Follow-up data were obtained for all 
patients.
Of the 85 patients, 63 (74%) were 
smokers; 1 smoked a pipe only. The 
cigarette smoking history ranged from 5 
to 165 pack-years. Other risk factors 
included hypertension in 47%, diabetes 
mellitus in 34%, obesity in 33% and 
hyperlipidemia in 9% of patients. Gener­
alized arteriosclerotic disease was 
manifest by previous myocardial infarc­
tion in 33%, angina pectoris in 28%, 
cerebrovascular accident in 16% and 
transient ischemic attack in 9% of 
patients.
The most advanced symptom was rest 
pain for 47 patients, ulceration for 23, 
pregangrene for 3 and gangrene for 12 
patients.
The 85 patients underwent translumi­
nal angioplasty of 92 lesions over the 
study period. At the time of the initial 
procedure, one lesion was dilated in 78 
patients and two lesions in 7. Nine
FIG. 1—Life-table analysis of success rate 
of percutaneous transluminal angioplasty.
patients underwent repeat angioplasty of 
the lesion(s) originally treated.
The vessels treated included the aorta 
(1 patient), iliac artery (36), superficial 
femoral or popliteal artery (46), deep 
femoral artery (1) and more distal vessels 
(3 patients). One patient underwent dila­
tation of a stenotic femoropopliteal 
venous bypass graft.
Early Deaths
Two patients (2%) died within 30 days 
of the procedure. In a 91-year-old patient 
with rest pain, ulceration and gangrene, 
common iliac artery angioplasty was 
attempted, but the catheter could not be 
advanced through the lesion. The patient 
required below-knee amputation and died 
of a cerebrovascular accident following 
surgery. The other early death was secon­
dary to myocardial infarction in a 
60-year-old patient with a history of 
angina and myocardial infarction who 
underwent successful dilatation of the 
superficial femoral artery for rest pain 
and ulceration.
Successful Angioplasty
In 69 patients the procedure was tech­
nically successful. Of the 69 patients, 40 
(58%) were symptomatically improved, 
10 (14%) were symptomatically worse 
and 19 (28%) were unchanged. Forty- 
eight percent of these patients had return 
of previously absent pulses. Seventy per­
cent experienced either a lessening of 
symptoms or return of previously absent 
pulses, or both. In the 20 patients whose 
pressure gradient across the lesion was 
measured before and after dilatation, the 
gradient fell from a mean of 53 mm Hg 
to 6 mm Hg (p < 0.05).
Failed Angioplasty
The procedure was technically unsuc­
cessful in 16 cases because the artery 
could not be cannulated (1 case), the 
catheter could not be advanced to the site 
of the lesion (1 case) or across the lesion 
(13 cases), or because immediate thrombosis
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FIG. 2—Life-table analysis o f success rate 
of percutaneous transluminal angioplasty for 
diabetic versus nondiabetic patients.
occurred (1 case). The technical failure 
rate therefore was 19%. The dilatation 
failed technically in 6 of 36 iliac lesions,
9 of 46 femoral lesions and 1 of 3 more 
distal lesions. These proportions were not 
significantly different. Ten of the 13 cases 
in which the catheter did not traverse the 
lesion were from the group of 37 patients 
with occluded arteries while only 3 cases 
were in the 48 patients with stenotic 
lesions. Again this difference in propor­
tions was not statistically significant. Seven 
of the 13 cases in which the catheter did 
not traverse the lesion were in 70 patients 
with a lesion less than 10 cm long and 6 
cases were in the 15 patients with a lesion
10 cm long or longer. This difference in 
proportions was statistically significant (p 
< 0.04). Fourteen of the failures occurred 
in the years 1979 to 1981 and only 1 tech­
nical failure occurred in each of the years 
1982 and 1983.
Nine of 16 patients whose procedures 
were technical failures were operated 
upon on an urgent basis after failed trans­
luminal angioplasty. One died of unre­
lated causes 8 months after angioplasty 
and 6 have been followed up for from 2 
to 47 months without surgery.
The patient who underwent dilatation 
of a femoropopliteal venous bypass graft 
required below-knee amputation 11 
months after the procedure.
Complications
Complications included slight over­
distension of the dilated artery in two 
patients, minor dissection at the puncture 
site in one patient and distal vessel throm­
bosis in one patient. The patient with dis­
tal vessel thrombosis required below-knee 
amputation but had severe pregangrenous 
changes before the procedure and may 
have required amputation in any case. 
The other complications were of no clin­
ical significance. The complication rate 
was 5%.
Repeat Angioplasty
Angioplasty was repeated on the same 
lesion(s) in nine patients 2 to 51 months 
after the first attempt (median 6 months). 
The immediate failure rate of repeat 
angioplasty was 56% (five of nine patients 
underwent bypass surgery or amputation 
within 1 month of the repeat procedure). 
However, there has been no failure of the 
other four repeat angioplasties after 4 to 
29 months.
Analysis o f  Findings
When life-table analysis was used to 
assess those patients whose angioplasty 
was technically successful initially, 76% 
of procedures were shown to be success­
ful at 6 months, 69% at 1 year, 62% at 
2 years and 54% at 5 years after 
angioplasty (Fig. 1).
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Results were compared for dilatation 
of iliac versus femoropopliteal lesions, 
stenoses versus occlusions, lesions less 
than versus greater than 10 cm long, 
lesions in diabetic versus nondiabetic 
patients and in smokers versus non- 
smokers. A significant difference was 
found only for diabetic versus nondia­
betic patients (Fig. 2). For diabetics, suc­
cess at 1, 2 and 5 years was 55Vo, 45Vo 
and 30Vo versus 77Vo, 75Vo and 74Vo 
respectively for nondiabetic patients (p < 
0.02). There was no failure in the nondi­
abetic group after 13 months of follow­
up, while in the diabetic group, failures 
continued to occur up to 36 months after 
the procedure.
Discussion
The role of transluminal angioplasty in 
treating patients with peripheral vascular 
disease is still evolving.8
If transluminal angioplasty is safe and 
effective, its advantages over surgery are 
many. The procedure is simple, quick and 
cheaper, it preserves the saphenous vein 
and creates no soft-tissue distortion to 
jeopardize the results of future surgery in 
case the procedure fails or the disease 
progresses.8 Postponement of bypass 
surgery or amputation for a few months 
or years may be all that is necessary since 
these patients often have a short life 
expectancy because of advanced age, 
generalized arteriosclerosis, diabetes or 
obesity. Angioplasty may obviate the 
need for further intervention in some 
patients. Flowever, bypass or amputation 
can still be performed if necessary.
Our study population comprised 
patients with rest pain, ulceration, 
pregangrene or gangrene, most of whom 
would have required surgical bypass or 
amputation had angioplasty not been 
available. This assumption is supported 
by the urgent surgical bypass and ampu­
tation rate of 56Vo in patients whose 
angioplasty was technically unsuccessful. 
There are several reasons why all patients 
whose angioplasty was technically unsuc­
cessful did not require immediate surgery. 
First, despite failure of the balloon 
catheter to cross the lesion, in many cases 
a guide wire was successfully passed and 
may have afforded some clinical improve­
ment. Further, the placebo effect, which 
produces clinical improvement in some 
patients after any sham treatment, may 
have accounted for the avoidance of sur­
gery in some cases.
The mortality of 2Vo and the compli­
cation rate of 5 Vo in this series illustrate 
the relative safety of transluminal 
angioplasty and compare favourably with 
rates reported by others,3‘7'9'10 particu­
larly in view of the high-risk population 
we studied. Furthermore, the mortality 
and complication rates reported here are
lower than those in a report of 20 differ­
ent series of bypass operations on patients 
at less risk and with less-advanced dis­
ease.8 The technical failure rate of 16Vo 
in this series is also acceptable.6 Long 
lesions (more than 10 cm) were more 
likely to produce technical failure, usually 
because the catheter could not be 
advanced across the lesion. The techni­
cal failure rate is expected to be much 
lower in future, since, of 16 such failures, 
14 occurred before 1982. This reflects the 
improved technical skill of the radiolo­
gists and better selection of candidates.
Seventy-six percent of our high-risk 
patients with advanced disease were 
spared vascular surgery and amputation 
for more than 6 months. In 62Vo of cases, 
vascular surgery and amputation were 
avoided for more than 2 years (by life- 
table analysis, Fig. 1). These results com­
pare favourably with those of other ser­
ies, which included few patients with 
advanced disease.10
In this study, although the majority of 
patients experienced relief of symptoms 
or return of previously absent pulses, or 
both, success was denoted by the 
avoidance of surgery. This criterion prob­
ably overestimates the success rate of the 
procedure since some patients might have 
refused surgery, despite unchanged sta­
tus after angioplasty. However, this 
proportion of patients was probably not 
large since all patients in the study had 
advanced disease, and it would not be 
possible in many cases to postpone inter­
vention because of severe symptoms or 
gangrene. Other objective criteria for suc­
cess such as repeat angiography, Doppler 
flow studies and exercise testing were 
lacking in this study. None of these 
criteria, unfortunately, are ideal and the 
correlation among them is not perfect.10 
Doppler studies before and after 
angioplasty became part of the routine 
office work-up of all vascular patients in 
1983 but there were insufficient data to 
assess the results.
Published series of patients who 
undergo bypass surgery for limb salvage 
have reported patency rates at 2 and 3 
years of 18Vo to 68Vo, depending on the 
anatomic site of the bypass and the con­
duit used (saphenous vein, human umbil­
ical vein or polytetrafluoroethylene).11'12 
Obviously these series are not strictly 
comparable to ours but they do indicate 
that angioplasty is a reasonable alterna­
tive to surgery.
It has previously been reported that 
success rates for transluminal angioplasty 
depend on the calibre of the vessel 
treated.3-5>1° The results of dilatation for 
iliac artery disease have been better than 
those for femoral artery or more distal 
disease. This difference was not demon­
strated in our series. Similarly, no differ­
ence in success rates for the procedure
were found for stenoses versus occlusions 
or smokers versus nonsmokers. Although 
trends were evident, the lack of a signifi­
cant difference between groups was most 
likely due to the small numbers of patients 
compared in subgroups.
Diabetics fared less well than nondia­
betics (Fig. 2). The 1-year success rate 
for diabetics was 55% versus 77% for 
nondiabetics. At 5 years, the success rate 
for diabetics was 30% versus 75% for 
nondiabetics (p < 0.02).
Our success rate for repeat angio­
plasties of 44% at follow-up, ranging 
from 4 to 29 months, indicates that repeat 
dilatation of the same lesion may further 
postpone surgery if angioplasty fails ini­
tially.
Conclusions
In a large group of high-risk patients 
with advanced peripheral vascular dis­
ease, percutaneous transluminal angio­
plasty was associated with a low mor­
bidity and mortality. The procedure was 
successful in avoiding surgery and ampu­
tation for more than 5 years in the 
majority of patients. For patients who are 
at high risk for surgery or who might 
otherwise require amputation, percutane­
ous transluminal angioplasty should be 
considered as treatment for those with 
dilatable lesions.
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Effects of Abdominal Aneurysmectomy, Aortoiliac Bypass 
Grafting and Angioplasty on Male Sexual Potency:
a Prospective Study
The preoperative frequency and 
postoperative status of male sexual 
potency was studied prospectively in 46 
patients who underwent abdominal aortic 
aneurysmectomy, aortoiliac and aorto- 
femoral bypass grafting, or percutaneous 
transluminal angioplasty of the iliac 
artery. The patients with aortic 
aneurysms were older; approximately 
half of them were potent. The frequency 
of impotence was highest in patients 
who underwent aortoiliac bypass, and 
correlated well with their low penile to 
brachial pressure index. Patients who 
had angioplasty had more localized 
lesions, a higher penile to brachial pres­
sure index and the lowest rate of impo­
tence. Postoperatively, 13% of the 
patients regained nocturnal erection and 
10% became functionally potent (defined 
as the ability to achieve penetration).
The improvements were similar in bypass 
and angioplasty patients. No patient 
experienced deterioration in sexual 
potency and all showed a markedly 
improved thigh to brachial pressure index 
postoperatively. Routine aortoiliofemoral 
artery angiograms were of limited value 
in predicting the status and outcome of 
sexual potency in this series of patients.
On a etudie de fagon prospective la viri­
lity pre- et postoperatoire de 46 hommes 
qui ont subi soit une anevrismectomie de 
I'aorte abdominale, soit un pontage 
aorto-iliaque ou aorto-femoral, ou encore 
une angioplastie transluminale percuta- 
nee de I'artere iliaque. Les patients souf-
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frant d'anevrisme aortique etaient plus 
ages; environ la moitiy d'entre-eux pos- 
sedaient encore leur virility. La frequence 
de I'impuissance sexuelle etait la plus 
elevye chez les patients qui ont subi un 
pontage aorto-iliaque et montrait une 
bonne correlation avec I'index tensionnel 
penis-bras. Les patients soumis a 
I’angioplastie avaient des lesions plus 
localisees, un index tensionnel penis- 
bras plus eleve et presentaient le plus 
faible taux d'impuissance. Apres I'inter- 
vention, 13% des patients ont recouvre 
la possibility d'avoir une erection noc­
turne et 10% etaient redevenus fonction- 
nellement virils (cet etat etant defini 
d'apres la capacity de reussir la penetra­
tion). Le pontage et I'angioplastie ont 
procury des amyiiorations identiques. 
Aucun patient n'a vu sa puissance 
sexuelle se deteriorer des suites de I'ope- 
ration et tous ont montry une nette ame­
lioration de I'index tensionnel cuisse- 
bras. L'angiogramme des arteres aorto- 
ilio-femorales pratique de fagon systema- 
tique a ete de peu d'utilite pour predire 
I'etat, puis I'amyiioration de la virilite 
chez ces patients.
Since Leriche described male impotence 
secondary to aortic occlusive disease in 
1940,1 the anatomy and physiology of 
male sexual function has been elucidated 
in great detail. The effects of aortoiliac 
reconstruction on male potency have been 
described by many authors.2-8 The prin­
ciples of nerve-sparing dissection of the 
aortoiliac system and of maintaining the 
patency of and flow to the internal iliac 
arteries are well established. Nevertheless, 
the ability to restore potency to patients 
who are impotent because of vascular 
inadequacy varies widely with different 
series.
The development of percutaneous 
transluminal balloon angioplasty to treat 
occlusive arterial disease creates an 
opportunity to study vasculogenic impo­
tence from another viewpoint. There is no 
question of operative neural damage with 
this technique, and using penile blood 
pressure available through the Doppler 
technique we can estimate the increase in
pelvic blood flow. This group can then 
be compared to the more conventional 
group of patients who have undergone 
operative vascular reconstruction.
We prospectively studied patients with 
either abdominal aortic aneurysm or 
occlusive disease of the aortoiliac system. 
The patients’ sexual performance was 
questioned both before and after inter­
vention. We found that both angioplasty 
and aortoiliac reconstruction increase pel­
vic and penile blood flow. Neither proce­
dure causes impotence, if the surgeon is 
cognizant of such a possibility. However, 
neither procedure does much to alleviate 
vasculogenic impotence; clear improve­
ment in our series was the exception 
rather than the rule. Thus, we can 
increase pelvic blood flow to some extent, 
we can spare neurologic reflex arc and 
sympathetic ganglia, but many patients 
had disease that was too diffuse or too 
distal to be amenable to our present tech­
niques of aortoiliac reconstruction.
Patients and Methods
We studied prospectively 46 patients 
with vascular disease, including abdomi­
nal aortic aneurysms and aortoiliac and 
peripheral vascular disease. There were no 
insulin-dependent diabetics or psychotic 
patients in the group. All emergency 
aneurysmectomies and revascularization 
procedures were excluded from this study.
Patients were selected for either oper­
ation or for transluminal balloon angio­
plasty, depending on the nature of their 
occlusive disease and the opinion of the 
vascular surgeon in consultation with the 
therapeutic angiographer (M.H.). As a 
rule, any localized lesions that were 
amenable to angioplasty were dilated.
All patients were questioned in a per­
sonal, private interview by the same nurse 
(D.L.) who performed the vascular 
laboratory studies. The study documented 
the availability of sexual contact, occur­
rence of nocturnal erections and ability 
to penetrate the vagina. In addition to 
routine Doppler vascular measurements, 
thigh, brachial and penile blood pressures 
were recorded and the indices calcu-
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lated.9 The patients then underwent rou­
tine peripheral angiography which 
documented the exact nature of their dis­
ease and the patency of the internal iliac 
arteries. Three months after operation, 
the Doppler vascular studies were 
repeated, the pressure indices recalculated 
and the questionnaire on sexual perfor­
mance was repeated by the technician
who had performed the previous exami­
nations.
The results were analysed using the 
paired Student’s t-test.
Results
The patients with abdominal aortic 
aneurysms were significantly (p <  0.05)
older than those with aortoiliac occlusive 
disease (Table I). Eleven aneurysmecto­
mies, 21 aortoiliac or aortobifemoral 
bypasses and 14 iliac artery angioplasties 
were performed.
Using the presence of nocturnal erec­
tions as a criterion of potency, we found 
that only 33% of the aortoiliac group 
were potent, compared with 54% of the 
much older patients with aneurysms. In 
the angioplasty group, 71% were still 
potent. When we used actual vaginal 
penetration as a measure of potency, the 
sexual dysfunction of patients in the 
bypass group became even more manifest 
(Table I).
The preoperative penile to brachial 
pressure index correlated well with the 
presence or absence of nocturnal erections 
and with the capacity for vaginal penetra­
tion (Table II).
When we calculated the thigh to 
brachial indices for each group to docu­
ment the adequacy of blood flow through 
the pelvis for assessing the degree of dis­
ease preoperatively and the success of the 
reconstruction postoperatively, we found 
as expected that the patients with the most 
diffuse disease, who underwent aortoiliac 
or femoral bypass grafting, had the lowest 
indices preoperatively. Postoperatively, 
the index was markedly improved in these 
patients and those who had transluminal 
angioplasty. The patients who had aor­
tic aneurysms had much better preoper­
ative indices, which were essentially 
unchanged after operation (Table III).
The penile to brachial pressure index 
was used as a measure of changes in 
penile blood flow. All patients served as 
their own controls for comparison of 
preoperative and postoperative indices. 
The patients who underwent aneurysmec­
tomy demonstrated no change, but 
patients in the other two groups 
manifested a significantly improved index 
(p < 0.02) (Table IV).
Four patients in this series of 46 
improved overall, 3 who had bypass 
grafting and 1 who underwent angio­
plasty. They all had marked improve­
ment in their postoperative penile to 
brachial pressure index. Of the 23 incapa­
ble of nocturnal erection before opera­
tion, 3 (13%) regained that ability and of 
the 30 who were known to be incapable 
of penetration before, 3 (10%) regained that 
capacity after operation. No patients 
were made worse by the procedures.
The vascular surgeon (P .E .B .) 
involved, reviewed the angiograms 
obtained preoperatively and in a double­
blind fashion estimated whether the 
patient was or was not potent and what 
effect the operation would have on the 
patient’s potency. The results (Table V) 
show that the surgeon tended to be overly 
optimistic in estimating function and in 
estimating a good outcome. He was much
Table I—Preoperative P o t e n c y ____________ ________
Preoperative potency,
no. (%)
Procedure _  ___
Abdominal aortic aneurysmectomy 
Aortoiliac or femoral bypass
Iliac angioplasty __
"Mean ± standard error. 
tNot attempted in 3 patients. 
4Not attempted in 1 patient.
Table II—Correlation of Preoperative Penile to Brachial Pressure Index With Potency 
No. of Penile to brachial
Potency patients pressure index*_____________p value
Nocturnal erection present 23 0.68 ± 0.02 < 0.001
Nocturnal erection absent 23 0.44 ± 0.02
Penetration present 12 0.76 ± 0.02 < 0.0001
Penetration absent 30 0.46 ± 0.02
Penetration not attempted 4 0.69 ± 0.03 ____________
’ Mean ± SEM.
Table III -Thigh to Brachial Pressure Indices*
Preoperative Postoperative
Procedure Right Left Right Left
Abdominal aortic aneurysmectomy 
Aortoiliac or femoral bypass 
Iliac angioplasty
0.88 ± 0.06 
0.63 ± 0.04 
0.75 ± 0.04
0.87 ± 0.07 
0.52 ± 0.04 
0.76 ± 0.05
0.90 ± 0.05 
0.84 ± 0.03 
0.86 ± 0.05
0.80 ± 0.06 
0.83 ± 0.40 
0.86 ± 0.05
"Figures are mean ± SEM.
Table IV-Penile to Brachial Pressure Indices* 
P r o c e d u r e ____________________ Preoperative
Abdominal aortic aneurysmectomy 0.63 ± 0.05
Aortoiliac or femoral bypass 0.50 ± 0.03
Iliac angioplasty______________________ 0.59 ± 0.05
"Figures are mean ± SEM.
NS = not significant.
Table V-Surgeon's Accuracy in Predicting Potency from the
Preoperative Angiogram _______
Accuracy of prediction, %
Prediction Penetration
Nocturnal
erection
Penile to brachial 
pressure index
Should be potent preoperatively 33 44 ~ 56
Should not be potent preoperatively 94 63 88
Should improve postoperatively 11 17 61
Should not improve postoperatively 100 100 50
Postoperative p value
0.64 ± 0.05 NS
0.57 ± 0.04 < 0.02
0.68 ± 0.05 < 0.01
No. of 
patients
Age,
yt*
Nocturnal
erection Penetration
~ TF~ 66.1 ± 1.8 T I54)- 5l45)
21 56.5 ± 2.4 71331 1 (5)t
14 56.6 ± 2.2 10171) 6 (43)4
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more accurate with respect to negative 
predictions.
Discussion
This prospective study of preoperative 
and postoperative sexual function of a 
group of patients with vascular disease 
compared the results of three interven­
tions, two of which were surgical and 
potentially could damage the neurologic 
structures necessary for ejaculation and, 
to some extent, erection. These two 
procedures can also threaten pelvic blood 
flow if performed without proper con­
sideration for morbid anatomy. The third 
procedure, percutaneous angioplasty, the­
oretically can only improve pelvic blood 
flow and poses no threat to the neurologic 
structures involved in male sexual func­
tion. We were, therefore, able to make 
some interesting comparisons.
We believe that a sensitive confidential 
interview was sufficiently accurate to 
gauge potency. The incidence of potency 
in four studies was reported as 25Vo,2 
50% ,10 71 % 4 and 88% ." Our study 
demonstrated one of the reasons for such 
wide variability. When our patients were 
questioned as to the presence of noctur­
nal erections, nearly 50% of the overall 
group were potent. Nocturnal erection, 
because it excludes psychological factors, 
had been used as the standard of clinical 
evidence of organic potency,10’12'13 but as 
recent studies of nocturnal penile tumes­
cence have shown, not all nocturnal erec­
tions are of the same quality.14 Thus, 
when potency was defined as the ability 
to achieve vaginal penetration, the func­
tional potency dropped to 26% in our ser­
ies. In other words, 50% of our patients 
had sufficient blood flow to experience 
nocturnal erections, but only 26% could 
perform sexually, indicating that the 
remaining patients suffered either from 
a psychological inhibition or from poor- 
quality penile erection, the latter 
presumably due to inadequate blood 
flow. In some patients who did not have 
nocturnal erections, certain medications 
such as antihypertensive drugs might have 
played a role, although most of these 
patients in our series were found to have 
a low penile to brachial pressure index, 
suggesting that the impotence was of vas­
cular origin.
Because of the difficulty in obtaining 
a sufficiently accurate history, and since 
fertility is unimportant in patients of this 
age group, we have ignored the question 
of retrograde ejaculation3 and concen­
trated solely on the relation of pelvic 
blood flow to erectile potency.2'13 
Others8 have demonstrated, however, 
that should the hypogastric plexus of 
nerves be disrupted either at the level of 
the inferior mesenteric artery take-off 
from the aorta or as the nerves cross 
anterior to the left common iliac artery,
a significant incidence of retrograde 
ejaculation will occur resulting in func­
tional potency but, de facto, sterility.
Various techniques for measuring 
penile blood flow, including the wave­
form analysis,15 penile vascular resist­
ance11 and absolute blood pressure, have 
been used, with each investigator claim­
ing superiority of his methods. We noted 
a close correlation between penile blood 
pressures and penile to brachial index4’16 
in our patients. We calculated these 
indices and compared them with the clin­
ical information we had gathered. As 
others6'11 have found, this index shows 
significant discriminatory ability to 
predict impotence. It is not foolproof and 
there is a grey zone,6’11 but certainly any 
patient complaining of impotence who 
has a penile to brachial pressure index of 
less than 0.6 probably has a vascular com­
ponent.47 Our results corroborate these 
earlier studies.
Our findings also show the relative 
unimportance of age and the clear neces­
sity of adequate pelvic blood flow for 
male sexual potency. The patients who 
had an abdominal aneurysm were 10 
years older on average than the patients 
who had aortoiliac or femoral artery dis­
ease and yet their rate of impotence was 
substantially lower. In addition to 
attempting to augment pelvic blood flow, 
we thought it essential to demonstrate 
that we had achieved the principal aim of 
the operations, namely, to bypass the 
atherosclerotic obstruction in the aor­
toiliac system. To this end, we measured 
the thigh to brachial pressure indices for 
each patient in this study and routinely 
found significant increases in the 
postoperative period, indicating the ade­
quacy of the repair. The preoperative data 
also demonstrated that patients with the 
worst thigh to brachial and penile to 
brachial indices were those selected for 
aortoiliac repair.
Our patients with aneurysms demon­
strated no change of pelvic blood flow 
after aneurysmectomy. Their functional 
capacity likewise did not change; this 
agrees with several reports4,6-8 in the 
literature. It is now quite clearly shown 
that if patency of the internal iliac artery 
is preserved and not isolated by repair, 
no iatrogenic impotence should 
result.3'5’7’17
The patients who had the most severely 
occlusive disease (those who underwent 
aortoiliac or femoral bypass grafting) 
showed some improvement in the penile 
to brachial pressure index (Table IV), but 
only 13% improved sufficiently to have 
nocturnal erections and only 10% became 
functionally potent again. These results 
are in marked contrast to reports that 
claim a 73% return of potency.4’11 
Others7 have shown a more modest 
improvement in about 30%. The
improved penile to brachial and thigh to 
brachial indices of our patients indicate 
that their repairs were anatomically cor­
rect. Nevertheless, it appears that the 
penile to brachial pressure index would 
have to increase to a level better than 0.6 
for the patient to experience a notable 
improvement.4,7 We suspect, as others 
have, that the reason lies in more distal 
occlusive disease of small vessels.13
To date, there have been few studies 
reporting the results of percutaneous 
transluminal angioplasty on sexual func­
tion, and there are no comparisons of this 
technique with the conventional surgical 
approach to aortoiliac disease. Our 
patients who had angioplasty certainly 
had less diffuse disease. This was reflected 
in their higher preoperative penile to 
brachial and thigh to brachial indices and 
lower incidence of impotence. However, 
as with the patients who had aortoiliac or 
femoral artery bypass, despite some 
improvement in these indices postopera- 
tively, demonstrated by paired analysis, 
only one of the four patients with no noc­
turnal erections before operation was 
improved after operation and only one of 
the seven patients who were incapable of 
penetration before was sexually func­
tional after operation. Our failure to 
achieve greater success in this group of 
patients reinforces our belief that the 
small-vessel changes make an important 
contribution to vasculogenic impotence in 
many such patients.
Our results, in common with others,4 
also illustrate the unreliability of routine 
aortoiliofemoral angiography to supply 
predictive information. Such predictions 
might be improved with more selective 
angiography10,11 of the pudendal arteries, 
which we are doing now in some cases.
The reported short-term success of 
direct pudendal vessel bypassing also sug­
gests the role of small-vessel disease in 
vasculogenic impotence, but the long­
term results of these microvascular tech­
niques have not been clearly estab­
lished.10,17'19
In conclusion, our results show that the 
incidence of male sexual impotence is high 
in patients with aortoiliac disease, and 
contemporary vascular surgery does not 
interfere with the neural mechanism 
associated with erection. We can increase 
pelvic blood flow, but usually not enough 
to make a functional difference. Per­
cutaneous angioplasty, when feasible, is 
the procedure of choice because it is less 
invasive, but there is no reason to believe 
that it causes less iatrogenic impotence 
than a careful bypass operation where 
efforts are made to preserve the distal 
aorta and its overlying neurologic struc­
tures.
Fortunately, we rarely cause sexual 
deterioration when we improve blood 
flow to the lower extremities. Conversely,
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we make few people better, but we can­
not predict with routine preoperative 
angiography who those fortunate ones 
will be. This suggests that in vasculogenic 
impotence, the disease often extends 
beyond our routine repair, and percutane­
ous angioplasty reaches no further than 
the knife.
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La splenectomie dans le purpura thrombocytopenique 
idiopathique. Etude retrospective de 40 cas
Les auteurs ont analyse de facon retros­
pective les dossiers de 40 malades sou- 
mis a une splenectomie pour purpura 
thrombocytopenique idiopathique chez 
qui un premier essai therapeutique aux 
corticosteroTdes avait prealablement 
abouti a un echec total ou partiel 
(recidive). La mortalite operatoire 
a ete nulle mais la morbidite. sur le 
plan respiratoire en particulier, a ete rela- 
tivement importante soit de 40% des 
cas. Un drainage chirurgical de la loge 
splenique dans de telles circonstances 
devrait systematiquement etre evite 
puisqu'il semble clairement etre associe 
a une frequence plus grande de compli­
cations pulmonaires. Le suivi hematologi- 
que moyen de 30.3 mois effectue chez 
37 des malades a montre un taux de 
remission complete post-splenectomie de 
89.2%. Ce resultat confirme la valeur 
therapeutique de la splenectomie dans le 
purpura thrombocytopenique idiopathi­
que, en particulier chez les malades 
ayant presente une reponse transitoire a 
la corticotherapie.
The authors analysed retrospectively the 
files of 40 patients who underwent 
splenectomy for idiopathic thrombocyto­
penic purpura and who were totally or 
partially (relapse) resistant to a therapeu­
tic trial of corticosteroids. There was no 
operative mortality but morbidity, espe­
cially respiratory, was substantial, being 
40% . Drainage of the splenic bed should 
be avoided because this is clearly asso-
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dated with a greater frequency of pul­
monary complications. In 37 patients 
with a mean follow-up of 30.3 months, 
there was complete remission in 89.2% 
after splenectomy. This confirms the 
therapeutic value of splenectomy in 
idiopathic thrombocytopenic purpura, 
especially in those who showed a partial 
(transitory) response to corticosteroids.
Le purpura thrombocytopenique idiopa­
thique (PTI) est une maladie caracterisee 
par la formation d’auto-anticorps anti- 
plaquettaires entraTnant dans le systeme 
reticulo-endotheliai et plus particuliere- 
ment dans la rate, une destruction prema- 
turee des plaquettes sanguines circulan- 
tes. La corticotherapie orale constitue le 
traitement initial habituel de cette mala­
die, tandis que la splenectomie est gene- 
ralement reservee aux malades qui resis- 
tent a un premier traitement medical ou 
qui presentent des recidives. La place des 
immuno-suppresseurs nonsteroldiens 
dans le traitement du PTI demeure con- 
troversee; ils sont le plus souvent 
employes chez les patients refractaires au 
traitement medical et chirurgical.1,2
Nous avons effectue une etude retros­
pective de 40 splenectomies consecutives 
pratiquees chez des patients atteints de 
PTI, au cours d’une periode de 10 ans. Le 
but de cette etude etait d ’evaluer dans un 
premier temps la morbidite et la morta­
lite operatoire et, dans un deuxieme 
temps, les resultats therapeutiques de la 
splenectomie. Nous avons aussi tente 
d’evaluer la valeur de certains elements 
dans la prediction du resultat de la sple­
nectomie.
Patients et methode
Les dossiers de 40 malades ayant subi 
une splenectomie pour PTI entre janvier 
1968 et janvier 1978 a l’Hopital du Saint- 
Sacrement a Quebec ont ete revus. La 
surveillance hematologique a ete effec- 
tuee par les membres du service 
d’hematologie.
Le diagnostic de PTI a ete porte sui- 
vant quatre criteres essentiels reconnus3 
soit, premierement, un decompte plaquet- 
taire de moins de 150 x 109/L , deux-
iemement un myelogramme revelant un 
nom bre norm al ou augmente de 
megacaryocytes, troisiemement une 
absence d ’histoire medicamenteuse et 
quatriemement une absence de spleno- 
megalie palpable.
Un cinquieme critere diagnostique soit 
la presence dans le sang circulant d ’an- 
ticorps anti-plaquettaires (IgG associees 
aux plaquettes) est maintenant suggeree 
dans la litterature1 meme s’il n’est pas 
essentiel au diagnostic. Cette epreuve 
n’etait pas offerte par nos laboratoires 
durant la periode couverte par 1’etude.
Les m alades atteints de lupus 
erythemateux dissemine ou chez qui une 
histoire de prise medicamenteuse aurait 
pu etre a 1’origine de la thrombocytopenie 
ont ete elimines de l’etude.
La remission apres corticotherapie ou 
apres splenectomie est definie a partir des 
criteres habituels4 soit, premierement 
une remission complete permanente 
(numeration plaquettaire a plus de 150 x 
109/L  pour plus de 14 jours), deuxieme- 
ment une remission complete transitoire 
(numeration plaquettaire a plus de 150 x 
109/L  pour moins de 14 jours), 
troisiemement une remission partielle 
(numerique plaquettaire maintenue entre 
50 et 150 x 109/L) et quatriemement 
une absence de remission (numeration 
plaquettaire a moins de 50 x 109/L).
La splenectomie a ete pratiquee soit par 
une incision para-mediane ou une incision 
sous-costale gauche. Une recherche atten­
tive de rate accessoire a toujours ete notee 
aux protocoles operatoires.
Resultats
Les patients ont ete subdivises en deux 
groupes, soit ceux de moins de 12 ans (7 
patients) et ceux de 12 ans et plus (33 
patients). L’age varie de 5 a 66 ans 
(moyenne de 28 ans), avec predominance 
chez la femme de 2 pour 1.
Le purpura et les ecchymoses ont con­
stitue la raison de consultation chez 39 
malades. Seule une patiente de 23 ans a 
presente des metrorragies comme premier 
symptome, sans manifestation cutanee de 
sa maladie.
Chez nos 40 malades, 1’echec du traite­
ment medical, soit la corticotherapie pen-
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dant une periode de 6 semaines ou plus, 
a constitue l’indication de la splenec- 
tomie; 19 malades ont presente une remis­
sion complete transitoire, 15 malades une 
remission partielle et 6 malades n’ont 
obtenu aucune remission.
Nous avons retrouve a Pexploration 
abdominale, des rates accessoires chez 
42.5% de nos malades. La majorite des 
rates accessoires etaient uniques et de 
diametre inferieur a 2 cm. Elies furent 
retrouvees le plus souvent (14 malades) au 
hile splenique, au ligament gastro- 
splenique et au ligament spleno-colique. 
Les localisations ectopiques moins fre- 
quentes ont ete au niveau de la queue du 
pancreas chez un patient et au grand 
epiploon chez un autre. Un patient 
presentait une rate accessoire au mesen- 
tere et un dernier au niveau du ligament 
lieno-renal.
L’etude de la morbidite operatoire a 
permis de constater la survenue de com­
plication chez 16 malades (40%). Dans 11 
cas, il s’agissait de complications pul- 
monaires, dans 3 cas, de thromboses 
veineuses des membres inferieurs sans 
embolie et dans 2 cas, de complications 
locales, soit un hematome et une 
ecchymose a la plaie operatoire.
Nous notons une frequence accrue des 
complications pulmonaires chez les six 
patients chez qui un drainage de la loge 
splenique a ete effectue. En effet, 4 des
6 patients ont presente des complications 
bronchopulmonaires alors que seulemerit
7 des 34 patients (20%) nondraines, ont 
presente ce meme type de complication. 
Le taux global des complications pul­
monaires a done ete de 27.5%.
La mortalite operatoire, definie comme 
etant celle survenant dans le mois qui suit 
le geste chirurgical, a ete nulle. Toutefois, 
un patient est decede au 38ieme jour post- 
splenectomie par hemorragie intra- 
cranienne suite a une recidive de sa 
thrombocytopenie.
Le suivi hematologique a ete realise 
chez 37 de nos 40 malades; sa duree varie 
entre 1 et 120 mois (moyenne de 30.3 
mois). Le resultat de la splenectomie a ete 
evalue separement pour chacun des deux 
groupes deja definis et pour l’ensemble 
des malades. Une remission complete per- 
manente (tableau I) fut obtenue chez 
100% des enfants et chez 86.6% des 
adultes pour un taux global de remission 
de 89.2%.
De tous les facteurs preoperatoires 
evalues, seule la reponse prealable aux 
corticosteroides semble avoir une valeur 
pronostique significative sur le resultat du 
traitement chirurgical. Ainsi 100% 
(18/18) des patients ayant obtenu une 
remission complete transitoire sous cor­
ticotherapie ont beneficie d’une remission 
complete permanente apres splenectomie 
alors que seulement 86.5% (13/15) des 
patients chez qui une remission partielle
en preoperatoire avait ete obtenue, ont 
vu leur condition amelioree de fa?on per­
manente par la splenectomie. La chirur- 
gie n ’a malheureusement pu offrir une 
remission complete permanente qu’a 50% 
(3/6) des malades chez qui une absence 
totale de reponse a la corticotherapie avait 
prealablement ete constatee.
Discussion
L’evolution naturelle du PTI chez l’en- 
fant est differente de celle generalement 
observee chez l’adulte. En effet, les taux 
de remission spontanee ou de remission 
a long terme observes apres traitement 
aux corticosteroides sont plus eleves que 
chez l’adulte. La litterature fait etat d ’une 
reponse favorable aux steroides chez 60% 
des enfants contrairement a 15% seule­
ment chez les adultes. C’est en raison de 
cette difference importante que nous 
avons du, pour cette etude, repartir les 
malades en deux groupes, soit les malades 
de moins de 12 ans et ceux de 12 ans et 
plus. Ces observations expliquent egale- 
ment la plus grande frequence de splenec­
tomies chez l’adulte. L’age moyen de 28 
ans dans notre groupe de malades est 
essentiellement celui que Ton retrouve 
dans la litterature.5
La presentation clinique caracteristique 
sous forme de purpura et d ’ecchymoses 
se retrouve chez tous nos patients sauf un. 
Les autres manifestations telles les hemor- 
ragies intra-craniennes et les hemorragies 
des muqueuses sont rares.6
L’indication chirurgicale est habituelle- 
ment portee d’apres l’absence d’une 
remission adequate apres traitement med­
ical.5,710 Tous nos malades ont done subi 
un premier essai therapeutique aux 
steroides et la remission complete tran­
sitoire, la remission partielle ou l’absence 
de remission ont constitue l’indication 
chirurgicale.
Dans aucun cas la splenectomie n’a ete 
provoquee en raison d ’une hemorragie 
intra-cranienne active ou de complication 
de la corticotherapie comme il est rap­
porte dans moins de 10% des cas des 
series revisees.5,11
Le taux de 42.5% de rates accessoires 
observees dans notre propre serie est plus 
eleve que le taux moyen de 15% a 30% 
cite dans la litterature.12"15 Aucune raison
evidente nous parait pouvoir expliquer 
cette difference pourtant importante.
La morbidite operatoire observee dans 
notre serie nous semble plutot elevee. Il 
nous faut insister sur la constatation que 
66% des patients draines suite a la 
splenectomie ont presente des complica­
tions respiratoires alors que seulement 
20% des patients qui ont subi leur 
splenectomie sans drainage ont presente 
ce meme type de complication. Ces 
chiffres evocateurs suggerent qu’un 
drainage systematique post-splenectomie 
augmenterait la morbidite de fa?on sig­
nificative. La frequence globale de nos 
complications pleuro-pulmonaires est 
beaucoup plus elevee que celle rapportee 
dans les series de Schw artz et 
collaborateurs11 et de Mintz et colla- 
borateurs5 avec des taux respectifs de 
5.8% et de 4.4%.
Quant aux complications thrombo- 
tiques veineuses que nous avons observees 
(7.5%) leur frequence se compare a peu 
pres au taux de 5.8% rapporte par Mintz 
et collaborateurs.5 En general, la sur­
venue d’accidents thrombo-emboliques 
post-splenectomies dans le PTI n’est pas 
plus frequente que celle observee apres 
d’autres interventions comme le souli- 
gnent Schwartz et collaborateurs.11
Finalement, le type d’incision utilisee, 
para-mediane ou sous-costale, ne nous 
parait pas avoir eu quelque influence que 
ce soit sur la frequence des complications, 
en particulier celles d’ordre pleuro- 
pulmonaire.
Un dernier point important de cette 
etude a trait a la remission obtenue suite 
a la splenectomie. Le taux observe de 
remissions (89.2%) nous apparait plus 
eleve dans notre serie que dans plusieurs 
autres et en particulier celle (77.3%) de 
Mintz et collaborateurs.5 Le suivi 
hematologique de 4.8 ans de cette derniere 
etude explique peut-etre cette difference 
de resultat. Par ailleurs, notre taux de 
remission est identique a celui de 88% 
rapporte par Schwartz et collabora­
teurs.11 Le seul facteur pronostique 
valable d’une remission complete du PTI 
apres splenectomie semble etre la surve­
nue prealable d’une remission transi­
toire aux corticosteroides en preope­
ra to ire .5 Dans notre etude, nous 
avons effectivement observe une remis-
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p e rm an e n te  
R e m is s io n  p a r t ie lle  
A b s e n c e  de  re m is s io n
7 1 0 0 2 6  8 6 . 6  
2  6 .7  
2  6 .7
3 3  8 9 . 2  
2  5 .4  
2  5 .4
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sion complete post-splenectomie chez tous 
les malades satisfaisant a ce critere, con- 
tre 86.5% chez ceux qui n ’avaient obtenu 
qu’urie remission partielle et 50% chez 
ceux qui n ’avaient obtenu aucune 
reponse. Mintz et collaborateurs5 obtient 
pour les groupes correspondants des 
valeurs de 92.3%, 68% et 50% respective- 
ment (p < 0.001). Notre nombre de 
patients etant relativement restreint, il est 
difficile d ’en tirer des conclusions statis- 
tiques. Toutefois, nos resultats semblent 
concorder avec ceux de l’etude citee.
Nous pouvons conclure que les resul­
tats de cette etude retrospective de 40 cas 
de splenectomie se comparent favorable- 
ment a ceux qui ont ete rapportes 
jusqu’ici dans la litterature et qu’ils justi-
fient l’usage du traitement chirurgical 
dans le PTI cortico-resistant.
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Mononucleose infectieuse et pseudokyste splenique:
presentation d’un cas
Les auteurs rapportent le cas Clinique 
d'un patient de 18 ans qui a presente 
une masse symptomatique a I'hypochon- 
dre gauche, precedee d'une mononu­
cleose infectieuse 6 mois auparavant. 
L'investigation preoperatoire a comprit 
principalement une echographie et une 
tomographie axiale de I'abdomen, 
demontrant une masse kystique au pole 
inferieur de la rate. Une splenectomie fut 
pratiquee. L’examen anatomo- 
pathologique revela un pseudokyste sple­
nique avec coque fibreuse et absence de 
revetement epithelial interne. La pathoge- 
nese du pseudokyste de la rate secon- 
daire a une mononucleose infectieuse est 
discutee, de meme que le traitement.
The authors report the clinical case of an 
18-year-old patient who presented with 
a symptomatic mass in the left upper 
quadrant 6 months after having infec­
tious mononucleosis. The preoperative 
investigation consisted principally of 
echography and computerized axial 
tomography of the abdomen, which 
demonstrated a cystic mass of the lower 
pole of the spleen. Splenectomy was 
carried out. Histologic examination 
showed a pseudocyst of the spleen with
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a fibrous capsule without an epithelial 
lining. The treatment and pathogenesis 
of pseudocysts of the spleen secondary 
to infectious mononucleosis are dis­
cussed.
Les pseudokystes spleniques sont des enti- 
tes cliniques rares. Dans la majorite des 
cas, ils surviennent a la suite d’un trau- 
matisme abdominal.
Les pseudokystes spleniques consecu- 
tifs a une mononucleose infectieuse sont 
d ’autant plus rares. A l’aide d ’un cas, 
nous en revoyons la presentation clinique 
et discutons de sa pathogenese et de son 
traitement.
Presentation clinique
Un jeune patient de 18 ans, sans antecedent 
contributoire, presente en decembre 1981 une 
mononucleose infectieuse caracterise par une 
asthenie, des adenopathies cervicales bilatera- 
les et une serologie positive.
Quatre mois plus tard le patient souffre d’un 
malaise a l’hypochondre gauche avec augmen­
tation du volume de I’abdomen. L’anamnese 
ne revele aucune notion de traumatisme, 
aucune douleur precise, aucun symptfime 
digestif associe. L’examen physique demontre 
seulement la presence d’une masse mal delimi- 
tee a l’hypochondre gauche, 8 cm sous le 
rebord costal, partiellement mobile, non dou- 
loureuse.
L’evaluation biologique de base s’avere
FIG. 1—L’echographie abdominale demontre une masse principalement kystique, d’origine 
splenique probable.
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negative. L’investigation radiologique consiste 
en une echographie et une tomographie axiale 
de l’abdomen.
L’echographie abdominale demontre une 
masse kystique avec loculations au quadrant 
superieur gauche en contact intime avec la rate, 
sans evidence de calcification (fig. 1).
La tomographie axiale determine une masse 
d ’aspect heterogene de 10 x 8 x 7 cm fixee 
au pole inferieur de la rate. Par ailleurs, la rate 
est legerement augmentee de volume (fig. 2).
Apres [’administration d’un vaccin antipneu- 
mococcique (Pneumovax 0.5 mL, 2 semaines 
en preoperatoire), une laparotomie est prati- 
quee par incision sous-costale gauche. Les 
constatations peroperatoires sont celles d’une 
rate de volume sensiblement normal avec une 
masse kystique, de coloration blanchatre, inti- 
mement liee a son pole inferieur (figs. 3 et 4). 
Devant la presence d’adherences locales, la 
masse kystique et la rate sont excisees en bloc.
L’examen anatomo-pathologique temoigne 
a la macroscopie d’une rate de 350 g (15 x 8 
x 3.5 cm) et d’une masse kystique de 9 cm de 
diametre contenant 450 mL de liquide bruna- 
tre . Cette masse kystique est extra- 
parenchymateuse, reliee au pole inferieur de 
la rate par une base de 5 cm de diametre.
FIG. 2—La tomographie axial de (’abdomen 
demontre une masse (10 x 8 X 7 cm) d’aspect 
heterogene, fixee au pole inferieur de la rate.
FIG. 3— Specimen post-chirurgical. 
Volumineuse masse kystique fixee au pole 
inferieur de la rate.
FIG. 4—Examen macroscopique. A la 
coupe, la coque du pseudokyste est visualisee. 
La partie interne se caracterise par de multi­
ples ramifications friables (hematome ancien).
L’examen microscopique revele une rate 
d ’aspect histologique normal et la presence 
d ’un kyste dont la paroi est formee de tissue 
de granulation avec presence de cellules gean- 
tes et d’exsudat hemorragique. Aucun revete- 
ment epithelial interne n’est mis en evidence 
a partir de multiples coupes histologiques (fig. 
5).
Discussion
Les pseudokystes spleniques secondai- 
res a une mononucleose infectieuse cons­
tituent une entite clinique peu frequente 
telle qu’en temoigne la rarete des publi­
cations disponibles. Une revue poussee de 
la litterature nous permet de retrouver la 
publication d ’un cas dans une revue polo­
naise, en 1977.1 Cependant, la rupture 
splenique spontanee avec hemoperitoine 
est une complication bien connue, quoi- 
que rare, de la mononucleose infec­
tieuse.2’5
La presentation clinique d’un pseu­
dokyste splenique est non-specifique et en 
relation avec une masse comprimant les 
organes avoisinants. La majorite des 
patients presente un simple malaise sans 
autre symptomatologie. Une minorite 
des patients presente des symptomes pre­
cis tels que douleurs a I’hypochondre gau­
che, douleur irradiant a l’epaule et satiete 
precoce. L’examen physique est de meme 
peu precis, revelant une masse mal deli-
Tableau I—Classification 
des kystes spleniques acquis 
Kystes parasitaires 
Echinococcus 
Kystes non-parasitaires 
Kystes vrais 
Kyste dermoi'de 
Kyste epidermoYde 
Kyste simple (sereux)
Pseudokyste
FIG. 5—Examen microscopique. Capsule 
fibreuse dense, trabeculaire, sans revetement 
epithelial interne. Presence d’un exsudat 
fibrino-hemorragique a la partie superieure du 
cliche (hematoxyline et eosin, reduit par 52% 
de x 160).
mitee, de diametre variable, au quadrant 
superieur gauche de l’abdomen.
Toute lesion kystique de la rate impli- 
que un diagnostic differentiel; ce dernier 
peut etre etabli a l’aide d’une classifica­
tion sommaire des kystes spleniques 
(tableau I).
Parmi les kystes spleniques, les kystes 
parasitaires sont les plus frequents quoi- 
que rares en Amerique du Nord. Par la 
suite, les pseudokystes figurent au 
deuxieme rang en frequence, constituant 
environ 70% a 80% des kystes non- 
parasitaires. La principale cause de pseu­
dokyste est le traumatisme abdominal; la 
mononucleose infectieuse et la malaria 
sont parmi les causes rares. Derniers en 
frequence, les kystes vrais constituent 
20% a 30% des kystes non-parasitaires.6
Done le diagnostic differentiel est prin- 
cipalement celui des kystes parasitaires et 
des pseudokystes post-traumatiques. 
D’ou 1’importance du questionnaire dans 
les notions de voyage recent et de trau­
matisme abdominal. Des cultures du 
liquide doivent etre effectuees lors de la 
possibility d’une etiologie infectieuse. 
L’examen anatomo-pathologique devient 
sou vent la cle du diagnostic.
La pathogenese d ’un pseudokyste sple­
nique apres mononucleose infectieuse 
s’explique probablement par une rupture 
splenique occulte suivie de la formation 
d’un hematome intra-parenchymateux ou 
sous-capsulaire. Par la suite, on assiste a 
l’organisation de cet hematome avec for­
mation d ’une capsule fibreuse par le tissu 
de granulation. De plus, lors d ’une mono­
nucleose infectieuse, il existe une augmen­
tation de volume et une friabilite de la 
rate, rendant celle-ci plus susceptible aux 
traumatismes mineurs qui echappent le 
plus souvent au questionnaire.
Conclusions
Le traitement du pseudokyste splenique 
est chirurgical. Dans la majorite des cas, 
une splenectomie s’avere necessaire, 
devant la presence d ’un pseudokyste 
intra-parenchymateux ou d ’adherences 
importantes. Une splenectomie partielle 
peut s’appliquer dans de rares cas de 
pseudokyste extra-parenchymateux et de 
conditions locales adequates.
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Spinal Cord Injury in the Work Force
Of 144 patients with spinal cord injury 
admitted to the Sunnybrook Medical 
Centre from 1974 to 1979, 25 (24 men) 
(17.4%) had sustained their injuries at 
work. The 25 patients ranged in age 
from 20 to 56 years, with more than 
half being in their third decade of life. 
Work-related spinal cord injury was more 
frequent in the thoracic region than spi­
nal injuries from other causes. The inju­
ries were generally severe, 2 4 %  of them 
being complete cord injuries (i.e., no sen­
sory or motor function below the level of 
injury). The mean neurologic grade of 
these patients did not change substan­
tially between the time of admission and 
discharge. The mortality was 8 % .
The pattern of spinal cord injury in this 
series was compared to that in the 
period 1948 to 1973, when 105 
(29.3%) of 358 spinal cord injuries 
occurred at work, constituting the 
second most frequent cause of acute 
spinal cord injury, after traffic accidents. 
In the current series, only 17.4%  sus­
tained their injuries at work. This was 
the third most common cause of spinal 
injuries in this period after traffic acci­
dents and sports-recreational injuries. 
Falls in industry were the most frequent 
mode of work injury from 1974 to 1979, 
compared with construction accidents in 
the earlier period.
The number of work-related spinal 
cord injuries is still too high. Further­
more, the severe neurologic damage 
suffered and the lack of substantial 
improvement emphasize the importance 
of preventive efforts, especially in indus-
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try. The fact that work injuries now rank 
third as a relative cause of spinal injury 
may indicate an absolute decline in this 
type of injury, especially among con- - 
struction workers.
Sur 144 victimes de blessures de la 
moelle epiniere hospitalises au Sunny­
brook Medical Centre entre 1974 et 
1979, 25 (dont 24 hommes) (17.4%) 
avaient eu un accident de travail. Leur 
age allait de 20 a 56 ans et plus de la 
moitie etaient dans la trentaine. Les 
lesions de la moelle subies au travail tou- 
chaient plus souvent la region thoracique 
que les blessures attribuables a d'autres 
causes. Les blessures etaient generale- 
ment graves; dans 2 4 %  des cas il y 
avait section complete (c. a d., absence de 
fonction sensitive ou motrice sous le niveau 
de la lesion). Le stade neurologi- 
que moyen de ces patients n'a pas 
change de facon appreciable entre leur 
arrivee a I'hopital et le moment ou ils 
obtinrent leur conge. La mortalite fut de 
8%.
Les types de blessures de la moelle 
observes dans cette serie ont ete compa­
res a ceux enregistres entre 1948 et 
1973 alors que 105 lesions de la moelle 
(2 9 .3% ) sur 358 sont survenues au tra­
vail, soit la deuxifeme cause de lesions de 
la moelle apres les accidents de la circu­
lation. Dans la periode la plus recente, 
17.4%  des patients ont ete blesses au 
travail. En frequence, il s'agit de la troi- 
sieme cause de lesion de la moelle apres 
les accidents de la route et les blessures 
sportives. Les chutes dans I'industrie ont 
ete la cause la plus frequente d'acci- 
dents de travail entre 1974 et 1979 
comparativement aux accidents de la 
construction durant la periode ant6rieure.
Le nombre de lesions de la moelle 
resultant d'un accident de travail est 
encore trop 6leve. De plus, les domma- 
ges neurologiques severe qui sont subis 
et le manque d'amelioration appreciable 
soulignent ('importance de la prevention, 
particulierement dans I'industrie. Le fait 
que les accidents de travail arrivent 
maintenant au troisi&me rang comme 
cause des lesions de la moelle indique 
possiblement que ce type de blessure
soit en regression, specialement chez les 
travailleurs de la construction.
Severe injury to the spinal cord occurring 
in the work place produces major disrup­
tion to the individual’s life, his family and 
to society in general. In most instances, 
the patient has to abandon his job, and 
his social life is significantly altered. The 
cost per injury can amount to hundreds 
of thousands of dollars in lost earnings 
and medical costs.1,2
Tator and Edmonds1 have analysed 
the epidemiologic factors related to acute 
spinal cord injury. They studied 358 
patients with acute spinal cord injury due 
to accidents, mainly in Ontario, between 
1948 and 1973, and found that accidents 
at work were the second most common 
cause of such injuries, accounting for 105 
(29.3%) cases; traffic accidents were the 
most common cause. Construction wor­
kers were the most frequently affected 
group (22.9%), followed by logging wor­
kers (17.1%), farmers (14.3%) and 
miners (9.5%) with the remainder belong­
ing to other small groups. In contrast, 
Peerless and Schweigel2 found that log­
ging accidents accounted for 45% of the 
work-related spinal cord injuries in Brit­
ish Columbia.
Although in the past decade, major 
advances into the pathophysiology of 
acute spinal cord injury have resulted in 
greater understanding o f the acute 
changes that occur in the cord after 
trauma,3-6 treatment of such injury is 
still far from perfect in terms o f recov­
ery of neurologic function. Thus, preven­
tion must be emphasized. We have, there­
fore, studied the epidem iology o f 
work-related accidents occurring in 
Ontario between 1974 and 1979 with the 
view that it is necessary to identify specific 
etiologic factors for systematic prevention 
of these devastating injuries.
Patients and M ethods
We reviewed the hospital records o f the 
first 144 consecutive patients admitted to 
the Acute Spinal Cord Injury Unit, Sun­
nybrook Medical Centre, University of 
Toronto, between 1974, when the unit
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was opened, and Dec. 31, 1979. The over­
all management of this group of patients 
was recently reported.7 The information 
was analysed at the University of Toronto 
Computer Centre using the “ Statistical 
Package for the Social Sciences” (SPSS). 
Patients included in the present study 
were restricted to those who sustained 
acute spinal cord or cauda equina injury 
while at work. Patients with chronic back 
or neck pain due to degenerative disc dis­
ease and other spinal disorders such as 
acute lumbar disc herniation and flexion- 
extension sprains were excluded.
Findings
Causes
Work was the third most common 
cause of acute spinal cord injury, after 
traffic accidents and sports injuries (Table 
I). Twenty-five (17.4%) of the 144 
patients sustained spinal cord or cauda 
equina injury in work-related accidents.
Sex and Age
Twenty-four (96%) of the 25 patients 
with work-related spinal cord injury 
(group 1) were men. The only woman was 
a 48-year-old farmer who fell off a trac­
tor she was driving and was run over by 
the hay wagon behind it. Of the other 119 
patients who were not injured at work 
(group 2), 89 (75%) were men.
The 25 patients in group 1 ranged in 
age from 20 to 56 years (Table II), with 
two peaks of frequency, one in the 20- to 
29-year age group, and the other in the 
50- to 59-year age group. In group 2, the 
ages of patients ranged from 12 to 83 
years.
Type o f  Work Injury
Table III shows that industrial acci­
dents were the most common type in 
group 1 (48%), followed by construction 
accidents (16%). Logging, farming and 
factory accidents each accounted for 8%, 
with 12% due to other causes. The indus­
trial accidents tended to occur in all age 
groups, the farming accidents involved 
older workers and three of the four 
patients injured in construction accidents 
were in the third decade of life.
Table 1-Causes of Acute Spinal Cord
Injuries in 144 Patients (1974-1979)
No. of
Cause patients (%|
Traffic 59(41.0]
Sports-recreation 32(22.2)
Work 25(17.4)
Falls at home 15(10.4)
Others 13(9.0)
Total 144(100)
Mechanism o f Injury
It is noteworthy that 14 patients (56%) 
in group 1 were injured in falls, 8 (32%) 
were struck or crushed and 3 (12%) were 
injured in automobile-related accidents 
(two farm vehicles and one truck) (Table 
IV). The majority of those truck or 
crushed were in the age group 20 to 29 
years, whereas falls involved all the age 
groups. Apart from the two patients in 
the logging category who were both 
struck by trees, falls were the predomi­
nant mechanism of injury in each of the 
other categories (Table V).
Level o f Spinal Injury
Eleven (44%) patients in group 1 had 
an injury of the cervical spine (Table VI), 
compared with almost 60% in group 2, 
but a higher proportion of workers 
(group 1) had an injury of the thoracic 
spine than the nonworkers (36% versus 
25.2%).
The Severity o f Injury
On admission, 19 patients had an 
incomplete spinal cord injury and 6 had 
a complete cord injury (i.e. no motor or 
sensory function below the level of
__________________________ Table 11-Age of Cord-Injured Patients_______
_________________________ No. of patients
V________________  Group 1 Group 2 Totals
1  30 30
12 37 49
A 17 21
2 9 11
7 9 16
0 17 17
Totals 25 U 9  144
Mean ±  SD 35.8 ±  12.7 33.6 ±  18.3 34.0 +  17.4
< 2 0
20-29
30-39
40-49
50-59
>60
Table Ill-Type of Work Related to Age at Injury
Category of injury
Age, yr Industrial Logging Construction Factory Farm Other Totals
20-29 5 1 3 1 0 2 12
30-39 3 0 0 0 0 1 4
40-49 1 0 0 0 1 0 2
50-59 3 1 1 1 1 0 7
Totals 12 2 4 2 2 3 25
Table IV-Mechanism Related to Age at Injury
Mechanism
Age, yr Fall Struck or crushed Motor vehicle accident Totals
20-29 5 6 1 12
30-39 3 0 1 4
40-49 1 1 0 2
50-59 5 1 1 7
Totals 14 8 3 25
Table V--Type of Work Related to Mechanism of Injury
Category 
of injury
Mechanism
Fall Struck or crushed Motor vehicle accident Totals
Industrial 8 2 2 12
Logging 0 2 0 2
Construction 2 2 0 4
Factory 1 1 0 2
Farm 1 1 0 2
Other 2 0 1 3
Totals 14 8 3 25
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injury). At discharge, the distribution was 
the same, although one patient with a 
complete cord injury improved to in­
complete status at the time of discharge 
and one patient whose injury was 
incomplete initially became complete 
after admission. On both admission and 
discharge, the mean severity grade of the 
neurologic injury was 4.6 based on the 
Sunnybrook severity scale,8 indicating 
virtually no recovery of neurologic 
function.
Mortality
The mortality in group 1 was 8% (2 of 
25) compared with 12.6% in group 2 (15 
of 119). The two patients in group 1 died 
during the initial hospitalization. One was 
a 27-year-old construction worker who 
fell and sustained an odontoid fracture 
with severe neurologic injury (grade 4 on 
the Sunnybrook scale). He died of 
respiratory failure 32 days after the fall, 
with other contributing factors being 
hypoxic encephalopathy and gastric 
hemorrhage. The second patient was a 
37-year-old industrial worker who fell, 
sustaining a third-degree burn to 60% of 
his body, a fracture-dislocation at C5-6 
and a grade 2 spinal cord injury. He died 
of renal failure 48 days after the injury.
Discussion
Our study identifies work as the third 
most common cause of acute spinal cord 
injury in Ontario, after traffic and sports- 
recreational injuries, in the period 1974 
to 1979. In comparison with an earlier 
study by Tator and Edmonds,1 covering 
the period 1948 to 1973, there has been 
a relative decrease in the frequency of 
work-related spinal cord injury (17.4% 
versus 29.3%). In that period, work- 
related spinal cord injury was the second 
most common cause, behind motor vehi­
cle accidents (34.4%) and ahead of sports- 
recreational accidents (15.4%). Unfor­
tunately, no accurate statistics are avail­
able on the total annual number and 
causes of spinal cord injuries in Ontario, 
but we believe there has been only a 
moderate increase between the two study 
periods. Thus, it is quite likely that the 
incidence of work-related spinal cord 
injury has declined slightly in this 
province. It is true that workers, 
employers, accident prevention associa­
tions, the Workers’ Compensation Board 
and governments now put greater empha­
sis on worker safety. However, much has 
still to be done.
Reviews in other parts of the world 
show that the incidence of work-related 
injury ranges from 20% to 50% of all spi­
nal cord injuries.2,9'12 The pattern of 
occupations resulting in such injuries 
shows regional and national variation, 
depending on the nature of the main 
industries. For example, Peerless and 
Schweigel2 found that logging was the 
cause of spinal cord injury in 45% of 
work-related spinal cord injuries in Brit­
ish Columbia. On the other hand, con­
struction accidents produced the highest 
number of work-related spinal cord inju­
ries in the earlier study in Ontario.1 It is 
encouraging to note that the relative fre­
quencies of construction and logging acci­
dents as causes of spinal cord injury are 
lower in this study than they were in the 
earlier one, and that there were no spinal 
cord injuries in mining in the recent study, 
perhaps due to safety campaigns in these 
fields.
Fourteen of our 25 injuries were due 
to falls and 10 of these occurred in 
patients in the third and sixth decades. 
Job inexperience might be a factor and 
in the older group some workers may be 
too old for jobs requiring the climbing of 
scaffolding and ladders. Prevention 
would require more specific instructions 
to new employees about climbing safety, 
including guidelines on how to stabilize 
ladders and scaffolds at work sites. 
Perhaps workers over 50 years of age 
should be prohibited from climbing.
In many epidemiologic studies of spi­
nal cord injury, the cervical spine is the 
most frequent site of injury.1,9 Although 
the same was true in our study, there were 
relatively more thoracic injuries among 
the workers, probably because of the 
predominance of falls.
This study again shows the poor recov­
ery of neurologic function after major 
cord injury. The average neurologic sta­
tus of the patients did not change substan­
tially between admission and discharge. 
Although the mortality among the wor­
kers was lower than that of the other 
group, presumably because of the youn­
ger mean age, an 8% mortality is still too 
high. The average duration of hospitali­
zation at Sunnybrook was 65 days fol­
T a b l e  V I - Leve l  o f  S p i n a l  C o r d  I n j u r y
G r o u p  1, G r o u p  2, T o t a l s ,
L e v e l no .  ( % ) no .  ( % ) no .  ( % )
C e r v i c a l 11 ( 4 4 ) 71 ( 5 9 . 7 ) 8 2 ( 5 6 . 9 )
T h o r a c i c 9 ( 3 6 ) 3 0  ( 2 5 . 2 ) 3 9  ( 2 7 . 1 )
T h o r a c o l u m b a r 1 (4) 2 ( 1 . 7 ) 3 ( 2 . 1 )
L u m b a r 4 ( 1 6 ) 1 6 ( 1 3 . 4 ) 2 0 ( 1 3 . 9 )
T o t a l s 2 5 1 1 9 1 4 4
lowed by several months in rehabilitation 
hospitals. The majority did not recover 
enough to return to their previous jobs, 
as determined by assessment 1 year after 
injury. A review by Nechwatal and 
Stoger13 of the employment status of 120 
patients with spinal cord injuries due to 
industrial accidents revealed that only 
patients with incomplete lesions were 
gainfully employed 5 years after injury, 
and that after 20 years only a few patients 
with complete cord injury were gainfully 
employed. This study confirmed the poor 
economic and social results of spinal cord 
injury and emphasized the need to pre­
vent industrial falls, in particular, and 
other work-related spinal cord injuries.
Conclusions
Work as a cause of spinal cord injury 
was found to be the third most common 
cause of spinal cord injury in Ontario, 
after traffic and sports. There has prob­
ably been a decrease in the frequency of 
work-related spinal cord injuries over the 
years, although the incidence, morbidity 
and mortality are still too high. Efforts 
to prevent these injuries must therefore 
continue.
We thank Miss Virginia Edmonds for her 
technical help.
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Surgical Management of Hydatid Disease of the Liver
The authors review 143 consecutive, 
surgically treated cases of hydatid dis­
ease of the liver seen over the past 10 
years. Of the 208 cysts found, 82  
(39.4%) were complicated; the 
remainder were simple. The complica­
tions included rupture into the biliary 
system (16.3%), suppuration (11.0%), 
partial calcification of the pericyst 
(5.8%), intraperitoneal rupture (4.8%), 
bronchobiliary fistula (0.9%) and cys- 
tocutaneous fistula (0.5%).
External capitonnage was the most 
commonly used surgical technique 
(63.0%), followed by cystectomy 
(17.8%), omentoplasty (10.6%), tube 
drainage (7.7%) and cystojejunostomy 
(0.9%). Capitonnage was carried out 
with or without tube drainage.
The complications of surgery were 
higher with drainage than without.
The main complications of surgery 
were infection in the residual cavity 
and biliary fistula. The patients who 
underwent external capitonnage without 
drainage or omentoplasty had good 
results with minimal complication rates 
(3.5% and 4.5%  respectively). For the 
patients in whom the cystectomy was 
established, the complication rate was 
8 . 1% .
Les auteurs ont etudie 143 cas consecu- 
tifs d'echinococcose hydatique du foie 
traites chirurgicalement au cours des 10 
dernieres annees. Des 208 kystes decou- 
verts, 82 (39.4%) presentaient des com­
plications; les autres etaient simples. 
Parmi les complications, on observa une 
rupture dans le systeme biliaire (16.3%), 
une suppuration (11.0%), une calcifica­
tion perikystique partielle (5.8%), une 
rupture intraperitoneale (4.8%), une fis- 
tule broncho-biliaire (0.9%) et une fistule 
kysto-cutanee (0.5%).
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La technique chirurgicale la plus cou- 
rammente utilisee fut le capitonnage 
externe (63.0%). Suivaient, la kystecto- 
mie (17.8%), I'omentoplastie (10.6%), le 
drainage (7.7%) et la kystojejunostomie 
(0.9%). Le capitonnage fut pratique avec 
ou sans drainage. Les complications 
chirurgicales ont ete plus frequentes 
avec que sans drainage. Les prin­
cipals complications furent I'infec- 
tion de la cavite residuelle et la fistule 
biliaire. De bons resultats ont ete obtenus 
avec le capitonnage externe sans drai­
nage ou I'omentoplastie et les taux de 
complications ont ete faibles (3.5% et 
4.5%  respectivement). Le taux de com­
plications rattache a la kystectomie fut 
de 8.1%.
Echinococcus granulosus is endemic in 
Turkey and the majority of liver masses 
presenting for evaluation are echinococ- 
cal cysts. One of the most remarkable 
clinical features of hydatid cysts of the 
liver is the absence of systemic distur­
bances. Currently available diagnostic 
tests cannot rule out hydatid disease.1 
However, Casoni and Weinberg tests 
were positive in 81.1% and 68.5% of 
cases in our series. Radioisotopic scan­
ning, ultrasonography and computerized 
tomography were the most useful diag­
nostic investigations (Fig. 1). Ultrasonog­
raphy should be the first diagnostic 
method used.2 We do not believe that 
invasive procedures, such as selective 
angiography or splenoportography, are 
necessary to diagnose hydatid disease.
The role of high-dose mebendazole 
and, recently, albendazole in treating 
hydatid disease is still undetermined and 
awaiting controlled trials. It is recom­
mended that mebendazole be given to 
patients with inoperable hydatid dis­
ease.3,4 Surgery is still the treatment of 
choice.5 The main steps of surgical 
management are killing of the fertile ele­
ments of the parasite by scolicidal agents, 
evacuation of the cyst and management 
of the residual cavity. Many surgical tech­
niques have been proposed for the 
remaining cavity. Some authors6,7 have 
recommended liver resection while 
others8,9 believe that this is too radical
for a benign condition. In this paper we 
present our experience with the operations 
of capitonnage, omentoplasty and cystec­
tomy at Qukurova University in Turkey.
Patients
The records of 143 consecutive patients 
(105 women, 38 men) with hydatid cyst 
of the liver treated surgically during a 
10-year period (1973 to 1983) were 
reviewed. They ranged in age from 7 to 
66 years. The most frequent complaint 
was dull pain in the upper abdomen. 
Hepatomegaly and a palpable cystic mass 
were the most common findings. Eleva­
tion of the right hemidiaphragm in the 
plain chest film was seen in 80 (55.9%) 
of the patients. A correct preoperative 
diagnosis was made in 81.1% of cases.
Two-hundred and eight cysts were 
found. Eighty-nine patients (62.2%) had 
a single cyst and 54 (37.8%) had multi­
ple cysts in the liver. The majority of cysts 
were in the right lobe. Daughter cysts 
were found in 38.9% of cases (Fig. 2). 
Some of the hydatid cysts had degenera­
tion of the parasite and calcification of 
the pericyst. Twenty-three patients 
(16.0%) had secondary bacterial infec­
tion. One patient had a cystocutaneous 
fistula with suppuration. The most com­
mon complication was rupture into the 
bile ducts, in 29 patients (20.3%). In addi­
tion, communication between cyst and 
right hepatic duct was found in five 
patients and bronchobiliary fistula in two. 
Exploration of the common bile duct and 
T-tube drainage were performed in these
FIG. 1—Ultrasonography showing two separate univesicular hydatid cysts of liver.
VOLUME 28, NO. 2, MARCH 1985 /  THE CANADIAN JOURNAL OF SURGERY 171
seven cases. Spontaneous intraperitoneal 
rupture o f the liver cyst and secondary 
peritoneal echinococcosis had occurred in 
six cases, and rupture after blunt trauma 
to the abdomen in four. There was one 
patient with associated cirrhosis and 
another with cavernous hemangioma.
Operative Management
Surgical access was through an upper 
right paramedian incision. In a few 
patients a right subcostal incision was 
used but never a thoracoabdominal inci­
sion. The surgical technique varied 
according to the features and location o f 
each cyst. External capitonnage with tube 
drainage was the procedure used most fre­
quently, in 102 liver cysts (49.0%). In 
external capitonnage, the cyst cavity was 
obliterated with external chromic catgut 
sutures usually after excision o f the 
redundant portion not containing any 
hepatic parenchyma. As a result, inver­
sion o f the adventitia was achieved (Fig. 
3). Early in the series capitonnage with 
tube drainage resulted in a high compli­
cation rate. For this reason we chose 
capitonnage without drainage and omen­
toplasty procedures in the last 3 years. 
Omentoplasty is more frequently used in 
multivesicular cysts and capitonnage 
without drainage in univesicular cysts. 
Cystectomy, capitonnage without drain­
age and omentoplasty were performed in 
37, 29 and 22 hydatid cysts, respectively. 
Tube drainage was utilized in 16 infected 
cysts as a surgical procedure.
FIG, 2— Evacuation of multivesicular 
hydatid cyst.
Complications of Operation
The most common complications were 
infection in the remaining cavity and leak­
age o f bile (Table I). Biliary fistula was 
seen in 3.5% o f the hydatid cysts that 
were treated by capitonnage without 
drainage and in 4.5% o f those treated by 
omentoplasty. Postoperative infection in 
the pericyst cavity was higher in patients 
treated with capitonnage with tube 
drainage. The other complications were 
serious bleeding, anaphylactic shock dur­
ing operation, systemic reactions to for­
malin, intra-abdominal abscess and 
peritonitis, hepatic coma in a patient who 
had cirrhosis, pulmonary infection and 
wound dehiscence.
Hospitalization
The average hospital stay was 12.3 and 
14.1 days in the groups treated by 
capitonnage without drainage and omen­
toplasty, respectively. For capitonnage 
with tube drainage, the average hospital
FIG. 3—External capitonnage. Closure and 
inversion of pericyst layer with (A ) or without 
(B) drainage.
Table 1 - Postoperative Complications
Procedure
Hydatid  
cysts, no.
Bile
fistu la
Complications, no. (%) 
Infection in 
the remaining 
cavity Totals
Capitonnage  
W ith tube drainage 1 0 2 1 3 ( 1 2 .7 ) 3 6 ( 3 5 .3 ) 4 9  (4 8 .0 )
W ithout drainage 2 9 1 (3 .5 ) — 1 (3 .5 )
C ystectom y 3 7 3 ( 8 .1 ) — 3 ( 8 .1 )
Om entoplasty 2 2 1 (4 .5 ) — 1 (4 .5 )
Tube drainage alone 16 4 ( 2 5 . 0 ) 2 ( 1 2 .5 ) 6 ( 3 7 .5 )
C ystojejunostom y 2 - - -
Totals 2 0 8 2 2 ( 1 0 .6 ) 3 8 ( 1 8 .2 ) 6 0  (2 8 .8 )
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stay was 18.9 days. In the tube-drainage 
group, in which the cavities were already 
infected, the average hospital stay was 45 
days.
Mortality
There were nine operative deaths 
(6.3*%) in our 143 patients (Table II). 
Three were due to secondary infection in 
the residual cavity with abscess formation 
or peritonitis. One occurred as a result of 
severe hemorrhage postoperatively.
Discussion
In hydatid cysts of the liver, leakage of 
bile causes rupture of the laminated mem­
brane and subsequent formation of 
daughter cysts that takes place over some 
time. Such cysts are multivesicular.1 For 
the univesicular cysts that contain only 
hydatid fluid, the postoperative compli­
cation rate was lower than for multivesic­
ular cysts. This was not dependent on the 
difference in surgical technique.
Rupture into the biliary tree is one of 
the most common complications of 
hydatid cysts of the liver. The other com­
plications such as suppuration, degener­
ation and calcification develop secondar­
ily to the intrabiliary rupture.10 In all 
forms of complicated hydatid cyst, the 
communications with the bile ducts can 
be seen after the cavity has been opened 
and its contents have been evacuated. We 
advocate closing these openings with fine 
chromic catgut sutures.
The operative field must be carefully 
walled off by towels to prevent spillage 
of the scolices. Plastic drapes11 and cryo­
genic cones' have been used to prevent 
spillage of the hydatid cyst contents into 
the adjacent tissue. We have injected into 
the cavity either formalin, hypertonic 
saline or povidone-iodine solution as a 
scolicidal agem. One of our patients died 
from a systemic reaction to formalin. This 
agent has not been used in the last 5 years. 
As alternative scolicidal agents exist, for­
malin should not be used. The most con­
venient scolicidal agents are 20% saline 
and povidone-iodine solutions. Applying 
effective concentrations of these agents 
and waiting for a specified period before
opening the cyst wall are important fac­
tors in preventing spillage of viable 
scolices into the peritoneal cavity.
A variety of surgical procedures has 
been proposed for the treatment of 
hydatid cysts of the liver.12’13 The surgi­
cal methods can be divided into two 
types. The conservative surgical proce­
dures include evacuation of the cyst and 
management of the pericyst cavity. Rad­
ical surgical procedures such as cystec­
tomy and hepatic resection involve en- 
bloc excision of the hydatid cyst.13,14 
There is no risk of cyst contents spilling 
and no danger of anaphylaxis in radical 
operations. Cystectomy can be performed 
safely in peripherally located cysts.8 This 
method was employed in 37 cysts with a 
complication rate of 8.1%. Hepatic resec­
tion has been strongly recommended by 
a number of surgeons.6’7’14 We believe 
that conservative surgical methods and 
cystectomy are adequate; there is no rea­
son for performing hepatectomy. Excel­
lent surgical results can be achieved in 
properly selected patients with cystec­
tomy, capitonnage without drainage and 
omentoplasty. The postoperative mor­
bidity is under 5% and mortality is close 
to zero.13 In the surgical treatment of a 
benign condition such as hydatid cysts of 
the liver, hepatectomy seems to be too 
aggressive and has increased the operative 
mortality in some series.11’14
One of the most controversial aspects 
of the surgical treatment for hydatid cysts 
of the liver is management of the 
remaining cavity. If the cyst is secondar­
ily infected, surgical drainage is almost 
mandatory.1 Tube drainage was carried 
out in our patients who had infected cavi­
ties. In the sterile cavities, drainage may 
result in secondary infection .1’5 In 
omentoplasty,15 filling the residual cavity 
with omentum, we have had a 4.5% inci­
dence of biliary fistula.
Capitonnage is ideal for hydatid cysts 
of the liver.10 In this operation a series of 
internal sutures of heavy chromic catgut 
are used to obliterate the cavity. This 
procedure runs the risk of injuring bile 
ducts and vessels and leaving dead spaces. 
Considering the disadvantages of internal 
capitonnage, we recommend the modifi­
Tab le II--O pe ra tive  Deaths
Cause Surg ica l techn ique
No. of 
p a tien ts
Se co nda ry  in fection  in the residua l cav ity
A b sce ss  form ation Cap itonnage + tube drainage 2
Pe rito n it is Cap itonnage + tube drainage 1
B ron chob ilia ry  fis tu la Cap itonnage + tube drainage 1
H epa tic  fa ilu re  (cirrhosis) Cap itonnage + tube dra inage 1
A n a p h y la c tic  shock during operation Cap itonnage  + tube drainage 1
Form a lin  to x ic ity Cap itonnage + tube drainage 1
P os to pe ra tive  hem orrhage Cap itonnage + tube  drainage 1
Seco nda ry  peritoneal e ch in o co cco s is C yste c tom y 1
cation of external capitonnage in the 
management of the remaining cavity.
In our series, external capitonnage was 
used in 139 cysts. Twenty-nine patients 
underwent external capitonnage without 
drainage and had a low complication rate. 
There was a significant difference in 
postoperative complications between 
capitonnage with tube drainage and 
capitonnage without drainage (p = 0.05, 
X2 test).
We advocate external capitonnage 
without drainage and omentoplasty in the 
surgical management of hydatid cysts of 
the liver.
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Prescribing Information
ZANTAC® INJECTION (ranitidine hydrochloride) 
PHARMACOLOGICAL CLASSIFICATION
Histamine H2-receptor antagonist
ACTION
Ranitidine is a selective antagonist of histamine at gastric H2-receptor sites. Thus 
ranitidine inhibits both basal gastric secretions and gastric acid secretion induced 
by histamine, pentagastrin and other secretagogues. On a weight basis, ranitidine is 
between 4 and 9 times more potent than cimetidine. Inhibition of gastric acid secre­
tion has been observed following intravenous, intraduodenal and oral admin­
istration of ranitidine and it is dose related, a maximum response being achieved at 
an oral dose of 150 mg.
Pepsin secretion is also inhibited but secretion of gastric mucus is not affected. 
Ranitidine does not alter the secretion of bicarbonate or enzymes from the pancreas 
in response to secretin and pancreozymin.
Ranitidine is rapidly absorbed after oral administration, peak plasma concentra­
tions being achieved within 2 to 3 hours. These plasma concentrations are not 
significantly influenced by the presence of food in the stomach at the time of the 
oral administration nor by regular doses of antacids.
Bioavailability of ranitidine administered orally is approximately 50%. Serum 
protein binding of ranitidine in man is in the range of 10% to 19%. The elimina­
tion half-life is approximately 3 hours. The principal route of excretion is the urine 
(40% recovery of free and metabolised drug in 24 hours).
Intramuscular ranitidine is fully bioavailable in comparison to intravenous 
ranitidine. The median elimination half-life of ranitidine injection 50 mg, adminis­
tered intravenously or intramuscularly was found to be 140 minutes (range 120 to 
160 minutes.) The half-life of ranitidine in patients with renal dysfunction is 
prolonged. However, in a study of 27 patients with varying degrees of renal impair­
ment therapeutic plasma levels of ranitidine were shown to be achieved without 
risk of drug accumulation, using half the normal dose of ranitidine in patients with 
plasma creatinine concentration greater than 300 /umols/litre.
There is a significant linear correlation between the dose administered and the 
inhibitory effect upon gastric acid secretion for doses up to 150 mg orally.
A plasma ranitidine concentration of 50 ng/mL has an inhibitory effect upon stimu­
lated gastric acid secretion of approximately 50%. Estimates of the IC50 range from 
36 to 94 ng/mL. Following the administration of 150 mg ranitidine orally, plasma 
concentrations in excess of this lasted for more than 8 hours and after 12 hours the 
plasma concentrations were sufficiently high to have a significant inhibitory effect 
upon gastric acid secretion. In patients with duodenal ulcer, 150 mg ranitidine 
given by mouth every 12 hours significantly reduced mean 24 hour hydrogen ion 
activity by 69% and nocturnal gastric acid output by 90%.
Following intramuscular injection of 50 mg ranitidine, plasma concentrations 
in excess of 100 ng/mL were achieved within five minutes of administration and 
remained above this level for 4 to 6 hours.
Intravenous infusion of ranitidine in seriously ill patients at a rate of
0.125 mg/kg/hour produced a rise of intragastric pH between 5.6 and 7.0 after two 
hours and maintained this level over the test period. The volume of gastric secre­
tion was reduced by more than 55%. Doubling the infusion rate to 
0.25 mg/kg/hour produced no further increases in gastric acid inhibition.
A single 50 mg intravenous bolus dose of ranitidine produced significant acid 
inhibition 8 to 9 hours after administration. When 13 seriously ill patients with two 
or more risk factors (shock, sepsis, respiratory failure, jaundice, renal insufficiency 
and peritonitis) were treated with a 50 mg intravenous bolus dose of ranitidine 
followed by a continuous infusion of 0.2 mg/kg/hour the number o f ‘at risk’ days 
when gastric pH was less than 3.5 on three consecutive four-hourly aliquots, was 
approximately half that for placebo treated patients.
Furthermore, in respect of both 24 hour acidity and nocturnal acid output, 
ranitidine, 150 mg twice daily was superior to cimetidine 200 mg three times daily 
and 400 mg at night (P <0.001 and <0.05, respectively).
Ranitidine injection is well tolerated following intravenous administration at 
dose levels of up to 100 mg four times daily for ten days. These levels are in excess 
of those recommended for normal clinical use.
Treatment of volunteers with ranitidine 150 mg twice daily for 7 days did not 
cause bacterial overgrowth in the stomach.
Volunteers treated with ranitidine have reported no significant gastrointestinal 
or central nervous system side effects; moreover, pulse rate, blood pressure, electro­
cardiogram and electroencephalogram were not significantly affected in man 
following ranitidine administration.
In healthy human volunteers and patients, ranitidine did not influence plasma 
levels of the following hormones: cortisol, testosterone, estrogens, growth 
hormone, follicle stimulating hormone, luteinizing hormone, thyroid stimulating 
hormone, aldosterone or gastrin -  although like cimetidine, ranitidine reduced 
vasopressin output. Treatment for up to 6 weeks with ranitidine 150 mg twice 
daily by mouth did not affect the human hypothalamic-pituitary-testicular-ovarian 
or -adrenal axes.
At 50 mg intravenously, ranitidine had no effect on prolactin levels. Only at 
the 300 mg i.v. dose level was an increase in prolactin secretion, equivalent to that 
produced by 200 mg of cimetidine i.v., observed.
At the high dose levels used in the tolerance studies, minor, transient increases 
in serum alanine transaminase (ALT/SGPT) and aspartate transaminase 
(AST/SGOT) levels were observed in some patients. No other liver function tests 
were abnormal for these subjects and the cause and clinical significance of these 
findings are unknown.
Laboratory studies have shown that ranitidine has negligible affinity for the 
cytochrome P4S0-linked hepatic mixed function oxidase system. In man, ranitidine 
treatment has been shown not to impair the metabolism of antipyrine, 
aminopyrine, warfarin or diazepam.
INDICATIONS AND CLINICAL USE
Zantac injection is indicated for the treatment of duodenal ulcer, benign gastric 
ulcer, post-operative ulcer, reflux esophagitis, Zollinger-Ellison syndrome and 
other conditions where reduction of gastric secretion and acid output is desirable. 
These include the prophylaxis of gastrointestinal haemorrhage from stress ulcera­
tion in seriously ill patients, the prophylaxis of recurrent haemorrhage in patients 
with bleeding peptic ulcers and before general anaesthesia in patients considered to 
be at risk of acid aspiration (Mendelson’s) syndrome, particularly obstetric patients 
during labour.
For appropriate cases Zantac Tablets are also available.
CONTRAINDICATIONS
There are no known contraindications to the use of Zantac (Ranitidine).
WARNINGS
Gastric ulcer -  Treatment with a histamine H2-antagonist may mask symptoms 
associated with carcinoma of the stomach and therefore may delay diagnosis of the 
condition. Accordingly, where gastric ulcer is suspected the possibility of malig­
nancy should be excluded before therapy with Zantac is instituted.
PRECAUTIONS
Use in pregnancy and nursing mothers -  The safety of Zantac in the treatment 
of conditions where a controlled reduction of gastric secretion is required during 
pregnancy has not been established. Reproduction studies performed in rats and 
rabbits have revealed no evidence of impaired fertility or harm to the fetus due to 
Zantac. If the administration of Zantac during pregnancy is considered to be neces­
sary, its use requires that the potential benefits be weighed against possible hazards 
to the patient and to the fetus. However, therapeutic doses of Zantac administered 
to obstetric patients in labour or undergoing caesarean section have been without 
adverse effect on labour, delivery, or subsequent neonatal progress.
Ranitidine is secreted in breast milk in lactating mothers but the clinical 
significance of this has not been fully evaluated.
Use in impaired renal function -  Ranitidine is excreted via the kidney and in 
the presence of severe renal impairment, plasma levels of ranitidine are increased 
and prolonged. Accordingly, in the presence of severe renal impairment, clinicians 
may wish to reduce the oral dose to half of the usual dose taken twice daily, simi­
larly it is recommended that ranitidine injection be administered in doses of 25 mg 
to patients with renal dysfunction.
Children -  Experience with Zantac in children is limited and such use has not been 
fully evaluated in clinical studies. It has however been used successfully in children 
aged 8-18 years in doses up to 150 mg orally twice daily without adverse effect.
ADVERSE REACTIONS
No serious adverse effects have been reported to date in patients treated with 
Zantac. There has been no clinically significant interference with endocrine, 
gonadal or liver function, nor has the drug adversely affected the central nervous 
system even in elderly patients.
The incidence of adverse events among Zantac-treated patients (8.1%) was very 
little greater than that among placebo-treated patients (7.7%). Only five adverse 
events, namely, tiredness (0.38%), headache (0.90%), dizziness (0.32%), diarrhea 
(0.52%) and skin rashes (0.52%) had a greater incidence in the ranitidine treated 
group than in the control group.
A small proportion (1.99%) of patients treated with ranitidine injection experi­
enced itching or burning at the injection site. This reaction was mild and usually 
subsided within 10-15 minutes.
Headache was experienced by 2.54% of patients receiving ranitidine injection. 
The majority of these cases were not thought to be treatment-related. In some in­
stances the headache was thought to be due to over-rapid injection of ranitidine, 
and did not recur on rechallenge with slow intravenous injection. Similarly, some 
patients experienced nausea after rapid injection of the drug, but on subsequent 
occasions with slow-intravenous injection, experienced no ill-effects.
OVERDOSAGE
Zantac is very specific in action and accordingly no particular problems are 
expected following overdosage with the drug. Symptomatic and supportive therapy 
should be given as appropriate. If need be, the drug may be removed from the 
plasma by haemodialysis.
DOSAGE AND ADMINISTRATION
Adults: Zantac injection may be given either as a slow (over one minute) intra­
venous injection of 50 mg, which may be repeated every six to eight hours; or as an 
intravenous infusion at a rate of 25 mg per hour for two hours; the infusion may be 
repeated at six to eight hour intervals.
In the prophylaxis of haemorrhage from stress ulceration in seriously ill 
patients or the prophylaxis of recurrent haemorrhage in patients bleeding from 
peptic ulceration, parenteral administration may be continued until oral feeding 
commences. Patients considered to be still at risk may then be treated with Zantac 
tablets 150 mg twice daily.
In patients considered to be at risk of developing acid aspiration syndrome 
Zantac injection 50 mg may be given intramuscularly or by slow intravenous injec­
tion (over one minute) 45-60 minutes before induction of general anaesthesia.
Experience with Zantac in children is limited and it has not been fully eval­
uated in clinical studies -  see PRECAUTIONS.
AVAILABILITY
Zantac Injection is available as 2mL ampoules each containing 50 mg ranitidine 
(as hydrochloride) in 2mL solution for intravenous or intramuscular administra­
tion. Packages of 10 ampoules.
Zantac Tablets are available as white film-coated engraved ZANTAC 150 on 
one face and GLAXO on the other containing 150 mg ranitidine (as the 
hydrochloride), in packs of 28 & 56 tablets.
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The Angelchik Antireflux Prosthesis
A silicone collar containing circumferen­
tial tape was tied around the cardio- 
esophageal junction in eight patients 
with symptomatic, refractory reflux, who 
were not good candidates for a standard 
antireflux procedure. A fine polypropy­
lene tie or clip secured the knot. In two 
patients with large hiatal defects, the 
crura were approximated loosely. Mean 
operating time, including one 
cholecystectomy and one ventral hernia 
repair, was 51 minutes. Patients who 
underwent this simple operation had a 
combination of hypertension, heart dis­
ease, obesity and old age, and two had 
undergone horizontal gastroplasty previ­
ously for morbid obesity. The reflux was 
associated with hiatal hernia in seven of 
the eight patients. Preoperative studies 
included barium swallow roentgenogra­
phy in all eight patients, and endoscopy, 
manometry and Bernstein test in six. All 
the studies were repeated postopera- 
tively. Follow-up ranged from 17 to 48 
months (mean 37.8 ± 10.6 months). 
Postoperatively, there was a significant 
(p <  0.01) improvement in symptoms, 
endoscopic findings and lower 
esophageal sphincter pressures. No 
prosthesis has migrated yet.
Chez huit patients souffrant d'un reflux 
symptomatique resistant et ne se pretant 
pas a une intervention antireflux stan­
dard, un collier de silicone renfermant en 
circonference un ruban a ete noue a la 
jonction du cardia et de I'oesophage. Un 
petit clip de polypropylene a servi a fixer 
le noeud solidement. Chez deux patients 
souffrant de hernies hiatales importantes 
les crura ont ete rapproches de facon 
approximative. La duree moyenne de 
I'intervention, incluant une cholecystec-
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tomie et la reparation d'un hernie ven- 
trale, fut de 51 minutes. Les patients qui 
ont subi cette operation simple souf- 
fraient d'une association d'hypertension, 
de maladie cardiaque, d'obesite et de 
vieillesse. Deux avaient subi dans le 
passe une gastroplastie horizontale pour 
obesite pathologique. Chez sept des huit 
patients le reflux etait relie a la hernie 
hiatale. A I'examen preoperatoire, une 
radiographie apres repas baryte a ete 
pratiquee chez les huit malades, et une 
endoscopie avec manometrie et test de 
Bernstein chez six. Ces examens furent 
repetes apres I'operation. Les examens 
de controle s'echelonnent sur de 17 a 
48 mois (moyenne de 37 .8 ± 10.6 mois). 
En postoperatoire, on a note une amelio­
ration marquee des symptomes (p <0.01), 
des observations d'endoscopie et de la 
pression de sphincter du bas oesophage. 
Aucune prothese n'a bouge jusqu’a 
maintenant.
The conventional operations for sympto­
matic, refractory gastroesophageal reflux 
during the past 15 years have been the Hill 
repair and Belsey and Nissen fundoplica- 
tions.1'3 These are major operations. 
When performed by experienced sur­
geons, the reported recurrence rate is 5% 
to 15%, which is an improvement over 
the 50% recurrence rate o f the Allison 
repair.4 Angelchik and Cohen5 reported 
their use of an antireflux prosthesis since 
1973, with good results. This prosthesis 
has been used widely; more than 20 000 
have been implanted to the present (Bar- 
rowcliff E: personal communication, 
1984). Although our standard antireflux 
procedure remains a fundoplication, we 
believe that the Angelchik device merits 
consideration. Thus, from August 1980 
to March 1983 we used the rapid Angel­
chik procedure in eight poor-risk patients 
with symptomatic reflux that was re­
fractory to vigorous medical therapy.
The Prosthesis
The prosthesis (Fig. 1) consists o f a C- 
shaped collar, with an outer silicone 
elastomer shell containing highly cross- 
linked silicone gel. A Dacron tie-tape is
incorporated in the outer casing of the 
prosthesis circumferentially. A radio­
paque tantulum strip is incorporated with 
the circumferential strap for radiologic 
identification of the prosthesis. The inner 
diameters of the prosthesis are 3.1 and 2.5 
cm and the outer diameters are 6 and 7 
cm. The prosthesis weighs 45 g.
Surgical Technique
The abdomen is entered through a 
short midline incision, the stomach is 
reduced if necessary and the lower 
esophagus mobilized with minimal dissec­
tion. If the hiatal crura are widely apart, 
they are approximated but not tightly 
(this was necessary in two patients). The 
tape is wound on the right index finger, 
and the prosthesis brought through from 
left to right and oriented with straps 
anteriorly. The straps are tied with a 
secure knot, which approximates the ends 
of the C anteriorly, encircling the lower 
end of the esophagus loosely (allowing 
room for two fingers between prosthesis 
and esophagus). The straps are cut about 
2 cm outside the knot, and a clip is 
applied or a nonabsorbable suture is tied 
(or both) just outside the knot in order 
to prevent knot slippage.
FIG- 1—Angelchik antireflux prosthesis.
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Patients and Methods
Indications for this operation were a 
com bination of hypertension (five 
patients), marked obesity (five), old age 
(three), atherosclerotic heart disease with 
previous myocardial infarctions (two), 
angina pectoris (one) and a previous 
horizontal gastric partitioning for morbid 
obesity (two). One patient (case 8, Table 
I) required drainage of an aspiration lung 
abscess in the right lower lobe 1 month 
before insertion of an Angelchik prosthe­
sis. One cholecystectomy and one ventral 
herniorrhaphy were performed under the 
same anesthetic as insertion of the 
prosthesis. The seven women and one 
man ranged in age from 28 to 75 years 
(mean 54 years). In all patients the gas­
troesophageal reflux had been refractory 
to medical management, including elevat­
ing the head of bed, taking cimetidine, 
metoclopramide and antacids, fasting 2 
hours before bedtime and attempting to 
lose weight. In all patients the reflux was 
associated with a sliding hiatal hernia 
except in one who had had a horizontal 
gastric partitioning who had free gas­
troesophageal reflux alone (patient 6). All 
eight patients have been followed up from 
17 to 48 months postoperatively (mean 
37.8 ± 10.6 months).
All eight patients had barium swallow 
and upper gastrointestinal roentgenogra­
phy preoperatively; these studies were 
repeated 3 to 9 months postoperatively. 
Although all have been followed up to the 
present, because they have no symptoms, 
they have refused to undergo a more long­
term repetition of the studies; only in 
patient 6 with persisting moderate heart­
Table 1-Results Pre- and Postimplantation of Angelchik Antireflu* Prosthesis
Case
no.
Age,
Vi
Date prosthesis 
Implanted
Symptom score, 
preop/postop*
Endoscopic
grade
preop/postopt
Mean LES 
pressure, 
mm Fig, 
preop/postop*
Bernstein
test
preop/postop§
i 75 Aug. 15, 1980 1.1/0.0 — — —
2 50 Aug. 18, 1980 1.0/0.6 — — —
3 68 Jan. 9, 1981 0.9/0.0 0/0 6/10 -1 -
4 39 Feb. 13, 1981 1.9/0.0 2/0 2/20 +1-
5 28 Mar. 10, 1981 1.4/0.0 1/0 7/18 - / -
6 53 Nov. 24, 1981 2.6/0.5 3/1 14/23 + / -
7 72 Feb. 28, 1982 1.8/0.0 2/0 8/18 + / -
8 47 Mar. 15, 1983 2.8/0.5 2/0 8/18 + / -
'Mean score ±  SD, 1.7 ±  0.7/0.2 ±  0.3 (p <  0.01). 
tMean grade ±  SD, 1.7 ±  1.0/0.2 ±  0.4 (p <  0.01). 
*Mean pressure ±  SD, 7.5 ±  3.9117.8 ± 4.3 Ip <  0.01). 
§+  -  positive result, -  = negative result.
LES -  lower esophageal sphincter.
Fig. 2a Fig. 2b
FIG. 2—Case 1. Roentgenogram after barium swallow (a) before and (b) after operation, 
showing prosthesis in position.
burn and in patient 7 (who was admitted 
to hospital for a femoropopliteal bypass 
graft) were we able to perform studies 
again, 24 and 30 months after operation 
respectively. Pre- and postoperative 
symptoms (regurgitation, heartburn, dys­
phagia, food intolerance, choking at 
night, chest pain, indigestion and weight 
loss in patients other than those who had 
had gastric partitioning) were graded 0 to 
3 (none, mild, moderate and severe). The 
mean values were compared.
On the last six patients, seen since 
January 1981, upper gastrointestinal 
endoscopy, esophageal manometry and 
Bernstein acid infusion test were also per­
formed preoperatively and 3 to 9 months 
postoperatively, and a second postoper­
ative study was done in patients 6 and 7 
at 24 and 30 months. The Olympus Q gas- 
troscope (W. Carsen Co., Don Mills, 
Ont.) was used. Esophagitis as seen 
through the endoscope was graded 
according to the criteria of Behar and 
Sheahan:6 0 — normal, 1 — erythema, 
2 — erythema, friability and exudate, 3 
— friability and linear erosions and 4 — 
all of the above plus deep ulcerations. 
Esophageal biopsies generally were not 
taken, as we believe that biopsies of the 
esophagus for reflux pathology are 
unreliable; we reserve biopsies and brush- 
ings to rule out the presence of malignant 
strictures and premalignant conditions.
Esophageal manometry utilized the 
triple-lumen polyethylene catheter with an 
internal diameter of 1.1 mm and three 
side-holes 120° from each other and 5 cm 
apart. The three ends of the catheter were 
connected to an Arndorfer pneumo- 
hydraulic low-compliance capillary infu­
sion system7 and Beckman four-channel 
dynograph recorder (Beckman Instru­
ments, Etobicoke, Ont.). The lower 
esophageal sphincter pressure was 
recorded using the mean of the six values 
from two station pull-throughs, with the 
mean gastric reading representing the 
baseline. A Bernstein test8 was done 
upon completion of the motility studies, 
using 0.1 N hydrochloric acid (and nor­
mal saline for confirmation) at a point 5 
cm above the lower esophageal sphincter. 
Only patient 6 had 24-hour pH electrode 
monitoring performed; this was done 
through the Toronto General Hospital, 
and showed considerable postoperative 
improvement in reflux score. This test has 
only recently become available at our 
hospital.
Symptoms, endoscopic findings and 
lower esophageal sphincter pressures were 
compared pre- and postoperatively by the 
f-test for paired samples.
Results
Mean operating time was 51 minutes 
(ranging from 35 to 68 minutes), includ-
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ing the concomitant cholecystectomy and 
ventral herniorrhaphy. Mean postopera­
tive hospital stay was 7 days (ranging 
from 5 to 12 days). No patient had reflux 
or hiatal hernia on postoperative roent­
genography after barium swallow (Figs. 
2 to 5). No prosthesis has yet migrated. 
The score of reflux symptoms was 
1.7 before implantation and 0.2 after 
(p <  0.01) (Table I). All eight patients 
were markedly improved, but two 
patients (cases 2 and 8) have persisting 
slight dysphagia to hard foods and patient 
6 (who had had horizontal gastric parti­
tioning) has moderate heartburn but is 
much improved. In the six patients 
studied, endoscopic grading changed 
from a mean of 1.7 before to 0.2 after 
implantation (p < 0.01). Patient 6, who 
had had horizontal gastric partitioning 
with free reflux, still had erythema, some 
friability and exudate at 9 months, but at 
30 months, endoscopy showed just 
erythema above the Z-line.
Resting lower esophageal sphincter 
pressure increased from a mean of 7.5 
mm Hg to 17.8 mm Hg (p < 0.01) (Table 
I). The Bernstein test preoperatively gave 
a positive result in four out of six patients, 
but a negative one in all postoperatively. 
The Bernstein test is not infallible in well- 
documented reflux disease; patients 3 and 
5 had severe regurgitation of bitter acid 
juice with choking at night preopera­
tively, without evidence of esophageal 
mucosal sensitivity to acid.
Discussion
With the evolution of operations to 
control reflux, good results are now being 
reported.1-3 However, there are compli­
cations with each repair.9-10 In Polk’s 
312 fundoplications, there was a 7% inci­
dence of splenectomy,11 and Ferraris and 
Sube12 reported an 11% incidence of 
incidental splenectomy. Late dehiscence 
of the fundoplication has been re­
ported.11,12 Other problems associated 
with fundoplication are a 6% to 51 % inci­
dence of “ gas bloat” and dysphagia,12,13 
but these tend to be temporary,14 and the 
operation is highly successful in the 
majority of cases.
Reports about the Angelchik antireflux 
prosthesis indicate that 80% to 100% of 
patients become completely asympto­
m atic.15 No deaths have been reported. 
The main side effect is transient postoper­
ative dysphagia which resolves in 1 to 3 
m onths.14 Patients initially take soft 
foods chewed well or those prepared in 
a blender.
The prosthesis has potential compli­
cations. Migration into the mediasti­
num 14,16,17 can be avoided by approxi­
mating the crura if they are wide apart, 
but without making the hiatus tight.18 
Migration to the pelvis, from knot slip­
page or torn straps, has been report­
ed ,*4,19,20 as originaiiy the straps were 
attached to the edges of the collar. 
Since February 1982, the polyester 
Dacron straps have been circumferential, 
and can no longer be pulled off their 
moorings. Knot slippage is avoided by 
multiple secure knots, with a nonabsorb­
able tie or large clip just beyond the tie, 
or both. Intraluminal erosion10,21 is 
avoided by not using the prosthesis near 
a suture line or over a hole in the esopha-
M.B.
gus. Minimal dissection will prevent the 
prosthesis from moving down the 
stomach.19
Infection is a potential problem with 
any foreign material, but has not been 
reported with this prosthesis. However, 
the device should not be used if bowel dis­
tal to the pyloroduodenal area is opened 
or if the patient has an infection else­
where. The silicone shell should not be 
handled more than necessary because
M.B.
Fig. 3b
(a) before, (b) after operation.
Fig. 3a
FIG. 3—Case 4. Barium studies
J.B. J.B.
Fig. 4a Fig. 4b
FIG. 4—Case 5. Barium studies (a) before, (b) after operation.
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starch from gloves and lint adhere to it 
and could cause fibrosis and stricture, and 
it must not be punctured. If the crura 
have to be approximated, this should be 
done before inserting the prosthesis.22 
We applied the prosthesis directly from 
its inner package or kept it in saline until 
ready for use. The device should proba­
bly not be used in patients with motility 
disorders. Furthermore, there is danger 
of it being used unnecessarily at the end 
of other operations, when the patient has 
a history of reflux. There has been nega­
tive opinion at some academic centres, 
without much basis, regarding use o f the 
prosthesis.23-25 However, we must also be 
cautious of marketing overtures by the 
manufacturers.
The mechanism of action of the Angel- 
chik prosthesis is not settled: the weight 
of the prosthesis may hold the cardia in 
the abdomen, allowing transmission of 
positive intra-abdominal and intragastric 
pressure to the lower esophageal sphinc­
ter;17’26 it may act as a posterior padding 
or buttress, displacing the posterior 
esophageal wall forward and decreasing 
the anterior-posterior diameter of the 
lower esophagus,26'27 or it may interrupt 
transmission of tension in the gastric wall, 
thereby preventing distraction of the 
lower esophageal sphincter.28
The prosthesis effectively controlled 
reflux in our small series of eight patients, 
who were selected because they were not 
good candidates for a standard antireflux 
procedure. Randomized studies compar­
ing the results obtained with this prosthe­
sis to those of the Nissen fundoplication 
are in progress at three separate cen­
tres.16,28-30 Presently, use of the device
should generally be restricted to investiga­
tional centres, with long-term surveil­
lance.
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Fournier’s Gangrene
Fournier's disease — gangrene o f the 
penis and scrotum  — is an uncommon 
condition. During the past 6 years, five  
patients, whose cases are described, 
were adm itted to  Toronto  General Hospi­
ta l w ith  th is  diagnosis. Four had preced­
ing traum a (ischiorectal abscess, punc­
tu re  wound, surgery) and fo u r had 
pre-existing debilita ting problems (dia­
betes, rectal carcinoma, acute lym pho­
cy tic  leukemia, a lcoholic cirrhosis).
Appropriate trea tm ent m ust include 
urgent radical surgery to  remove all
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FIG. 1—Case 1. Early gangrene of penis and scrotum.
necrotic tissue, and com bination antib i­
o tic  therapy directed against the likely 
organisms, w hich are aerobic gram­
negative rods, gram -positive cocci and 
anaerobes. C lindam ycin in combination 
w ith  tobram ycin or gentam icin proved to 
be e ffective  in th is  series.
La maladie de Fournier, so it la gangrene 
du penis e t du scrotum , est une affec­
tion rare qui fu t decrite  pour la premiere 
fo is en 1883. Au cours des 6 dernieres 
annees, cinq patients porteurs de ce dia­
gnostic on t ete hospitalises au Toronto 
General Hospital. Quatre avaient prece- 
demment subi un traum atism e (abces 
ischiorectal, blessure par perforation, chi- 
rurgie) et quatre souffra ient ddja d'une 
maladie debilitante (diabete, cancer du 
rectum, leucemie lym phocyta ire  aigue, 
cirrhose alcoolique).
Le tra item ent approprie necessite un 
traitem ent ch irurg ica l radical d 'urgence 
afin d 'e lim iner to u t tissu necrotique et 
I'adm in istration d 'une antibiotherapie
FIG. 2—Case 1. Appearance after second debridement of necrotic tissue.
efficace contre les microorganismes 
soupconnes, so it les batonnets gram- 
negatifs, les cocci gram -positifs et les 
anaerobies. Une association clindamy- 
c ine-tobram ycine ou clindamycine-genta- 
mycine s 'es t averde efficace dans les cas 
decrits ici.
Fournier’s gangrene — a necrotizing, sub­
cutaneous infection o f the penis and scro­
tum — was first described by the French 
venerologist, Fournier, in 1883.1 He 
reported five previously healthy patients 
in whom the condition was o f abrupt 
onset and progressed rapidly. In that 
preantibiotic era, he stated that the con­
dition was idiopathic.
Today, much more is known about 
Fournier’ s gangrene. Most cases proba­
bly develop by one o f three mechanisms: 
local trauma, extension from a urinary 
tract infection, or extension from the peri­
anal or ischiorectal area.24 Many 
patients have diabetes mellitus or some 
other debilitating condition. Fournier’ s
FIG. 3—Case 1. Penis and abdominal wall were resurfaced with split-thickness skin grafts, testes were buried into subcutaneous pockets in medial thighs.
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gangrene may affect patients of all ages 
— from newborns to the elderly.2’4 The 
typical bacteriologic flora usually includes 
aerobic gram-negative rods, gram­
positive cocci and anaerobes, especially 
Bacteroides fragilis.2'5-6 The condition is 
usually accompanied by fever and toxe­
mia and is often life-threatening.2
During the past 6 years, five patients 
have been referred to the Toronto 
General Hospital for treatment of Four­
nier’s gangrene. This study analyses these 
patients.
Case Reports
Case 1
A 45-year-old man was seen 48 hours after
FIG. 4—Case 2. Appearance after extensive 
debridement of necrotic tissue from penis, scro­
tum and abdominal wall.
drainage of an ischiorectal abscess at another 
hospital. There was massive swelling and cel­
lulitis of the penis, scrotum and lower abdomi­
nal wall (Fig. 1), and a fecal, anaerobic odour. 
Clindamycin (250 mg), penicillin G (2 million 
units) and gentamicin (80 mg) were given 
intravenously, and the patient was prepared 
directly for surgery.
At operation, much of the skin of the penis, 
scrotum and lower abdominal wall was found 
to be devitalized and this was excised. He was 
then treated with hyperbaric oxygen and was 
returned to the operating room for further exci­
sion the following day, at which time the 
remainder of the necrotic skin and soft tissue 
was excised from the involved areas (Fig. 2). 
The exposed areas were treated with wet to dry 
dressings for 10 days, and the penis and 
abdominal wall were resurfaced with split-
FIG. 5—Case 2. Penis and abdominal wall 
have been resurfaced with skin grafts and left 
testicle has been buried into subcutaneous thigh 
pocket.
thickness skin grafts. The exposed testes were 
buried into pockets in the medial portion of 
the thighs (Fig. 3). These wounds healed 
smoothly and the patient was discharged on the 
24th hospital day. He had recurrent bouts of 
lymphangitis of the penis which responded to 
antibiotic therapy but has not had any lym­
phangitis for the past 6 months. He remains 
sexually active and has no other specific 
problems.
Case 2
A 68-year-old man was admitted with 
impending gangrene of the penis, scrotum and 
lower abdominal wall, 2 weeks after he sus­
tained trauma to the perineal region. He had 
accidentally fallen on his lawn-mower and the 
wheel-adjustment lever had pierced his 
perineum! He had swelling and pain in the 
penis and scrotum within 2 days but did not 
seek medical help for a full week. He was then 
given antibiotics to be taken orally. He 
returned several days later with a fully deve­
loped Fournier’s gangrene.
On admission, he was given clindamycin 
(250 mg intravenously) and ampicillin (1 g) and 
operated on immediately. The procedure 
involved radical debridement of the involved 
skin and soft tissue of his penis, scrotum and 
lower abdominal wall (Fig. 4). A large part of 
the abdominal wall was involved. The open 
areas were treated with dressings for about 10 
days and then were covered with split-thickness 
meshed skin grafts. The exposed left testicle 
was placed into a pocket in the left thigh (Fig. 
5). His wounds healed well. He was discharged 
from hospital on the 29th day and has had no 
further problems.
Case 3
A 61-year-old man originally underwent an 
anterior resection of the rectosigmoid colon for 
rectal carcinoma. Subsequently, a colonic 
fistula developed, causing dehiscence of the 
abdominal wound. This was followed by gan­
grene of the scrotum and penis which was 
treated with radical surgery. The exposed areas 
were treated with local skin grafting. He was 
subsequently discharged from hospital and 
made a complete recovery.
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Case 4
In this 71-year-old man, who was a diet- 
regulated diabetic, an ischiorectal abscess deve­
loped which was drained at another hospital. 
Gangrene of the scrotum and penis developed 
and he was admitted through our emergency 
department. Tobramycin, cloxacillin and clin­
damycin were started intravenously. Radical 
debridement and skin grafting were done. He 
had several complications, including tobramy­
cin nephrotoxicity and a fistula-in-ano, but he 
eventually made a full recovery.
Case 5
A 44-year-old man, with a known diagno­
sis of acute lymphocytic leukemia, was admit­
ted with an incarcerated inguinal hernia, alco­
holic hepatitis and Fournier’s gangrene of the 
scrotum, abdominal wall and left upper thigh. 
Unfortunately, he died within hours of admis­
sion. Death was attributed to sepsis.
Discussion
Our five patients with Fournier’s gan­
grene ranged in age from 44 to 71 years. 
All had definite predisposing factors: four 
had a history of local ischial or perineal 
trauma, and four had debilitating condi­
tions (diabetes, rectal carcinoma, leuke­
mia, alcoholic cirrhosis) (Table I).
All five patients were referred to us 
after the diagnosis of Fournier’s gangrene 
had been made. Several had been started 
on antibiotics before they were admitted 
to our hospital. Positive wound cultures 
demonstrated multiple aerobic and 
anaerobic organisms, suggesting the pos­
sibility of a synergistic interaction among 
different bacterial species.2,7 Antibiotic 
therapy was directed against the antici­
pated flora: gram-negative bacilli, gram­
positive cocci and anaerobic bacteria, 
including Bacteroides fragilis (Table I). A 
reasonable choice of antibiotics appeared 
to be clindamycin (for gram-positive and 
anaerobic bacteria) and tobramycin or 
gentamicin (for gram-negative rods).
All patients underwent urgent radical 
surgery with excision of the involved 
necrotic areas. Antibiotics were only an 
adjunct to this more important definitive 
treatment. Three patients had further 
debridement after 24 hours. One patient 
underwent hyperbaric oxygen therapy. 
This may be useful but only in addition 
to surgery and appropriate antibiotic 
therapy.
Each of our surviving patients under­
went a single uncomplicated skin-grafting 
procedure 10 to 14 days after the initial
operation. In two, exposed testes were 
placed into subcutaneous pockets in the 
medial part of the thigh. Secondary scro­
tal reconstruction8 was considered in two 
others, but was declined.
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The Military Surgeon — Not Least
*
►
a
i
i
►
i r 
►
>
The h istory o f the  surgeon in warfare is 
briefly reviewed. The steady im prove­
m ent in m orta lity  and m orb id ity  in the 
major wars o f the 20 th  cen tury has been 
based on a melding of sound surgical 
and medical m ilitary principles.
A number o f points are emphasized. 
Care in the fo rw ard  area is directed 
tow ards those measures th a t w ill 
preserve life and fac ilita te  early and com ­
fortab le  evacuation to  fo rw ard  surgical 
hospitals. Triage is v ita l a t th is level w ith  
criteria fo r admission to  hospita l depend­
ing at any one tim e on casualty loads 
and surgical potentia l, the  remaining 
patients being sent to  large and relatively 
fixed hospitals in the rear. A ll selected 
patients are adm itted to  a resuscitation 
ward where, a fte r thorough evaluation, 
life-saving measures are ins titu ted  and 
blood-volume defic its  rapidly replaced 
before operation. The aim is to  debride 
thoroughly all w ounds w ith in  8 hours of 
injury. The w ounds are le ft open and 
dressed to  be fo llow ed by delayed 
prim ary closure in 7 to  10 days. Repara­
tive  surgery, except to  save lim b or life, 
is undertaken only when the wound has 
healed.
The author reminisces about some 
Canadian m ilitary surgeons he has 
know n and relates some surgical vig­
nettes from  the tw o  w ars in w h ich  he 
participated.
On examine brievem ent I'h is to ire  du chi- 
rurgien dans la guerre. Le declin conti­
nue! dans la m orta lite  et la morbidite 
durant les guerres majeures du XXeme 
siecle a ete base sur une combinaison de 
principes solides chirurg icaux et mili- 
taires.
On accentue les points qui suivent.
Les soins dans la zone avancee sont
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bases sur les mesures qui sauveront la 
vie et fac ilite ron t l'6vacuation  rapide et 
confortable vers les hopitaux ch irurg i­
caux avances. Le triage des patients est 
v ita l a cette etape, et les e n tire s  pour 
admission a I'hop ita l dependent en to u t 
tem ps du nombre de blesses et le p o ten ­
tia l chirurgical. Les autres blesses son t 
envoy6s aux hopitaux plus spacieux et 
plus permanents a I'arriere. Tous les 
blesses admis a I'hop ita l dans la zone 
avancee sont places dans une salle de 
resuscitation et evalues a fond. Les 
mesures de resuscitation sont entreprises 
et les defic its  de volum e sanguin sont 
remplaces rapidem ent avant la ch irurg ie. 
Ensuite, le but est de debrider a fond  
toutes les blessures durant les premieres 
8 heures. Les blessures demeurent 
ouvertes et pansees et puis sont ferm ees 
en seconde in tention  7 a 10 jours plus 
tard. On n'entreprend la chirurgie repara- 
trice que quand une blessure est guerie, 
sauf quand il y a necessity de sauver le 
membre ou la vie.
En term inant, I'au teur raconte ses sou­
venirs de quelques chirurgiens m ilita ires 
canadiens q u 'il a connu et fa it le rec it de 
quelques v ignettes chirurgicales qui ont 
eu lieu pendant les guerres dans lesquel- 
les il a participe.
Civilian surgery is an ongoing process 
with a constant improvement in diagno­
sis, treatment and technique. But the prin­
ciples of military surgery, so dearly 
learned during a war, are quickly forgot­
ten in peacetime only to be expensively 
relearned by a new generation forced to 
participate in another conflict.
Most members of the present Canadian 
medical profession have had no more 
than a fleeting contact with military sur­
gery. Furthermore, no medical student, 
intern or resident in Canada has had any 
exposure to the principles of military 
surgery.
As this is the 25th anniversary of the 
Canadian Forces Medical Service, and 40 
years since “ D Day” , it is appropriate to 
review briefly the role of the military sur­
geon in warfare and to discuss some of 
the reasons for the improvements in sur­
in the Crusade
gical results made in each new war. 
Finally, I would like to reminisce for a 
moment about some Canadian military 
surgeons I have known.
Historical Background
One would think that in the long his­
tory of military conflict the treatment of 
the battle casualty should have been of 
prime importance to the military com­
manders, for the saving of life or limb fre­
quently meant that the soldier could fight 
another day.1 Another equally important 
consideration was not only humanitarian 
but one of morale.2 A soldier who could 
face sudden death from enemy action 
with equanimity might well give way 
when confronted with the prospect of 
dying on the battlefield in agony from a 
mutilating wound without receiving med­
ical attention.
Unfortunately, these considerations 
were ignored in most wars for many cen­
turies.
Early Wars
The battle of Waterloo was fought on 
June 15, 1815.3 Nine hours of fighting 
left more than 40 000 men lying dead and 
wounded in an area little more than 
5 km2. Evacuation of the casualties was 
haphazard. Some of the wounded were 
transported the 32 km to Brussels in 
rough army wagons or were carried on 
stretchers by regimental bandsmen. Many 
were left to make their own way either on 
horseback or on foot and many more 
were left on the battlefield to die. Some 
of the available medical officers carried 
out first aid on the battlefield, but most 
remained in Brussels.
Some 10 000 soldiers died under hor­
rible circumstances in the Crimea in 
1854,3 many of them in the mud of the 
battlefield as, once again, no organized 
evacuation was available. Of those able 
to make their way to hospital, many died 
in the filthy, pest-ridden barracks hospi­
tal at Scutari.
Fewer than 100 years ago, Rudyard 
Kipling gave this grim advice in the poem 
“ The Young British Soldier” :
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When you’re wounded and lie on 
Afghanistan’s Plains,
And the women come out to cut up 
what remains,
Jest roll to your musket and blow 
out your brains
An’ go to your Gawd like a Soldier.
Indeed, it was not until the turn of the 
20th century, with the formation of the 
British4 and Canadian5 medical corps, 
that military commanders reluctantly 
accepted medical units with fixed estab­
lishments in the battle plan.
Military surgeons quickly discovered 
that war wounds had dire consequences 
for the soldier and the more sophisticated 
the weapon, the more complicated was 
the injury. Serious wounds in most cases 
led to death. However, if the soldier did 
survive the initial wound he could then 
look forward, all too frequently, to infec­
tion, gangrene, secondary hemorrhage, 
amputation and eventually death or per­
manent deformity or disability.
Many bizarre methods of treatment 
were used.6 In the 16th century it was 
common practice to cauterize gunshot 
wounds with boiling water mixed with 
treacle and to use boiling pitch to control 
secondary hemorrhage. These forms of 
treatment proved so unsatisfactory and 
the mortality from gangrene was so high 
in the hospitals that wholesale amputa­
tion became the treatment of choice.7 It 
was thought better to remove the limb 
and have a live patient. Unfortunately, 
amputation did little to prevent infection 
and death.
World War I
At the outbreak of World War I on 
Aug. 4, 1914, the answers to the myster­
ies of the wounds of war seemed to have 
been solved. Pasteur had discovered bac­
teria and, as a result, Lister advocated 
antisepsis. It is little wonder then that the 
surgeons set out for France with high 
hopes and gallons of antiseptics. Further­
more, new mobile forward medical units, 
the field ambulance and the casualty 
clearing station were to assure adequate 
first aid and early evacuation of casual­
ties.
Unfortunately, this is not how it 
worked out. Because of overwhelming 
numbers of wounded, surgery was often 
delayed up to 48 hours. Moreover, the 
increased destructive power of the new 
types of missile inflicted severe and com­
plicated injuries. The mortality, although 
improved, was anything but satisfactory. 
Infection and gas gangrene remained a 
problem. Amputation rates were unac­
ceptably high, soldiers continued to die 
of shock in spite of a very limited use of 
blood, and the head, abdominal and chest 
wounds were fatal in more than half the 
cases.
There was one bright spot — with the
introduction of antitoxin, tetanus was 
almost eliminated.
At the end of this terrible war, there 
were 2 000 000 battle casualties, 700 000 
deaths and a hospital mortality of over 
120/o.6
Unfortunately, the answer to the treat­
ment of war wounds did not lie with 
antiseptic irrigations — the solution 
would have to await another conflict.
World War II
World War II saw the introduction of 
the advanced surgical centre (ASC).8 
These units were located as far forward 
as possible to facilitate early surgery. 
They consisted of a casualty clearing sta­
tion or field dressing station as the par­
ent unit, with a field surgical unit and 
field transfusion unit attached. The field 
surgical and field transfusion units were 
small and self-contained, with complete 
facilities in personnel and equipment 
(including canvas and transportation) for 
forward surgery or resuscitation. The 
great advantage was that they could be 
quickly attached to or detached from a 
parent unit as tactics demanded.
The ASC screened all cases coming 
from the front, the sorting being carried 
out in a large unobstructed admission 
area by skilled triage surgeons and staff. 
Triage was vital at this level, for mistakes 
were frequently fatal.
Approximately 15% of patients were 
admitted to the ASC. The remaining 85% 
were evacuated to larger and relatively 
fixed hospitals in the rear. The wounded 
who were admitted included all patients 
in shock, those with penetrating abdomi­
nal and chest wounds, amputations, 
femoral fractures and major vascular 
injuries. Soldiers with head and maxil­
lofacial injuries were transferred to spe­
cial centres located close behind the 
ASCs.
All patients were admitted to the resus­
citation ward. This was also a large unob­
structed area where their condition was 
thoroughly evaluated. Wounds of en­
trance and exit were noted and resulting 
organ and limb damage was assessed. 
Life-saving measures were instituted and 
blood-volume deficits rapidly restored 
with whole blood and electrolyte solutions 
before operation.
It became evident in 1940, as shown by 
the excellent results of Trueta9 in the 
Spanish Civil War and by a very limited 
number of surgeons in World War I,10 
that the terrible infection rate of previ­
ous wars could be prevented by early 
debridement of all wounds.11 By 
debridement was meant the enlargement 
of the wounds of entrance and exit and 
the removal of all dead and devitalized 
skin, subcutaneous tissue, fat, muscle and 
detached bone fragments with muscle 
debridement being continued until only
pink bleeding and contracting muscle 
remained. Fasciotomies were done, as 
indicated, to relieve tension and ensure 
drainage of subfascial hematomas.
Minimal reparative surgery was under­
taken deep to the skin except for those 
structures that needed restored function 
to maintain life or limb, such as a rup­
tured small bowel or severed femoral 
artery. Following debridement, the 
wounds were drained and, most impor­
tantly, left open. Pressure dressings were 
applied and splinting was used as indi­
cated. In approximately 7 days the previ­
ously debrided wounds were closed by 
direct suture, rotation flap or skin graft. 
These principles were enthusiastically 
incorporated in the battle plan of the sur­
geons in the desert and in Europe.
The results were indeed rewarding. The 
answer to gas gangrene and the infected 
wound had arrived. The hospital mortal­
ity in World War II was reduced to 
4.5% .12
Morbidity was also reduced; the frac­
tured femur was an excellent example.13 
After initial debridement and immobili­
zation in a Tobruk splint in the forward 
area, these patients were evacuated to the 
base hospital where delayed primary 
closure was done. They were then placed 
in balanced traction with a tibial tuber­
cle pin, and knee-joint movement was 
begun early. When the fracture was con­
sidered to be stable, they were immobi­
lized in a spica cast and sent home.
Recent Wars
Advances in the Korean War included 
repair of major arterial injuries, the treat­
ment of post-traumatic renal insufficiency 
and the introduction of helicopter evacu­
ation.
Before the Korean War, ligation was 
the accepted treatment of major arterial 
injuries, resulting in an amputation rate 
of 50% in World War II. In the Korean 
conflict, direct arterial repair was 
attempted in 304 cases of major arterial 
injury with an overall amputation rate of 
16.5%.14 End-to-end anastomosis with­
out tension was possible in 40%. In the 
remaining 60% an autogenous vein graft 
was inserted between the divided ends.
Post-traumatic renal insufficiency in 
battle casualties was first described in 
World War II in crush victims and later 
was recognized as a delayed cause of 
death in many who had sustained a pro­
longed period of shock. No satisfactory 
treatment was available and most estab­
lished cases proved fatal. In Korea a 
renal centre was established behind the 
mobile army surgical hospital (MASH) 
units where soldiers in whom oliguria 
developed were evacuated by helicop­
ter.15’16 Of these patients, 50% were 
treated successfully by conservative meas-
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ures. Of the remaining 50% who were 
treated by dialysis, 50% survived.
A limited number of helicopters were 
made available as airborne ambulances. 
They could transport two patients in 
pods. This resulted in rapid and comfort­
able evacuation of certain severely 
wounded patients, with the saving of 
lives. The overall hospital mortality in the 
Korean War was 2.5% .12
In Vietnam, helicopter evacuation of 
all wounded was introduced.17 These 
large machines carried up to nine patients, 
who received resuscitation en route. 
Casualties were in hospital 1 to 2 hours 
after wounding.
Resuscitation became more sophisti­
cated, with much improved monitoring of 
patients pre- and postoperatively. An 
interesting beneficial effect of early resus­
citation was that post-traumatic renal 
insufficiency as seen in Korea was almost 
nonexistent,18 the marked reduction in 
the incidence of severe and prolonged 
hypotension being a major factor.
In contrast to what happened in the 
Korean War, all major arterial injuries 
were repaired, surgeons with vascular 
training being available in each forward 
surgical centre. A thousand cases were 
reported by Rich and associates19 with 
an amputation rate of 13.1%.
It was learned the hard way in previ­
ous wars that thoracotomy should be 
reserved for the patients with chest 
wounds who continue to bleed in spite of 
chest-tube drainage and adequate resus­
citation.20 These principles were accepted 
in Vietnam. With better resuscitation and 
more successful repair of heart, lung and 
great-vessel injuries, an overall mortality 
of 2.9% was reported.20,21
Wounds of the abdomen have always 
been an enigma to the military surgeon. 
Laparotomy was first used in World War 
I with disastrous results — more than half 
the patients died. In World War II and 
the Korean War earlier evacuation, avail­
ability of blood-electrolyte solutions and 
penicillin, the use of nasogastric suction 
and the standardization of treatment such 
as exteriorization of all colonic injuries 
and the direct suture of small-bowel 
wounds, reduced the mortality to 20%.22
In two series from Vietnam, mortali­
ties of 10% in 135 cases and 2.4% in 358 
cases of penetrating abdominal wounds 
were reported.23,24 Four factors seem to 
be largely responsible for this improve­
ment in mortality:
• Rapid evacuation and effective resus­
citation made early surgery possible with 
a decrease in the incidence of peritonitis 
and other sequelae.
• Substantial improvements in opera­
tive technique made possible better con­
trol of hemorrhage from the liver,25,26 
the exploration of all retroperitoneal 
hematomas with the recognition and
repair of duodenal, kidney and pancreatic 
wounds, and major vascular injuries and 
improvement in handling wounds of the 
rectum27 and right colon.28
• Improved anesthesia.
• Improved postoperative care.
In Vietnam the hospital mortality was 
2.6%, approximately the same as in 
Korea. However, helicopter evacuation 
brought into the hospital many seriously 
wounded patients who would have died 
en route in other wars. A better index is 
the ratio of soldiers killed in action to 
those wounded in action. In Korea it was 
1:4.1. In Vietnam 1:5.6.12
Reminiscences
To reminisce about the two wars in 
which I did surgery will bring back 
memories to some, but most will have had 
no firsthand knowledge of these conflicts. 
I hope that these reminiscences will tell 
the story of the Canadian military sur­
geon in action — his heartaches, frustra­
tions, failures and successes.
Dr. Angus McLaughlin, Professor of 
Surgery at the University of Western 
Ontario, recently made two interesting 
points concerning forward surgery in 
World War II: first, that his approach to 
many surgical problems had been greatly 
influenced by his experience as a military 
surgeon; he quoted his pioneer work in 
delayed primary skin closure29 of con­
taminated abdominal wounds and in the 
surgical management of diabetic gan­
grene,30 and second, that the lasting 
friendships he made during the war with 
surgeons across Canada facilitated the 
setting up of residency systems and new 
departments and divisions of surgery. As 
a result, the value of the Canadian fellow­
ship in surgery, a hallmark of surgical 
competence, was established.
During World War II, Dr. Ross Tilley 
served with distinction as chief of surgery 
in the Royal Canadian Air Force plastic 
surgical wing of the Queen Victoria 
Hospital at East Grinstead, England. He 
was one of the pioneers in the saline treat­
ment of burns and performed the plastic 
surgery on most of the Canadian airmen 
who were burned in action — an extraor­
dinary experience. Many of his grateful 
patients, who call themselves the “ Guinea 
Pigs” , are still alive and meet regularly, 
at which time they honour their surgeon.
Dr. D.L.C. Bingham, Professor Emeri­
tus of Surgery at Queen’s University, did 
forward surgery in North Africa on the 
wounded of the famous Eighth Army. 
This surgery was often done under appall­
ing conditions, with limited supplies and 
frequently when in retreat. A distin­
guished gentleman and always a friend of 
the armed forces, he is now retired and 
lives on the west coast.
Dr. John Hillsman was born in Vir­
ginia but married a Winnipeg girl and set 
up practice there before the war. He 
looked and talked exactly like General 
George Patton. He always wore his steel 
helmet, even in the operating room, and 
his pistol was also worn at the ready, for 
he disdained the Red Cross arm band. He 
was a superb and fearless surgical tech­
nician. He diagnosed and operated on 
four patients with wounds of the heart, 
two of whom survived. He was the author 
of the book entitled “ Eleven Men and a 
Scalpel” ,31 in which he accurately 
describes the battle conditions confront­
ing the new military surgeon, who had no 
comparable experience in civilian life.
We operated in Secqueville for ten days and 
covered the attack that took the City of Caen. 
During those ten days we changed from mere 
soldiers to war-wise veterans. We saw the tragic 
sights from which we were never to be free for 
ten long months. Men with heads shattered and 
grey, dirty brains oozing out from the jagged 
margins of skull bones. Youngsters with holes 
in their chests fighting for air and breathing 
with a ghastly sucking noise. Soldiers with 
intestines draining feces onto their belly walls 
and with their guts churned into a bloody mess 
by high explosives. Legs that were dead and 
stinking — but still wore a muddy boot. Oper­
ating floors that had to be scrubbed with lysol 
to rid the Theatre of the stench of dead flesh. 
Red blood that flowed and spilled over while 
life held on by the slender thread of time. Boys 
who came to you with a smile and died on the 
operating table. Boys who lived long enough 
for you to learn their names and then were car­
ried away in trucks piled high with the dead. 
We became the possessors of bitter knowledge 
that no man had ever been able to describe. 
Only by going through it do you possess it.
No. 3 Canadian casualty clearing sta­
tion was set up in Nijmegen, Holland, in 
December 1944. When I came on duty to 
work the evening shift in resuscitation, a 
patient was admitted in profound shock 
with a German bomb, 75 x  4.5 cm, pro­
truding from his left lower quadrant. 
Roentgenograms showed the head firmly 
imbedded in the left sacroiliac joint. 
Would dislodging the bomb from the 
bone be sufficient to detonate it? The 
officer in charge of surgery was the late 
Dr. Lawrence Rabson from Winnipeg. 
After the patient was resuscitated and 
anesthetized, Dr. Rabson made everyone, 
including the anesthetist, leave the oper­
ating room. With great difficulty he 
extracted the bomb. It didn’t explode. We 
then returned to the operating room 
and completed the operation. Unfor­
tunately, the patient died. Rabson was 
nominated for the Distinguished Service 
Order but he was turned down.
The Canadian field surgical team in 
Korea was attached to 8055 MASH. Dr. 
Richard Hooker was a surgical staff 
member and author o f the book 
“ MASH” . Those of us who knew the
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MASH could probably identify the 
characters in the television series. Dr. 
Gerry Lippart was the first commanding 
officer o f the team. He is now practising 
in Kitchener-Waterloo. He was followed 
by the late Dr. Alan Davidson, a perma­
nent service officer.
Summary
I have attempted to outline the princi­
ples o f military surgery that have evolved 
in the major wars of the 20th century. 
With the advent of each new war, the 
young civilian surgeon must learn these 
principles and at the same time bring to 
the field new surgical skills acquired 
between the wars. When the war is finally 
over and he makes the long journey 
home, he brings with him a unique 
experience that will be a stimulus to him 
in civilian surgery.
A  quotation from Brigadier Price’s 
“ The Hymn to the Fallen” of the Royal 
Army Medical Corps seems also to be a 
fitting tribute to my comrades-in-arms — 
the military surgeons.
Unarmed they bore an equal burden
Shared each adventure undismayed
Not less they earned the victors 
guerdon
Not least were they in the Crusade.
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BOOK REVIEW S  
continued from page 137
and discussed. However, no mention is made 
of skin expansion techniques which surely must 
be included for completeness if future editions 
are planned.
The chapters on reconstruction of the nip­
ple areolar complex and the management of 
congenital malformations of the thoracic area 
are concise and include a detailed discussion 
of Poland’s syndrome. The chapter on the tho­
rax as a donor site for various flaps is also of 
interest. The authors conclude with a chapter 
on the management of lymphedema; the sub­
ject is presented briefly, but the main points 
of controversy are mentioned.
In summary, this new textbook represents 
the combined experience of three surgeons with 
extensive clinical knowledge. The various 
procedures are presented in a logical manner 
and the diagrams are excellent. 1 recommend 
it for medical libraries and as an addition to
the personal libraries of surgeons particularly 
interested in breast reconstruction.
H. Bruce Williams, md, frcsc
Director, Division of Plastic and 
Reconstructive Surgery,
Montreal General Hospital,
Montreal, PQ 
H3G 1A4
SURGERY OF THE SKULL BASE. Edited 
by Clarence T. Sasaki, Brian F. McCabe 
and John A. Kirchner. 254 pp. Illust. J.P. 
Lippincott Company , Philadelphia, 1984. 
$72.50 (US). ISBN 0-397-50513-2.
This book is an outline to surgery of the skull 
base. The text is edited by three otolaryngolo­
gists but emphasizes the combined approach 
to this region, involving the expertise of the 
neurologic surgeon, the otolaryngologist and 
the plastic surgeon.
Each chapter, written in a similar format by
authors from various disciplines, lists an out­
line of the relevant surgical anatomy of the 
skull base, as well as the indications for each 
surgical approach. The surgical technique is 
described and well illustrated by black and 
white photographs and drawings. Instruments 
and equipment required, as well as a diagram 
of the arrangement of the operating room, are 
included. Postoperative complications are 
briefly discussed. Each chapter contains a limi­
ted but adequate reference section.
I found the text easy to read despite the 
multiple-author format. This text would be of 
use to residents in training with an interest in 
surgery of the skull base, and to the 
experienced surgeon as a simple guideline and 
concise reference.
Martin J. Black, md, frcsc
Chief, Department of Otolaryngology,
The Sir Mortimer B. Davis-
Jewish General Hospital,
Montreal, PQ 
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DIRECTOR OF MEDICAL/SURGICAL 
INTENSIVE CARE UNIT
The Moncton Hospital, a teaching 540-bed regional 
hospital is looking for an intensivist to direct a 
Medical/Surgical Intensive Care Unit of 18 beds.
The hospital serves as a tertiary centre to a population 
base of over 200 000 people and has five intensive care 
units.
The candidate is expected to provide leadership, advice 
and guidance to all staff in the Medical/Surgical Unit and 
for all staff involved in the care of seriously ill or injured 
patients.
Candidates should be qualified in Intensive Care, i.e., 
FRCPC in Surgery, Anesthesia or Internal Medicine with 
Fellowship in Intensive Care or at least 1 year's formal 
training in Intensive Care.
Applications may be submitted in confidence to:
Dr. Ginette Gagne-Koch 
Medical Director 
The Moncton Hospital 
135 MacBeath Avenue 
Moncton, NB
E1C 6Z8 -S85-10
ORTHOPAEDIC SURGEON TO BE CHIEF 
OF SURGERY
ORTHOPAEDIC AND ARTHRITIC HOSPITAL 
43 Wellesley Street East 
Toronto, Ontario
The Orthopaedic and Arthritic Hospital, a 140-bed fully ac­
credited facility in downtown Toronto, is actively recruiting an 
academic orthopaedic surgeon to be its Chief of Surgery.
The hospital offers opportunities for patient care, research and 
teaching in the midst of a vibrant setting.
The hospital's orthopaedic service is affiliated with the Faculty 
of Medicine, University of Toronto, and consists of 100 beds, a 
new 8-bed day surgery unit and busy outpatient clinics. There 
are currently five full-time orthopaedic surgeons on staff as well 
as six part-time staff.
Our rheumatology service consists of 27 beds and busy outpa­
tient clinics; expansion of the rheumatology service is also in 
progress. We have three full-time rheumatologists on staff and 
plans to increase this number to five in the near future. There are 
also four internists on staff.
Income on a fee-for-service basis. Remuneration and support 
of administrative and academic functions to be negotiated.
This is a challenging position and applicants are requested to 
send their resume, in confidence, by April 30, 1985, to:
Chairm an, Search Com m ittee  
Chief of Surgery 
c /o  M r. B .J. Monaghan  
A dm inistrator
Orthopaedic and A rthritic  Hospital 
43 W ellesley S treet East 
Toronto , Ontario
M 4Y 1H1 -S85-12
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GENERAL SURGEON
A general surgeon is required im­
mediately to take up practice in a 
66-bed, accredited general hospital in 
Napanee, Ontario.
Experience in gynecological and 
orthopedic procedures would be an 
asset.
The hospital, serving a population 
of 30 000 has an active medical staff 
of 12 general practitioners, an inter­
nist, a radiologist and a pathologist.
Napanee is located in a scenic part 
of eastern Ontario close to the lake, 
and with convenient access to a 
variety of recreational activities.
Applicants should submit their cur­
riculum vitae in confidence to:
Dr. Paul Kenny, Chief of Staff 
Lennox and Addington County 
General Hospital 
8 Park Street 
Napanee, Ontario
K7R 2Z4 -S85-07
CHIEF, DIVISION OF CARDIAC SURGERY:
NF — Health Sciences Centre, St. John's, 
Newfoundland. The successful candidate will 
be responsible to the Chairman of Surgery for 
clinical, administrative and academic leadership 
to the Division of Cardiac Surgery at the major 
teaching institution of Memorial University 
Medical School. Approximately 300 adult pump 
cases are undertaken per year in the hospital. In 
addition the Division of Cardiac Surgery plays a 
role in the undergraduate teaching and in the 
General Surgical Residency Training Program. 
There are active clinical and basic research pro­
grams. Applicants should submit an up-to-date 
curriculum vitae together with the names of two 
referees to: Dr. C. Heughan, Chairman of 
Cardiac Surgery Search Committee, De­
partment of Surgery, Health Sciences Cen­
tre, St. John's, NF A1B 3V6 by April 15, 1985
S85-09
GENERAL SURGEON: ON — required for clean, 
congenial, northern community of 3000. Total 
population 18 000 served by two hospitals in town. 
Thirteen GPs including four GP/anesthetists. 
Ob/gyn/ortho an asset. Underserviced area grant 
available. Dr. R. Minty, PO Box 489, Sioux 
Lookout, ON P0V 2T0, (807) 737-3803. -  S85-06
ORTHOPEDIC SURGEON: ON -  Busy modern 
350-bed Toronto suburban hospital requires an or­
thopedic surgeon with fellowship. Reply in con­
fidence to: Box S107, CJS. S85-11
GENERAL SURGEON 
ONTARIO
Required to replace a general surgeon retiring 1985 03 
31 in the community of Arnprior, situated on the Ottawa 
River approximately 70 km from Ottawa.
Fully accredited 50 acute and 20 chronic care bed 
hospital with two ORs. Practice draws from a communi­
ty population of 6000 and a catchment area of approx­
imately 14 000. Current medical staff includes nine 
general practitioners and two general surgeons.
Excellent schools and recreational area including golf 
courses, curling club, ski hills nearby and a community 
centre.
Apply to:
Lt. Col. J.A. Gaumond (Ret.), Chairman
Arnprior & District Memorial Hospital Board 
350 John St. N., Arnprior, ON K7S 3H4
-S85-08
SURGICAL RESEARCH FELLOW 
INTESTINAL TRANSPLANTATION
A 1-2 year research fellowship at the Toronto 
General Hospital, University of Toronto. Techni­
ques of canine and rat intestinal transplantation 
and transplant immunology will be learned. 
Surgical experience necessary, Computer 
knowledge helpful.
For more information contact:
Dr. Zane Cohen 
Toronto General Hospital 
101 College St., 9E-211 
Toronto, ON M5G 1L7
(416) 595-3846 -S85-05
GENERAL SURGEON: — with training and ex­
perience in fracture surgery. The opening is 
available immediately with staff privileges at St. 
Mary's General Hospital, an 184-bed active treat­
ment facility. This is an excellent opportunity to take 
over an established practice in a district referral cen­
tre, with private office space available in a 
downtown professional building. The call schedule 
is shared in cooperation with three other certified 
general surgeons. Canadian certification is required. 
For further information contact: Mrs. Irene Krys, 
Acting Executive Director, St. Mary's General 
Hospital, 41 Pine St. N., Timmins, ON P4N 6K7. 
Tel: (705) 267-2131, or Dr. Peter Richardson, 
Chief of Staff, St. Mary's General Hospital. 
Tel: (705) 264-2368 or 235-2834. S85-13
CHIEF OF SURGERY 
Victoria Hospital Corporation 
London, Ontario
This 835-bed university affiliated active treatment 
teaching and research hospital requires a Chief of 
Surgery to direct a department with large outpatient 
and inpatient facilities in the existing and developing 
new hospital complex. The successful candidate will 
assume adm inistrative duties and coordinate 
undergraduate and postgraduate teaching. He/She 
must be licensed in the Province of Ontario and hold a 
Certificate of the Royal College of Physicians and 
Surgeons of Canada. A teaching appointment at the 
University of Western Ontario, at an appropriate 
academic rank, usually accompanies this position.
Applications with a curriculum vitae and the names of 
three references should be sent to: The Chairman, 
Joint Selection Committee for Chief of Surgery, 
c/o Executive Offices, Victoria Hospital Corpora­
tion, 375 South St., London, ON N6A 4G5. S85-14
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